US20230023141A1 - Sorbitan esters and process for enzymatically preparing same - Google Patents
Sorbitan esters and process for enzymatically preparing same Download PDFInfo
- Publication number
- US20230023141A1 US20230023141A1 US17/757,528 US202017757528A US2023023141A1 US 20230023141 A1 US20230023141 A1 US 20230023141A1 US 202017757528 A US202017757528 A US 202017757528A US 2023023141 A1 US2023023141 A1 US 2023023141A1
- Authority
- US
- United States
- Prior art keywords
- sorbitol
- evonik
- gmbh
- acid
- lipase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 76
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical class OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 title claims description 27
- -1 sorbitan carboxylates Chemical class 0.000 claims abstract description 101
- 230000002255 enzymatic effect Effects 0.000 claims abstract description 12
- 238000002360 preparation method Methods 0.000 claims abstract description 9
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 152
- 239000000203 mixture Substances 0.000 claims description 152
- 239000000600 sorbitol Substances 0.000 claims description 152
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 83
- 108090001060 Lipase Proteins 0.000 claims description 52
- 239000004367 Lipase Substances 0.000 claims description 52
- 102000004882 Lipase Human genes 0.000 claims description 52
- 150000001733 carboxylic acid esters Chemical class 0.000 claims description 52
- 235000019421 lipase Nutrition 0.000 claims description 52
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 40
- 239000000194 fatty acid Substances 0.000 claims description 40
- 229930195729 fatty acid Natural products 0.000 claims description 40
- 125000002252 acyl group Chemical group 0.000 claims description 34
- 150000004665 fatty acids Chemical class 0.000 claims description 33
- KLDXJTOLSGUMSJ-JGWLITMVSA-N Isosorbide Chemical compound O[C@@H]1CO[C@@H]2[C@@H](O)CO[C@@H]21 KLDXJTOLSGUMSJ-JGWLITMVSA-N 0.000 claims description 17
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 17
- MPCAJMNYNOGXPB-SLPGGIOYSA-N 1,5-anhydro-D-glucitol Chemical compound OC[C@H]1OC[C@H](O)[C@@H](O)[C@@H]1O MPCAJMNYNOGXPB-SLPGGIOYSA-N 0.000 claims description 16
- MCHWWJLLPNDHGL-JGWLITMVSA-N (2s,3s,4s,5r)-2,5-bis(hydroxymethyl)oxolane-3,4-diol Chemical compound OC[C@H]1O[C@@H](CO)[C@@H](O)[C@@H]1O MCHWWJLLPNDHGL-JGWLITMVSA-N 0.000 claims description 15
- 150000001735 carboxylic acids Chemical class 0.000 claims description 14
- 230000032050 esterification Effects 0.000 claims description 14
- 238000005886 esterification reaction Methods 0.000 claims description 14
- 239000003755 preservative agent Substances 0.000 claims description 12
- 230000002335 preservative effect Effects 0.000 claims description 12
- 229960002479 isosorbide Drugs 0.000 claims description 11
- 239000011541 reaction mixture Substances 0.000 claims description 11
- 239000002904 solvent Substances 0.000 claims description 9
- 150000001413 amino acids Chemical class 0.000 claims description 8
- 125000004432 carbon atom Chemical group C* 0.000 claims description 7
- 239000003795 chemical substances by application Substances 0.000 claims description 6
- 241001661345 Moesziomyces antarcticus Species 0.000 claims description 4
- 239000004480 active ingredient Substances 0.000 claims description 4
- 239000003995 emulsifying agent Substances 0.000 claims description 4
- 239000006260 foam Substances 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- 230000000845 anti-microbial effect Effects 0.000 claims description 3
- 239000003974 emollient agent Substances 0.000 claims description 3
- 150000008028 secondary esters Chemical class 0.000 claims description 3
- 241000228245 Aspergillus niger Species 0.000 claims description 2
- 241000222175 Diutina rugosa Species 0.000 claims description 2
- 241001373560 Humicola sp. Species 0.000 claims description 2
- 101710098556 Lipase A Proteins 0.000 claims description 2
- 101710099648 Lysosomal acid lipase/cholesteryl ester hydrolase Proteins 0.000 claims description 2
- 102100026001 Lysosomal acid lipase/cholesteryl ester hydrolase Human genes 0.000 claims description 2
- 241001507683 Penicillium aurantiogriseum Species 0.000 claims description 2
- 235000002245 Penicillium camembertii Nutrition 0.000 claims description 2
- 241000235402 Rhizomucor Species 0.000 claims description 2
- 241000235403 Rhizomucor miehei Species 0.000 claims description 2
- 241000235545 Rhizopus niveus Species 0.000 claims description 2
- 240000005384 Rhizopus oryzae Species 0.000 claims description 2
- 235000013752 Rhizopus oryzae Nutrition 0.000 claims description 2
- 241000223258 Thermomyces lanuginosus Species 0.000 claims description 2
- NGXUUAFYUCOICP-UHFFFAOYSA-N aminometradine Chemical group CCN1C(=O)C=C(N)N(CC=C)C1=O NGXUUAFYUCOICP-UHFFFAOYSA-N 0.000 claims description 2
- 239000011230 binding agent Substances 0.000 claims description 2
- 238000005260 corrosion Methods 0.000 claims description 2
- 230000007797 corrosion Effects 0.000 claims description 2
- 239000002270 dispersing agent Substances 0.000 claims description 2
- 239000003906 humectant Substances 0.000 claims description 2
- 239000003112 inhibitor Substances 0.000 claims description 2
- 239000002736 nonionic surfactant Substances 0.000 claims description 2
- 239000003605 opacifier Substances 0.000 claims description 2
- 239000008375 oral care agent Substances 0.000 claims description 2
- 239000003381 stabilizer Substances 0.000 claims description 2
- 101710098554 Lipase B Proteins 0.000 claims 1
- 241000228147 Penicillium camemberti Species 0.000 claims 1
- 239000004599 antimicrobial Substances 0.000 claims 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 123
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 89
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 76
- 235000011187 glycerol Nutrition 0.000 description 59
- 239000002253 acid Substances 0.000 description 44
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 44
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 39
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 36
- 238000009472 formulation Methods 0.000 description 32
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 29
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 27
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 27
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 26
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 25
- 239000006210 lotion Substances 0.000 description 25
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 24
- 239000000047 product Substances 0.000 description 24
- 108090000790 Enzymes Proteins 0.000 description 23
- 102000004190 Enzymes Human genes 0.000 description 23
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 22
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 22
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 22
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 22
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 22
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 22
- 229960002216 methylparaben Drugs 0.000 description 22
- 240000002989 Euphorbia neriifolia Species 0.000 description 21
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 20
- 229940100555 2-methyl-4-isothiazolin-3-one Drugs 0.000 description 20
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 20
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 20
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 20
- BEGLCMHJXHIJLR-UHFFFAOYSA-N methylisothiazolinone Chemical compound CN1SC=CC1=O BEGLCMHJXHIJLR-UHFFFAOYSA-N 0.000 description 20
- PXTQQOLKZBLYDY-UHFFFAOYSA-N bis(2-ethylhexyl) carbonate Chemical compound CCCCC(CC)COC(=O)OCC(CC)CCCC PXTQQOLKZBLYDY-UHFFFAOYSA-N 0.000 description 19
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 description 19
- 239000003921 oil Substances 0.000 description 19
- 235000019198 oils Nutrition 0.000 description 19
- 239000000230 xanthan gum Substances 0.000 description 19
- 229920001285 xanthan gum Polymers 0.000 description 19
- 235000010493 xanthan gum Nutrition 0.000 description 19
- 229940082509 xanthan gum Drugs 0.000 description 19
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 18
- 239000013256 coordination polymer Substances 0.000 description 18
- 229940008099 dimethicone Drugs 0.000 description 18
- 239000004205 dimethyl polysiloxane Substances 0.000 description 18
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 18
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 18
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 18
- 239000000243 solution Substances 0.000 description 18
- NCZPCONIKBICGS-UHFFFAOYSA-N 3-(2-ethylhexoxy)propane-1,2-diol Chemical compound CCCCC(CC)COCC(O)CO NCZPCONIKBICGS-UHFFFAOYSA-N 0.000 description 17
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 17
- 238000006243 chemical reaction Methods 0.000 description 17
- 229940100524 ethylhexylglycerin Drugs 0.000 description 17
- 229940075529 glyceryl stearate Drugs 0.000 description 17
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 16
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 16
- ZQPPMHVWECSIRJ-MDZDMXLPSA-N elaidic acid Chemical compound CCCCCCCC\C=C\CCCCCCCC(O)=O ZQPPMHVWECSIRJ-MDZDMXLPSA-N 0.000 description 16
- 150000002148 esters Chemical class 0.000 description 16
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 16
- 239000000126 substance Substances 0.000 description 16
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 15
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 15
- 229960005323 phenoxyethanol Drugs 0.000 description 15
- 238000003756 stirring Methods 0.000 description 15
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 14
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 14
- 239000005642 Oleic acid Substances 0.000 description 14
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N iron oxide Inorganic materials [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 14
- 235000021313 oleic acid Nutrition 0.000 description 14
- FTLLYZOWBWEERE-UHFFFAOYSA-N 2-phenoxyethyl octanoate Chemical compound CCCCCCCC(=O)OCCOC1=CC=CC=C1 FTLLYZOWBWEERE-UHFFFAOYSA-N 0.000 description 13
- 230000000475 sunscreen effect Effects 0.000 description 13
- 239000000516 sunscreening agent Substances 0.000 description 13
- 239000005711 Benzoic acid Substances 0.000 description 12
- 235000021355 Stearic acid Nutrition 0.000 description 12
- 235000010233 benzoic acid Nutrition 0.000 description 12
- 229940087068 glyceryl caprylate Drugs 0.000 description 12
- 229940039346 isoamyl cocoate Drugs 0.000 description 12
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 12
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 12
- GHBFNMLVSPCDGN-UHFFFAOYSA-N rac-1-monooctanoylglycerol Chemical compound CCCCCCCC(=O)OCC(O)CO GHBFNMLVSPCDGN-UHFFFAOYSA-N 0.000 description 12
- 239000008117 stearic acid Substances 0.000 description 12
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 11
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 11
- 229920002125 Sokalan® Polymers 0.000 description 11
- XVAMCHGMPYWHNL-UHFFFAOYSA-N bemotrizinol Chemical compound OC1=CC(OCC(CC)CCCC)=CC=C1C1=NC(C=2C=CC(OC)=CC=2)=NC(C=2C(=CC(OCC(CC)CCCC)=CC=2)O)=N1 XVAMCHGMPYWHNL-UHFFFAOYSA-N 0.000 description 11
- 229960003237 betaine Drugs 0.000 description 11
- 229960001631 carbomer Drugs 0.000 description 11
- 235000013980 iron oxide Nutrition 0.000 description 11
- 229960001679 octinoxate Drugs 0.000 description 11
- 239000002304 perfume Substances 0.000 description 11
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 description 11
- WCOXQTXVACYMLM-UHFFFAOYSA-N 2,3-bis(12-hydroxyoctadecanoyloxy)propyl 12-hydroxyoctadecanoate Chemical compound CCCCCCC(O)CCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCC(O)CCCCCC)COC(=O)CCCCCCCCCCC(O)CCCCCC WCOXQTXVACYMLM-UHFFFAOYSA-N 0.000 description 10
- QWGRWMMWNDWRQN-UHFFFAOYSA-N 2-methylpropane-1,3-diol Chemical compound OCC(C)CO QWGRWMMWNDWRQN-UHFFFAOYSA-N 0.000 description 10
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 10
- FMRHJJZUHUTGKE-UHFFFAOYSA-N Ethylhexyl salicylate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1O FMRHJJZUHUTGKE-UHFFFAOYSA-N 0.000 description 10
- 239000005639 Lauric acid Substances 0.000 description 10
- DYUQAZSOFZSPHD-UHFFFAOYSA-N Phenylpropanol Chemical compound CCC(O)C1=CC=CC=C1 DYUQAZSOFZSPHD-UHFFFAOYSA-N 0.000 description 10
- 239000004202 carbamide Substances 0.000 description 10
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 10
- FDATWRLUYRHCJE-UHFFFAOYSA-N diethylamino hydroxybenzoyl hexyl benzoate Chemical compound CCCCCCOC(=O)C1=CC=CC=C1C(=O)C1=CC=C(N(CC)CC)C=C1O FDATWRLUYRHCJE-UHFFFAOYSA-N 0.000 description 10
- 229940100573 methylpropanediol Drugs 0.000 description 10
- 229960000601 octocrylene Drugs 0.000 description 10
- 229950009195 phenylpropanol Drugs 0.000 description 10
- 239000011780 sodium chloride Substances 0.000 description 10
- 239000004408 titanium dioxide Substances 0.000 description 10
- TYYHDKOVFSVWON-UHFFFAOYSA-N 2-butyl-2-methoxy-1,3-diphenylpropane-1,3-dione Chemical compound C=1C=CC=CC=1C(=O)C(OC)(CCCC)C(=O)C1=CC=CC=C1 TYYHDKOVFSVWON-UHFFFAOYSA-N 0.000 description 9
- SZAMSYKZCSDVBH-CLFAGFIQSA-N [(z)-octadec-9-enyl] (z)-docos-13-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCC(=O)OCCCCCCCC\C=C/CCCCCCCC SZAMSYKZCSDVBH-CLFAGFIQSA-N 0.000 description 9
- 229960005193 avobenzone Drugs 0.000 description 9
- 235000019445 benzyl alcohol Nutrition 0.000 description 9
- 239000002537 cosmetic Substances 0.000 description 9
- 229920006037 cross link polymer Polymers 0.000 description 9
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 9
- WRUGWIBCXHJTDG-UHFFFAOYSA-L magnesium sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Mg+2].[O-]S([O-])(=O)=O WRUGWIBCXHJTDG-UHFFFAOYSA-L 0.000 description 9
- 229940061634 magnesium sulfate heptahydrate Drugs 0.000 description 9
- 229940120511 oleyl erucate Drugs 0.000 description 9
- 239000000523 sample Substances 0.000 description 9
- 235000010384 tocopherol Nutrition 0.000 description 9
- 229960001295 tocopherol Drugs 0.000 description 9
- 229930003799 tocopherol Natural products 0.000 description 9
- 239000011732 tocopherol Substances 0.000 description 9
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 9
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 8
- 244000303965 Cyamopsis psoralioides Species 0.000 description 8
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 8
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 8
- 238000005481 NMR spectroscopy Methods 0.000 description 8
- 229960004101 bemotrizinol Drugs 0.000 description 8
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 8
- 150000005690 diesters Chemical class 0.000 description 8
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 description 8
- VBMVTYDPPZVILR-UHFFFAOYSA-N iron(2+);oxygen(2-) Chemical class [O-2].[Fe+2] VBMVTYDPPZVILR-UHFFFAOYSA-N 0.000 description 8
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 8
- 229960002446 octanoic acid Drugs 0.000 description 8
- FMJSMJQBSVNSBF-UHFFFAOYSA-N octocrylene Chemical group C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 description 8
- 229940116351 sebacate Drugs 0.000 description 8
- CXMXRPHRNRROMY-UHFFFAOYSA-L sebacate(2-) Chemical compound [O-]C(=O)CCCCCCCCC([O-])=O CXMXRPHRNRROMY-UHFFFAOYSA-L 0.000 description 8
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 8
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 7
- DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical compound CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 description 7
- 239000007857 degradation product Substances 0.000 description 7
- 239000002781 deodorant agent Substances 0.000 description 7
- UVCJGUGAGLDPAA-UHFFFAOYSA-N ensulizole Chemical compound N1C2=CC(S(=O)(=O)O)=CC=C2N=C1C1=CC=CC=C1 UVCJGUGAGLDPAA-UHFFFAOYSA-N 0.000 description 7
- 229960000655 ensulizole Drugs 0.000 description 7
- 229940068171 ethyl hexyl salicylate Drugs 0.000 description 7
- 239000007789 gas Substances 0.000 description 7
- RNNBHZYEKNHLKT-UHFFFAOYSA-N isopropylmethylpyrazolyl dimethylcarbamate Chemical compound CC(C)N1N=C(C)C=C1OC(=O)N(C)C RNNBHZYEKNHLKT-UHFFFAOYSA-N 0.000 description 7
- 239000004200 microcrystalline wax Substances 0.000 description 7
- 235000019808 microcrystalline wax Nutrition 0.000 description 7
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 7
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 7
- 239000004299 sodium benzoate Substances 0.000 description 7
- 235000010234 sodium benzoate Nutrition 0.000 description 7
- OPJWPPVYCOPDCM-UHFFFAOYSA-N 2-ethylhexyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(CC)CCCC OPJWPPVYCOPDCM-UHFFFAOYSA-N 0.000 description 6
- 244000144725 Amygdalus communis Species 0.000 description 6
- 235000011437 Amygdalus communis Nutrition 0.000 description 6
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 108010084311 Novozyme 435 Proteins 0.000 description 6
- 244000025272 Persea americana Species 0.000 description 6
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 6
- 230000001166 anti-perspirative effect Effects 0.000 description 6
- 239000003213 antiperspirant Substances 0.000 description 6
- 239000006071 cream Substances 0.000 description 6
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 6
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 6
- 239000004615 ingredient Substances 0.000 description 6
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 6
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 6
- 239000000376 reactant Substances 0.000 description 6
- 229940058349 sodium levulinate Drugs 0.000 description 6
- RDKYCKDVIYTSAJ-UHFFFAOYSA-M sodium;4-oxopentanoate Chemical compound [Na+].CC(=O)CCC([O-])=O RDKYCKDVIYTSAJ-UHFFFAOYSA-M 0.000 description 6
- 239000001069 triethyl citrate Substances 0.000 description 6
- VMYFZRTXGLUXMZ-UHFFFAOYSA-N triethyl citrate Natural products CCOC(=O)C(O)(C(=O)OCC)C(=O)OCC VMYFZRTXGLUXMZ-UHFFFAOYSA-N 0.000 description 6
- 235000013769 triethyl citrate Nutrition 0.000 description 6
- 235000013311 vegetables Nutrition 0.000 description 6
- 229940043375 1,5-pentanediol Drugs 0.000 description 5
- RZRNAYUHWVFMIP-KTKRTIGZSA-N 1-oleoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-KTKRTIGZSA-N 0.000 description 5
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 description 5
- 241000871495 Heeria argentea Species 0.000 description 5
- 229920002385 Sodium hyaluronate Polymers 0.000 description 5
- PHYFQTYBJUILEZ-UHFFFAOYSA-N Trioleoylglycerol Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC PHYFQTYBJUILEZ-UHFFFAOYSA-N 0.000 description 5
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 5
- 125000005250 alkyl acrylate group Chemical group 0.000 description 5
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 5
- 229940081733 cetearyl alcohol Drugs 0.000 description 5
- 229940071160 cocoate Drugs 0.000 description 5
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 5
- 229960001630 diethylamino hydroxybenzoyl hexyl benzoate Drugs 0.000 description 5
- DLAHAXOYRFRPFQ-UHFFFAOYSA-N dodecyl benzoate Chemical compound CCCCCCCCCCCCOC(=O)C1=CC=CC=C1 DLAHAXOYRFRPFQ-UHFFFAOYSA-N 0.000 description 5
- 238000000769 gas chromatography-flame ionisation detection Methods 0.000 description 5
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 5
- 235000010213 iron oxides and hydroxides Nutrition 0.000 description 5
- 239000004407 iron oxides and hydroxides Substances 0.000 description 5
- WWZKQHOCKIZLMA-UHFFFAOYSA-M octanoate Chemical compound CCCCCCCC([O-])=O WWZKQHOCKIZLMA-UHFFFAOYSA-M 0.000 description 5
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 5
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 5
- 230000035484 reaction time Effects 0.000 description 5
- 229940010747 sodium hyaluronate Drugs 0.000 description 5
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 5
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 4
- CUVSTAMIHSSVKL-UWVGGRQHSA-N (4s)-4-[(2-aminoacetyl)amino]-5-[[(2s)-6-amino-1-(carboxymethylamino)-1-oxohexan-2-yl]amino]-5-oxopentanoic acid Chemical compound NCCCC[C@@H](C(=O)NCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)CN CUVSTAMIHSSVKL-UWVGGRQHSA-N 0.000 description 4
- ULQISTXYYBZJSJ-UHFFFAOYSA-N 12-hydroxyoctadecanoic acid Chemical compound CCCCCCC(O)CCCCCCCCCCC(O)=O ULQISTXYYBZJSJ-UHFFFAOYSA-N 0.000 description 4
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 4
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 4
- WSSJONWNBBTCMG-UHFFFAOYSA-N 2-hydroxybenzoic acid (3,3,5-trimethylcyclohexyl) ester Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C1=CC=CC=C1O WSSJONWNBBTCMG-UHFFFAOYSA-N 0.000 description 4
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 4
- 108010031797 Candida antarctica lipase B Proteins 0.000 description 4
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 4
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- MSPCIZMDDUQPGJ-UHFFFAOYSA-N N-methyl-N-(trimethylsilyl)trifluoroacetamide Chemical compound C[Si](C)(C)N(C)C(=O)C(F)(F)F MSPCIZMDDUQPGJ-UHFFFAOYSA-N 0.000 description 4
- 240000007817 Olea europaea Species 0.000 description 4
- OQILCOQZDHPEAZ-UHFFFAOYSA-N Palmitinsaeure-octylester Natural products CCCCCCCCCCCCCCCC(=O)OCCCCCCCC OQILCOQZDHPEAZ-UHFFFAOYSA-N 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 239000004904 UV filter Substances 0.000 description 4
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 4
- 241001135917 Vitellaria paradoxa Species 0.000 description 4
- 229960001422 aluminium chlorohydrate Drugs 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 4
- 229940048851 cetyl ricinoleate Drugs 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 description 4
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 4
- LVYZJEPLMYTTGH-UHFFFAOYSA-H dialuminum chloride pentahydroxide dihydrate Chemical compound [Cl-].[Al+3].[OH-].[OH-].[Al+3].[OH-].[OH-].[OH-].O.O LVYZJEPLMYTTGH-UHFFFAOYSA-H 0.000 description 4
- 239000000975 dye Substances 0.000 description 4
- 239000000839 emulsion Substances 0.000 description 4
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 4
- GJQLBGWSDGMZKM-UHFFFAOYSA-N ethylhexyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(CC)CCCCC GJQLBGWSDGMZKM-UHFFFAOYSA-N 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 4
- XAMHKORMKJIEFW-AYTKPMRMSA-N hexadecyl (z,12r)-12-hydroxyoctadec-9-enoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCCC\C=C/C[C@H](O)CCCCCC XAMHKORMKJIEFW-AYTKPMRMSA-N 0.000 description 4
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 4
- 229920002674 hyaluronan Polymers 0.000 description 4
- 229960003160 hyaluronic acid Drugs 0.000 description 4
- 239000001257 hydrogen Substances 0.000 description 4
- 229910052739 hydrogen Inorganic materials 0.000 description 4
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 4
- FBUKVWPVBMHYJY-UHFFFAOYSA-N nonanoic acid Chemical compound CCCCCCCCC(O)=O FBUKVWPVBMHYJY-UHFFFAOYSA-N 0.000 description 4
- CNVZJPUDSLNTQU-SEYXRHQNSA-N petroselinic acid Chemical compound CCCCCCCCCCC\C=C/CCCCC(O)=O CNVZJPUDSLNTQU-SEYXRHQNSA-N 0.000 description 4
- 239000000049 pigment Substances 0.000 description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
- 239000004302 potassium sorbate Substances 0.000 description 4
- 235000010241 potassium sorbate Nutrition 0.000 description 4
- 229940069338 potassium sorbate Drugs 0.000 description 4
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 4
- 238000007127 saponification reaction Methods 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- FRHNXUKHAUWMOQ-UHFFFAOYSA-M sodium;16-methylheptadecanoate Chemical compound [Na+].CC(C)CCCCCCCCCCCCCCC([O-])=O FRHNXUKHAUWMOQ-UHFFFAOYSA-M 0.000 description 4
- 239000004334 sorbic acid Substances 0.000 description 4
- 235000010199 sorbic acid Nutrition 0.000 description 4
- 229940075582 sorbic acid Drugs 0.000 description 4
- 239000004094 surface-active agent Substances 0.000 description 4
- 229940094879 tetrapeptide-21 Drugs 0.000 description 4
- UEUXEKPTXMALOB-UHFFFAOYSA-J tetrasodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O UEUXEKPTXMALOB-UHFFFAOYSA-J 0.000 description 4
- 239000002562 thickening agent Substances 0.000 description 4
- 150000005691 triesters Chemical class 0.000 description 4
- XMGQYMWWDOXHJM-JTQLQIEISA-N (+)-α-limonene Chemical compound CC(=C)[C@@H]1CCC(C)=CC1 XMGQYMWWDOXHJM-JTQLQIEISA-N 0.000 description 3
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 3
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 3
- OVSKIKFHRZPJSS-UHFFFAOYSA-N 2,4-D Chemical compound OC(=O)COC1=CC=C(Cl)C=C1Cl OVSKIKFHRZPJSS-UHFFFAOYSA-N 0.000 description 3
- MSXVEPNJUHWQHW-UHFFFAOYSA-N 2-methylbutan-2-ol Chemical compound CCC(C)(C)O MSXVEPNJUHWQHW-UHFFFAOYSA-N 0.000 description 3
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 3
- AKUPYGILGNUOIG-UHFFFAOYSA-N 5-methoxy-4-phenyltriazine Chemical compound COC1=CN=NN=C1C1=CC=CC=C1 AKUPYGILGNUOIG-UHFFFAOYSA-N 0.000 description 3
- 239000008873 AXOL Substances 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 235000019489 Almond oil Nutrition 0.000 description 3
- 235000021357 Behenic acid Nutrition 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 3
- UUGLJVMIFJNVFH-UHFFFAOYSA-N Hexyl benzoate Chemical compound CCCCCCOC(=O)C1=CC=CC=C1 UUGLJVMIFJNVFH-UHFFFAOYSA-N 0.000 description 3
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- 240000007228 Mangifera indica Species 0.000 description 3
- 235000014826 Mangifera indica Nutrition 0.000 description 3
- 229920006152 PA1010 Polymers 0.000 description 3
- 235000008673 Persea americana Nutrition 0.000 description 3
- 235000011236 Persea americana var americana Nutrition 0.000 description 3
- 108010020346 Polyglutamic Acid Proteins 0.000 description 3
- 241001558929 Sclerotium <basidiomycota> Species 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 239000007983 Tris buffer Substances 0.000 description 3
- 239000008168 almond oil Substances 0.000 description 3
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 235000013871 bee wax Nutrition 0.000 description 3
- 239000012166 beeswax Substances 0.000 description 3
- 229940116226 behenic acid Drugs 0.000 description 3
- 238000004422 calculation algorithm Methods 0.000 description 3
- MRUAUOIMASANKQ-UHFFFAOYSA-N cocamidopropyl betaine Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC([O-])=O MRUAUOIMASANKQ-UHFFFAOYSA-N 0.000 description 3
- 229940073507 cocamidopropyl betaine Drugs 0.000 description 3
- 229940080421 coco glucoside Drugs 0.000 description 3
- 238000004590 computer program Methods 0.000 description 3
- JDRSMPFHFNXQRB-IBEHDNSVSA-N decyl glucoside Chemical compound CCCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O JDRSMPFHFNXQRB-IBEHDNSVSA-N 0.000 description 3
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 3
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 229960004881 homosalate Drugs 0.000 description 3
- 150000002431 hydrogen Chemical class 0.000 description 3
- 238000011835 investigation Methods 0.000 description 3
- PYIDGJJWBIBVIA-UYTYNIKBSA-N lauryl glucoside Chemical compound CCCCCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O PYIDGJJWBIBVIA-UYTYNIKBSA-N 0.000 description 3
- 229940048848 lauryl glucoside Drugs 0.000 description 3
- 229940087305 limonene Drugs 0.000 description 3
- 235000001510 limonene Nutrition 0.000 description 3
- 229930007744 linalool Natural products 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 238000010979 pH adjustment Methods 0.000 description 3
- 229920005862 polyol Polymers 0.000 description 3
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 3
- 239000003380 propellant Substances 0.000 description 3
- FTBUKOLPOATXGV-UHFFFAOYSA-N propyl dodecanoate Chemical group CCCCCCCCCCCC(=O)OCCC FTBUKOLPOATXGV-UHFFFAOYSA-N 0.000 description 3
- 239000002453 shampoo Substances 0.000 description 3
- 229940057910 shea butter Drugs 0.000 description 3
- 229940080321 sodium anisate Drugs 0.000 description 3
- AETSDHMVQHOYPB-UHFFFAOYSA-M sodium;4-methoxybenzoate Chemical compound [Na+].COC1=CC=C(C([O-])=O)C=C1 AETSDHMVQHOYPB-UHFFFAOYSA-M 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 229960000281 trometamol Drugs 0.000 description 3
- 239000011787 zinc oxide Substances 0.000 description 3
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 2
- JYEUMXHLPRZUAT-UHFFFAOYSA-N 1,2,3-triazine Chemical compound C1=CN=NN=C1 JYEUMXHLPRZUAT-UHFFFAOYSA-N 0.000 description 2
- 229940015975 1,2-hexanediol Drugs 0.000 description 2
- ARXJGSRGQADJSQ-UHFFFAOYSA-N 1-methoxypropan-2-ol Chemical compound COCC(C)O ARXJGSRGQADJSQ-UHFFFAOYSA-N 0.000 description 2
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 2
- 229940114072 12-hydroxystearic acid Drugs 0.000 description 2
- OXEDXHIBHVMDST-UHFFFAOYSA-N 12Z-octadecenoic acid Natural products CCCCCC=CCCCCCCCCCCC(O)=O OXEDXHIBHVMDST-UHFFFAOYSA-N 0.000 description 2
- SXNBVULTHKFMNO-UHFFFAOYSA-N 2,2-dihydroxyoctadecanoic acid Chemical compound CCCCCCCCCCCCCCCCC(O)(O)C(O)=O SXNBVULTHKFMNO-UHFFFAOYSA-N 0.000 description 2
- ASKIVFGGGGIGKH-UHFFFAOYSA-N 2,3-dihydroxypropyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(O)CO ASKIVFGGGGIGKH-UHFFFAOYSA-N 0.000 description 2
- FPVJYHHGNGJAPC-UHFFFAOYSA-N 2-[3-(decanoylamino)propyl-dimethylazaniumyl]acetate Chemical compound CCCCCCCCCC(=O)NCCC[N+](C)(C)CC([O-])=O FPVJYHHGNGJAPC-UHFFFAOYSA-N 0.000 description 2
- SUZKAIPUWCLPCH-UHFFFAOYSA-N 2-[dimethyl-[3-(octanoylamino)propyl]azaniumyl]acetate Chemical group CCCCCCCC(=O)NCCC[N+](C)(C)CC([O-])=O SUZKAIPUWCLPCH-UHFFFAOYSA-N 0.000 description 2
- XMVBHZBLHNOQON-UHFFFAOYSA-N 2-butyl-1-octanol Chemical compound CCCCCCC(CO)CCCC XMVBHZBLHNOQON-UHFFFAOYSA-N 0.000 description 2
- JGUMTYWKIBJSTN-UHFFFAOYSA-N 2-ethylhexyl 4-[[4,6-bis[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 JGUMTYWKIBJSTN-UHFFFAOYSA-N 0.000 description 2
- NKEQOUMMGPBKMM-UHFFFAOYSA-N 2-hydroxy-2-[2-(2-hydroxy-3-octadecanoyloxypropoxy)-2-oxoethyl]butanedioic acid Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)COC(=O)CC(O)(C(O)=O)CC(O)=O NKEQOUMMGPBKMM-UHFFFAOYSA-N 0.000 description 2
- IREAODMQYCOAGP-UHFFFAOYSA-N 3-(hexadecanoylamino)propyl-trimethylazanium;chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC(=O)NCCC[N+](C)(C)C IREAODMQYCOAGP-UHFFFAOYSA-N 0.000 description 2
- JOOXCMJARBKPKM-UHFFFAOYSA-N 4-oxopentanoic acid Chemical compound CC(=O)CCC(O)=O JOOXCMJARBKPKM-UHFFFAOYSA-N 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- DPUOLQHDNGRHBS-UHFFFAOYSA-N Brassidinsaeure Natural products CCCCCCCCC=CCCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-UHFFFAOYSA-N 0.000 description 2
- 235000004936 Bromus mango Nutrition 0.000 description 2
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 2
- 235000005956 Cosmos caudatus Nutrition 0.000 description 2
- AERBNCYCJBRYDG-UHFFFAOYSA-N D-ribo-phytosphingosine Natural products CCCCCCCCCCCCCCC(O)C(O)C(N)CO AERBNCYCJBRYDG-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 2
- 206010013786 Dry skin Diseases 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- URXZXNYJPAJJOQ-UHFFFAOYSA-N Erucic acid Natural products CCCCCCC=CCCCCCCCCCCCC(O)=O URXZXNYJPAJJOQ-UHFFFAOYSA-N 0.000 description 2
- 229920001503 Glucan Polymers 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- JHWNWJKBPDFINM-UHFFFAOYSA-N Laurolactam Chemical compound O=C1CCCCCCCCCCCN1 JHWNWJKBPDFINM-UHFFFAOYSA-N 0.000 description 2
- 244000178870 Lavandula angustifolia Species 0.000 description 2
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 2
- 108010048733 Lipozyme Proteins 0.000 description 2
- 235000017011 Mandorlo dulce Nutrition 0.000 description 2
- 244000076313 Mandorlo dulce Species 0.000 description 2
- BBAFBDLICMHBNU-MFZOPHKMSA-N N-(2-hydroxyoctadecanoyl)-4-hydroxysphinganine Chemical compound CCCCCCCCCCCCCCCCC(O)C(=O)N[C@@H](CO)[C@H](O)[C@H](O)CCCCCCCCCCCCCC BBAFBDLICMHBNU-MFZOPHKMSA-N 0.000 description 2
- ATGQXSBKTQANOH-UWVGARPKSA-N N-oleoylphytosphingosine Chemical compound CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@H](CO)NC(=O)CCCCCCC\C=C/CCCCCCCC ATGQXSBKTQANOH-UWVGARPKSA-N 0.000 description 2
- 229920000299 Nylon 12 Polymers 0.000 description 2
- 235000002725 Olea europaea Nutrition 0.000 description 2
- 235000021314 Palmitic acid Nutrition 0.000 description 2
- 239000005643 Pelargonic acid Substances 0.000 description 2
- 239000004264 Petrolatum Substances 0.000 description 2
- CNVZJPUDSLNTQU-UHFFFAOYSA-N Petroselaidic acid Natural products CCCCCCCCCCCC=CCCCCC(O)=O CNVZJPUDSLNTQU-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 235000009184 Spondias indica Nutrition 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 235000019486 Sunflower oil Nutrition 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 2
- 244000098338 Triticum aestivum Species 0.000 description 2
- 229920004482 WACKER® Polymers 0.000 description 2
- GCDXVKZXCQGDHC-BLCQCPAESA-N [30-oxo-30-[[(2s,3s,4r)-1,3,4-trihydroxyoctadecan-2-yl]amino]triacontyl] (9z,12z)-octadeca-9,12-dienoate Chemical compound CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@H](CO)NC(=O)CCCCCCCCCCCCCCCCCCCCCCCCCCCCCOC(=O)CCCCCCC\C=C/C\C=C/CCCCC GCDXVKZXCQGDHC-BLCQCPAESA-N 0.000 description 2
- 239000000443 aerosol Substances 0.000 description 2
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 2
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 2
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 2
- 235000011126 aluminium potassium sulphate Nutrition 0.000 description 2
- 235000021342 arachidonic acid Nutrition 0.000 description 2
- 229940114079 arachidonic acid Drugs 0.000 description 2
- 239000010478 argan oil Substances 0.000 description 2
- OWBTYPJTUOEWEK-UHFFFAOYSA-N butane-2,3-diol Chemical compound CC(O)C(C)O OWBTYPJTUOEWEK-UHFFFAOYSA-N 0.000 description 2
- 235000014121 butter Nutrition 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 229940073742 capramidopropyl betaine Drugs 0.000 description 2
- KHAVLLBUVKBTBG-UHFFFAOYSA-N caproleic acid Natural products OC(=O)CCCCCCCC=C KHAVLLBUVKBTBG-UHFFFAOYSA-N 0.000 description 2
- 239000012159 carrier gas Substances 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 229940086668 ceramide eop Drugs 0.000 description 2
- 229940085262 cetyl dimethicone Drugs 0.000 description 2
- 229960001701 chloroform Drugs 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 230000003750 conditioning effect Effects 0.000 description 2
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 2
- 229960003624 creatine Drugs 0.000 description 2
- 239000006046 creatine Substances 0.000 description 2
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-M decanoate Chemical compound CCCCCCCCCC([O-])=O GHVNFZFCNZKVNT-UHFFFAOYSA-M 0.000 description 2
- PGRHXDWITVMQBC-UHFFFAOYSA-N dehydroacetic acid Chemical compound CC(=O)C1C(=O)OC(C)=CC1=O PGRHXDWITVMQBC-UHFFFAOYSA-N 0.000 description 2
- SWXVUIWOUIDPGS-UHFFFAOYSA-N diacetone alcohol Chemical compound CC(=O)CC(C)(C)O SWXVUIWOUIDPGS-UHFFFAOYSA-N 0.000 description 2
- LRCFXGAMWKDGLA-UHFFFAOYSA-N dioxosilane;hydrate Chemical compound O.O=[Si]=O LRCFXGAMWKDGLA-UHFFFAOYSA-N 0.000 description 2
- GLCJMPWWQKKJQZ-UHFFFAOYSA-L disodium;2-[4-(4,6-disulfonato-1h-benzimidazol-2-yl)phenyl]-1h-benzimidazole-4,6-disulfonate;hydron Chemical compound [Na+].[Na+].C1=C(S(O)(=O)=O)C=C2NC(C3=CC=C(C=C3)C3=NC4=C(C=C(C=C4N3)S(=O)(=O)O)S([O-])(=O)=O)=NC2=C1S([O-])(=O)=O GLCJMPWWQKKJQZ-UHFFFAOYSA-L 0.000 description 2
- 229940102552 disteardimonium hectorite Drugs 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 229940090949 docosahexaenoic acid Drugs 0.000 description 2
- 230000037336 dry skin Effects 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 2
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 2
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 2
- DPUOLQHDNGRHBS-KTKRTIGZSA-N erucic acid Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-KTKRTIGZSA-N 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- LQJBNNIYVWPHFW-QXMHVHEDSA-N gadoleic acid Chemical compound CCCCCCCCCC\C=C/CCCCCCCC(O)=O LQJBNNIYVWPHFW-QXMHVHEDSA-N 0.000 description 2
- 238000004817 gas chromatography Methods 0.000 description 2
- 229930182478 glucoside Natural products 0.000 description 2
- 150000008131 glucosides Chemical class 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- 239000001307 helium Substances 0.000 description 2
- 229910052734 helium Inorganic materials 0.000 description 2
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- VKOBVWXKNCXXDE-UHFFFAOYSA-N icosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCC(O)=O VKOBVWXKNCXXDE-UHFFFAOYSA-N 0.000 description 2
- 239000011630 iodine Substances 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 2
- 229940119170 jojoba wax Drugs 0.000 description 2
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 2
- 229960004488 linolenic acid Drugs 0.000 description 2
- FCCDDURTIIUXBY-UHFFFAOYSA-N lipoamide Chemical compound NC(=O)CCCCC1CCSS1 FCCDDURTIIUXBY-UHFFFAOYSA-N 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- 150000004702 methyl esters Chemical class 0.000 description 2
- UQDUPQYQJKYHQI-UHFFFAOYSA-N methyl laurate Chemical compound CCCCCCCCCCCC(=O)OC UQDUPQYQJKYHQI-UHFFFAOYSA-N 0.000 description 2
- LPUQAYUQRXPFSQ-DFWYDOINSA-M monosodium L-glutamate Chemical compound [Na+].[O-]C(=O)[C@@H](N)CCC(O)=O LPUQAYUQRXPFSQ-DFWYDOINSA-M 0.000 description 2
- 229940078812 myristyl myristate Drugs 0.000 description 2
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- SJWFXCIHNDVPSH-UHFFFAOYSA-N octan-2-ol Chemical compound CCCCCCC(C)O SJWFXCIHNDVPSH-UHFFFAOYSA-N 0.000 description 2
- 125000002801 octanoyl group Chemical group C(CCCCCCC)(=O)* 0.000 description 2
- 229940049964 oleate Drugs 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 238000007248 oxidative elimination reaction Methods 0.000 description 2
- 238000005949 ozonolysis reaction Methods 0.000 description 2
- 229940037624 palmitamidopropyltrimonium chloride Drugs 0.000 description 2
- SECPZKHBENQXJG-FPLPWBNLSA-N palmitoleic acid Chemical compound CCCCCC\C=C/CCCCCCCC(O)=O SECPZKHBENQXJG-FPLPWBNLSA-N 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- 229940066842 petrolatum Drugs 0.000 description 2
- 235000019271 petrolatum Nutrition 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- AERBNCYCJBRYDG-KSZLIROESA-N phytosphingosine Chemical compound CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@@H](N)CO AERBNCYCJBRYDG-KSZLIROESA-N 0.000 description 2
- 229940033329 phytosphingosine Drugs 0.000 description 2
- 229920002643 polyglutamic acid Polymers 0.000 description 2
- 229940100518 polyglyceryl-4 isostearate Drugs 0.000 description 2
- 150000003077 polyols Chemical class 0.000 description 2
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 2
- 229940050271 potassium alum Drugs 0.000 description 2
- GRLPQNLYRHEGIJ-UHFFFAOYSA-J potassium aluminium sulfate Chemical compound [Al+3].[K+].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O GRLPQNLYRHEGIJ-UHFFFAOYSA-J 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- PHZLMBHDXVLRIX-UHFFFAOYSA-M potassium lactate Chemical compound [K+].CC(O)C([O-])=O PHZLMBHDXVLRIX-UHFFFAOYSA-M 0.000 description 2
- 239000001521 potassium lactate Substances 0.000 description 2
- 235000011085 potassium lactate Nutrition 0.000 description 2
- 229960001304 potassium lactate Drugs 0.000 description 2
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 2
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 2
- RUOJZAUFBMNUDX-UHFFFAOYSA-N propylene carbonate Chemical compound CC1COC(=O)O1 RUOJZAUFBMNUDX-UHFFFAOYSA-N 0.000 description 2
- 229960003415 propylparaben Drugs 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 238000000197 pyrolysis Methods 0.000 description 2
- WBHHMMIMDMUBKC-XLNAKTSKSA-N ricinelaidic acid Chemical compound CCCCCC[C@@H](O)C\C=C\CCCCCCCC(O)=O WBHHMMIMDMUBKC-XLNAKTSKSA-N 0.000 description 2
- 229960003656 ricinoleic acid Drugs 0.000 description 2
- FEUQNCSVHBHROZ-UHFFFAOYSA-N ricinoleic acid Natural products CCCCCCC(O[Si](C)(C)C)CC=CCCCCCCCC(=O)OC FEUQNCSVHBHROZ-UHFFFAOYSA-N 0.000 description 2
- 229960004889 salicylic acid Drugs 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 229960004029 silicic acid Drugs 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- 229940079781 sodium cocoyl glutamate Drugs 0.000 description 2
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 2
- 229940045898 sodium stearoyl glutamate Drugs 0.000 description 2
- KDHFCTLPQJQDQI-BDQAORGHSA-M sodium;(4s)-4-amino-5-octadecanoyloxy-5-oxopentanoate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC(=O)OC(=O)[C@@H](N)CCC([O-])=O KDHFCTLPQJQDQI-BDQAORGHSA-M 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 239000002600 sunflower oil Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 2
- DZKXJUASMGQEMA-UHFFFAOYSA-N tetradecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC DZKXJUASMGQEMA-UHFFFAOYSA-N 0.000 description 2
- CZDYPVPMEAXLPK-UHFFFAOYSA-N tetramethylsilane Chemical compound C[Si](C)(C)C CZDYPVPMEAXLPK-UHFFFAOYSA-N 0.000 description 2
- 230000008719 thickening Effects 0.000 description 2
- AQWHMKSIVLSRNY-UHFFFAOYSA-N trans-Octadec-5-ensaeure Natural products CCCCCCCCCCCCC=CCCCC(O)=O AQWHMKSIVLSRNY-UHFFFAOYSA-N 0.000 description 2
- 229960002703 undecylenic acid Drugs 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- GAWWVVGZMLGEIW-GNNYBVKZSA-L zinc ricinoleate Chemical compound [Zn+2].CCCCCC[C@@H](O)C\C=C/CCCCCCCC([O-])=O.CCCCCC[C@@H](O)C\C=C/CCCCCCCC([O-])=O GAWWVVGZMLGEIW-GNNYBVKZSA-L 0.000 description 2
- 229940100530 zinc ricinoleate Drugs 0.000 description 2
- NKJOXAZJBOMXID-UHFFFAOYSA-N 1,1'-Oxybisoctane Chemical compound CCCCCCCCOCCCCCCCC NKJOXAZJBOMXID-UHFFFAOYSA-N 0.000 description 1
- QLAJNZSPVITUCQ-UHFFFAOYSA-N 1,3,2-dioxathietane 2,2-dioxide Chemical compound O=S1(=O)OCO1 QLAJNZSPVITUCQ-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- VTBOTOBFGSVRMA-UHFFFAOYSA-N 1-Methylcyclohexanol Chemical class CC1(O)CCCCC1 VTBOTOBFGSVRMA-UHFFFAOYSA-N 0.000 description 1
- HXKKHQJGJAFBHI-UHFFFAOYSA-N 1-aminopropan-2-ol Chemical compound CC(O)CN HXKKHQJGJAFBHI-UHFFFAOYSA-N 0.000 description 1
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 1
- ZQCIPRGNRQXXSK-UHFFFAOYSA-N 1-octadecoxypropan-2-ol Chemical compound CCCCCCCCCCCCCCCCCCOCC(C)O ZQCIPRGNRQXXSK-UHFFFAOYSA-N 0.000 description 1
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 1
- KZVIUXKOLXVBPC-UHFFFAOYSA-N 16-methylheptadecanamide Chemical compound CC(C)CCCCCCCCCCCCCCC(N)=O KZVIUXKOLXVBPC-UHFFFAOYSA-N 0.000 description 1
- JNAYPSWVMNJOPQ-UHFFFAOYSA-N 2,3-bis(16-methylheptadecanoyloxy)propyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C JNAYPSWVMNJOPQ-UHFFFAOYSA-N 0.000 description 1
- PKAUICCNAWQPAU-UHFFFAOYSA-N 2-(4-chloro-2-methylphenoxy)acetic acid;n-methylmethanamine Chemical compound CNC.CC1=CC(Cl)=CC=C1OCC(O)=O PKAUICCNAWQPAU-UHFFFAOYSA-N 0.000 description 1
- RXDGYXFSRKKYRC-UHFFFAOYSA-N 2-(hexanoylamino)propanoic acid Chemical compound CCCCCC(=O)NC(C)C(O)=O RXDGYXFSRKKYRC-UHFFFAOYSA-N 0.000 description 1
- DWHIUNMOTRUVPG-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-(2-dodecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCO DWHIUNMOTRUVPG-UHFFFAOYSA-N 0.000 description 1
- PUAQLLVFLMYYJJ-UHFFFAOYSA-N 2-aminopropiophenone Chemical compound CC(N)C(=O)C1=CC=CC=C1 PUAQLLVFLMYYJJ-UHFFFAOYSA-N 0.000 description 1
- OYINQIKIQCNQOX-UHFFFAOYSA-M 2-hydroxybutyl(trimethyl)azanium;chloride Chemical compound [Cl-].CCC(O)C[N+](C)(C)C OYINQIKIQCNQOX-UHFFFAOYSA-M 0.000 description 1
- DWYHDSLIWMUSOO-UHFFFAOYSA-N 2-phenyl-1h-benzimidazole Chemical compound C1=CC=CC=C1C1=NC2=CC=CC=C2N1 DWYHDSLIWMUSOO-UHFFFAOYSA-N 0.000 description 1
- ZUYVPAKYYMBQBT-UHFFFAOYSA-N 3,4-diethyl-2-hexoxyphenol Chemical compound CCCCCCOC1=C(O)C=CC(CC)=C1CC ZUYVPAKYYMBQBT-UHFFFAOYSA-N 0.000 description 1
- RMTFNDVZYPHUEF-XZBKPIIZSA-N 3-O-methyl-D-glucose Chemical compound O=C[C@H](O)[C@@H](OC)[C@H](O)[C@H](O)CO RMTFNDVZYPHUEF-XZBKPIIZSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- 244000125300 Argania sideroxylon Species 0.000 description 1
- 235000016108 Argania sideroxylon Nutrition 0.000 description 1
- JSUVCAQGWVUMPD-QXUQJYLISA-N Arjuna Natural products O([C@H]([C@@H](O)C=O)[C@H]1[C@H](O)COC(=O)c2c(c(O)c(O)c(O)c2)-c2c(O)c(O)c3OC(=O)c4c(c(O)c(O)c5OC(=O)c2c3-c45)-c2c(O)c(O)c(O)cc2C(=O)O1)C(=O)c1cc(O)c(O)c(O)c1 JSUVCAQGWVUMPD-QXUQJYLISA-N 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- 102100021851 Calbindin Human genes 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 239000004287 Dehydroacetic acid Substances 0.000 description 1
- OKKJLVBELUTLKV-MZCSYVLQSA-N Deuterated methanol Chemical compound [2H]OC([2H])([2H])[2H] OKKJLVBELUTLKV-MZCSYVLQSA-N 0.000 description 1
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 description 1
- 241000509579 Draco Species 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- FPVVYTCTZKCSOJ-UHFFFAOYSA-N Ethylene glycol distearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOC(=O)CCCCCCCCCCCCCCCCC FPVVYTCTZKCSOJ-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005792 Geraniol Substances 0.000 description 1
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 1
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 1
- 229930186217 Glycolipid Natural products 0.000 description 1
- 244000020551 Helianthus annuus Species 0.000 description 1
- 235000003222 Helianthus annuus Nutrition 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- CMBYOWLFQAFZCP-UHFFFAOYSA-N Hexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCC CMBYOWLFQAFZCP-UHFFFAOYSA-N 0.000 description 1
- 101000898082 Homo sapiens Calbindin Proteins 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 244000062730 Melissa officinalis Species 0.000 description 1
- 235000010654 Melissa officinalis Nutrition 0.000 description 1
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 1
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 1
- CJKGLEVYDCRGBX-FQYIUYQHSA-N N-(30-(9Z,12Z-octadecadienoyloxy)-tricontanoyl)-sphing-4-enine Chemical compound CCCCCCCCCCCCC\C=C\[C@@H](O)[C@H](CO)NC(=O)CCCCCCCCCCCCCCCCCCCCCCCCCCCCCOC(=O)CCCCCCC\C=C/C\C=C/CCCCC CJKGLEVYDCRGBX-FQYIUYQHSA-N 0.000 description 1
- NPRJSFWNFTXXQC-QFWQFVLDSA-N N-(hexanoyl)sphing-4-enine Chemical compound CCCCCCCCCCCCC\C=C\[C@@H](O)[C@H](CO)NC(=O)CCCCC NPRJSFWNFTXXQC-QFWQFVLDSA-N 0.000 description 1
- DAAZGMWCIAIMCL-ZDXQCDESSA-N N-hexanoylphytosphingosine Chemical compound CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@H](CO)NC(=O)CCCCC DAAZGMWCIAIMCL-ZDXQCDESSA-N 0.000 description 1
- KZTJQXAANJHSCE-OIDHKYIRSA-N N-octodecanoylsphinganine Chemical compound CCCCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)CCCCCCCCCCCCCCC KZTJQXAANJHSCE-OIDHKYIRSA-N 0.000 description 1
- YKFRUJSEPGHZFJ-UHFFFAOYSA-N N-trimethylsilylimidazole Chemical compound C[Si](C)(C)N1C=CN=C1 YKFRUJSEPGHZFJ-UHFFFAOYSA-N 0.000 description 1
- GLZPCOQZEFWAFX-JXMROGBWSA-N Nerol Natural products CC(C)=CCC\C(C)=C\CO GLZPCOQZEFWAFX-JXMROGBWSA-N 0.000 description 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000021319 Palmitoleic acid Nutrition 0.000 description 1
- 241000282372 Panthera onca Species 0.000 description 1
- 244000271379 Penicillium camembertii Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 235000011432 Prunus Nutrition 0.000 description 1
- 241000220299 Prunus Species 0.000 description 1
- 101001021643 Pseudozyma antarctica Lipase B Proteins 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 244000044822 Simmondsia californica Species 0.000 description 1
- 235000004433 Simmondsia californica Nutrition 0.000 description 1
- NWGKJDSIEKMTRX-AAZCQSIUSA-N Sorbitan monooleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-AAZCQSIUSA-N 0.000 description 1
- 235000000538 Terminalia arjuna Nutrition 0.000 description 1
- 244000071109 Terminalia arjuna Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- NWGKJDSIEKMTRX-BFWOXRRGSA-N [(2r)-2-[(3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)C1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-BFWOXRRGSA-N 0.000 description 1
- FENRSEGZMITUEF-ATTCVCFYSA-E [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].OP(=O)([O-])O[C@@H]1[C@@H](OP(=O)([O-])[O-])[C@H](OP(=O)(O)[O-])[C@H](OP(=O)([O-])[O-])[C@H](OP(=O)(O)[O-])[C@H]1OP(=O)([O-])[O-] Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].OP(=O)([O-])O[C@@H]1[C@@H](OP(=O)([O-])[O-])[C@H](OP(=O)(O)[O-])[C@H](OP(=O)([O-])[O-])[C@H](OP(=O)(O)[O-])[C@H]1OP(=O)([O-])[O-] FENRSEGZMITUEF-ATTCVCFYSA-E 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 238000005904 alkaline hydrolysis reaction Methods 0.000 description 1
- 235000020224 almond Nutrition 0.000 description 1
- 239000001140 aloe barbadensis leaf extract Substances 0.000 description 1
- 239000004411 aluminium Substances 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 159000000013 aluminium salts Chemical class 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 229940071248 anisate Drugs 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 239000012062 aqueous buffer Substances 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 239000010480 babassu oil Substances 0.000 description 1
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical class CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- FQUNFJULCYSSOP-UHFFFAOYSA-N bisoctrizole Chemical compound N1=C2C=CC=CC2=NN1C1=CC(C(C)(C)CC(C)(C)C)=CC(CC=2C(=C(C=C(C=2)C(C)(C)CC(C)(C)C)N2N=C3C=CC=CC3=N2)O)=C1O FQUNFJULCYSSOP-UHFFFAOYSA-N 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229940092542 ceramide eos Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- YZIYKJHYYHPJIB-UUPCJSQJSA-N chlorhexidine gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.C1=CC(Cl)=CC=C1NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC1=CC=C(Cl)C=C1 YZIYKJHYYHPJIB-UUPCJSQJSA-N 0.000 description 1
- MJSNUBOCVAKFIJ-LNTINUHCSA-N chromium;(z)-4-oxoniumylidenepent-2-en-2-olate Chemical compound [Cr].C\C(O)=C\C(C)=O.C\C(O)=C\C(C)=O.C\C(O)=C\C(C)=O MJSNUBOCVAKFIJ-LNTINUHCSA-N 0.000 description 1
- SECPZKHBENQXJG-UHFFFAOYSA-N cis-palmitoleic acid Natural products CCCCCCC=CCCCCCCCC(O)=O SECPZKHBENQXJG-UHFFFAOYSA-N 0.000 description 1
- 229940043350 citral Drugs 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 229960000956 coumarin Drugs 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- DTPCFIHYWYONMD-UHFFFAOYSA-N decaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO DTPCFIHYWYONMD-UHFFFAOYSA-N 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 235000019258 dehydroacetic acid Nutrition 0.000 description 1
- 229940061632 dehydroacetic acid Drugs 0.000 description 1
- 238000001212 derivatisation Methods 0.000 description 1
- 239000011903 deuterated solvents Substances 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 description 1
- 229940047642 disodium cocoamphodiacetate Drugs 0.000 description 1
- 229940079779 disodium cocoyl glutamate Drugs 0.000 description 1
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 description 1
- GLSRFBDXBWZNLH-UHFFFAOYSA-L disodium;2-chloroacetate;2-(4,5-dihydroimidazol-1-yl)ethanol;hydroxide Chemical compound [OH-].[Na+].[Na+].[O-]C(=O)CCl.OCCN1CCN=C1 GLSRFBDXBWZNLH-UHFFFAOYSA-L 0.000 description 1
- 238000002072 distortionless enhancement with polarization transfer spectrum Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 238000011067 equilibration Methods 0.000 description 1
- 239000012259 ether extract Substances 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000010408 film Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000003084 food emulsifier Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 229920000370 gamma-poly(glutamate) polymer Polymers 0.000 description 1
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 1
- 229940113087 geraniol Drugs 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- 150000002314 glycerols Chemical class 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- 229940074052 glyceryl isostearate Drugs 0.000 description 1
- 229940074046 glyceryl laurate Drugs 0.000 description 1
- 229940049294 glyceryl stearate se Drugs 0.000 description 1
- 229940100608 glycol distearate Drugs 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 150000004688 heptahydrates Chemical class 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 1
- UQEAIHBTYFGYIE-UHFFFAOYSA-N hexamethyldisiloxane Chemical class C[Si](C)(C)O[Si](C)(C)C UQEAIHBTYFGYIE-UHFFFAOYSA-N 0.000 description 1
- 229940100463 hexyl laurate Drugs 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 239000000077 insect repellent Substances 0.000 description 1
- 238000010813 internal standard method Methods 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 229940001447 lactate Drugs 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 229940031674 laureth-7 Drugs 0.000 description 1
- 239000000171 lavandula angustifolia l. flower oil Substances 0.000 description 1
- 239000001102 lavandula vera Substances 0.000 description 1
- 235000018219 lavender Nutrition 0.000 description 1
- 229940040102 levulinic acid Drugs 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 229940044591 methyl glucose dioleate Drugs 0.000 description 1
- DDIZAANNODHTRB-UHFFFAOYSA-N methyl p-anisate Chemical compound COC(=O)C1=CC=C(OC)C=C1 DDIZAANNODHTRB-UHFFFAOYSA-N 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- 239000002324 mouth wash Substances 0.000 description 1
- 229940051866 mouthwash Drugs 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- BARWIPMJPCRCTP-CLFAGFIQSA-N oleyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC BARWIPMJPCRCTP-CLFAGFIQSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
- 229960001173 oxybenzone Drugs 0.000 description 1
- 239000003346 palm kernel oil Substances 0.000 description 1
- 235000019865 palm kernel oil Nutrition 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 125000004817 pentamethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[*:1] 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229940043707 polyglyceryl-6 distearate Drugs 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- RMGVATURDVPNOZ-UHFFFAOYSA-M potassium;hexadecyl hydrogen phosphate Chemical compound [K+].CCCCCCCCCCCCCCCCOP(O)([O-])=O RMGVATURDVPNOZ-UHFFFAOYSA-M 0.000 description 1
- 229940078491 ppg-15 stearyl ether Drugs 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- MYBAXOBGFKMWLR-UHFFFAOYSA-N propane-1,2,3-triol heptahydrate Chemical compound O.O.O.O.O.O.O.OCC(O)CO MYBAXOBGFKMWLR-UHFFFAOYSA-N 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- ARIWANIATODDMH-UHFFFAOYSA-N rac-1-monolauroylglycerol Chemical compound CCCCCCCCCCCC(=O)OCC(O)CO ARIWANIATODDMH-UHFFFAOYSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000013558 reference substance Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229940066675 ricinoleate Drugs 0.000 description 1
- WBHHMMIMDMUBKC-QJWNTBNXSA-M ricinoleate Chemical compound CCCCCC[C@@H](O)C\C=C/CCCCCCCC([O-])=O WBHHMMIMDMUBKC-QJWNTBNXSA-M 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 235000003441 saturated fatty acids Nutrition 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 150000003333 secondary alcohols Chemical class 0.000 description 1
- 230000037307 sensitive skin Effects 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 229940080272 sodium coco-sulfate Drugs 0.000 description 1
- 229940096501 sodium cocoamphoacetate Drugs 0.000 description 1
- 229940065859 sodium cocoyl glycinate Drugs 0.000 description 1
- 239000011775 sodium fluoride Substances 0.000 description 1
- 235000013024 sodium fluoride Nutrition 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 229940057950 sodium laureth sulfate Drugs 0.000 description 1
- 229940007636 sodium lauroyl methyl isethionate Drugs 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 229940083982 sodium phytate Drugs 0.000 description 1
- NTYZDAJPNNBYED-UHFFFAOYSA-M sodium;2-(2-dodecanoyloxypropanoyloxy)propanoate Chemical compound [Na+].CCCCCCCCCCCC(=O)OC(C)C(=O)OC(C)C([O-])=O NTYZDAJPNNBYED-UHFFFAOYSA-M 0.000 description 1
- IKGKWKGYFJBGQJ-UHFFFAOYSA-M sodium;2-(dodecanoylamino)acetate Chemical compound [Na+].CCCCCCCCCCCC(=O)NCC([O-])=O IKGKWKGYFJBGQJ-UHFFFAOYSA-M 0.000 description 1
- SXHLENDCVBIJFO-UHFFFAOYSA-M sodium;2-[2-(2-dodecoxyethoxy)ethoxy]ethyl sulfate Chemical compound [Na+].CCCCCCCCCCCCOCCOCCOCCOS([O-])(=O)=O SXHLENDCVBIJFO-UHFFFAOYSA-M 0.000 description 1
- NVIZQHFCDBQNPH-UHFFFAOYSA-M sodium;2-dodecanoyloxypropane-1-sulfonate Chemical compound [Na+].CCCCCCCCCCCC(=O)OC(C)CS([O-])(=O)=O NVIZQHFCDBQNPH-UHFFFAOYSA-M 0.000 description 1
- CRPCXAMJWCDHFM-UHFFFAOYSA-M sodium;5-oxopyrrolidine-2-carboxylate Chemical compound [Na+].[O-]C(=O)C1CCC(=O)N1 CRPCXAMJWCDHFM-UHFFFAOYSA-M 0.000 description 1
- 238000006561 solvent free reaction Methods 0.000 description 1
- 239000011877 solvent mixture Substances 0.000 description 1
- WSWCOQWTEOXDQX-MQQKCMAXSA-N sorbic acid group Chemical group C(\C=C\C=C\C)(=O)O WSWCOQWTEOXDQX-MQQKCMAXSA-N 0.000 description 1
- 229950004959 sorbitan oleate Drugs 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- ABTZKZVAJTXGNN-UHFFFAOYSA-N stearyl heptanoate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)CCCCCC ABTZKZVAJTXGNN-UHFFFAOYSA-N 0.000 description 1
- 229940098758 stearyl heptanoate Drugs 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 229940034610 toothpaste Drugs 0.000 description 1
- 239000000606 toothpaste Substances 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 229940098385 triisostearin Drugs 0.000 description 1
- HADKRTWCOYPCPH-UHFFFAOYSA-M trimethylphenylammonium hydroxide Chemical compound [OH-].C[N+](C)(C)C1=CC=CC=C1 HADKRTWCOYPCPH-UHFFFAOYSA-M 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 229940043810 zinc pyrithione Drugs 0.000 description 1
- XOOUIPVCVHRTMJ-UHFFFAOYSA-L zinc stearate Chemical compound [Zn+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O XOOUIPVCVHRTMJ-UHFFFAOYSA-L 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
- PICXIOQBANWBIZ-UHFFFAOYSA-N zinc;1-oxidopyridine-2-thione Chemical compound [Zn+2].[O-]N1C=CC=CC1=S.[O-]N1C=CC=CC1=S PICXIOQBANWBIZ-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
- C12P7/6436—Fatty acid esters
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/02—Monosaccharides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/18—Carboxylic ester hydrolases (3.1.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/18—Carboxylic ester hydrolases (3.1.1)
- C12N9/20—Triglyceride splitting, e.g. by means of lipase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/44—Preparation of O-glycosides, e.g. glucosides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/62—Carboxylic acid esters
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
- C12P7/6436—Fatty acid esters
- C12P7/6445—Glycerides
- C12P7/6454—Glycerides by esterification
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
- Y02E50/00—Technologies for the production of fuel of non-fossil origin
- Y02E50/10—Biofuels, e.g. bio-diesel
Definitions
- the invention provides a process for enzymatic preparation of sorbitan carboxylates, and the sorbitan carboxylates obtainable by this process.
- Sorbitol carboxylates are products of interest to the food and cosmetics industries not only on account of their surfactant properties, but also because of the possibility of obtaining them from natural and renewable raw materials.
- DE102009001748A describes sorbitan esters obtained from the solvent-free reaction of 1 mol of sorbitol (also called glucitol) with 1.55 mol of caprylic acid, and the use of the sorbitan esters thus obtained as thickener for aqueous surfactant systems. It is a disadvantage of the process that, under the reaction conditions described, the sorbitol is dehydrated virtually completely, but at least partially, and forms what is called sorbitan (a product mixture).
- JP63133991 describes the reaction of 1.0 equivalent of oleic acid with 1.0 equivalent of sorbitol in the presence of >9% lipase ( Candida Sp) at 40-50° C. and 100 mmHg (133 mbar).
- a disadvantage of this process described in the prior art is that only about 70% esterification is attained.
- a further disadvantage is that only pure oleic acid is used, which is too costly for industrial applications in the food and cosmetics sector and hence uneconomic.
- DE3430944 describes the reaction of ⁇ 4.0 equivalents of oleic acid or stearic acid with 1.0 equivalent of sorbitol in the presence of about 7% lipase at 40° C. for 72 h, wherein the reactants and the enzyme are reacted with one another in a concentration by mass of about 28 g per 1000 ml in an aqueous buffer system.
- a disadvantage of this process described in the prior art is the use of aqueous phosphate buffer, the salt burden of which in the product is undesirable for use in cosmetics.
- a further disadvantage is that the concentration by mass of the reactants and of the lipase in the buffer system is only about 3%, which means much too low a space-time yield for industrial conversions.
- a further disadvantage is that only pure oleic acid and pure stearic acid are used.
- EP1755545B1 describes a mixture of sorbitan esters and sorbitol esters, wherein the chain length of the fatty acid of the sorbitan ester is greater than the chain length of the fatty acid of the sorbitol ester, and more than 80% saturated fatty acids is always used.
- the sorbitan esters are at least 50% of the mixture.
- the sorbitol esters consist solely of mono- and diesters, with at least 40% monoesters and less than 60% diesters, and are used to influence emulsion stability and viscosity. Proceeding from lauric acid, a mixture consisting of 7% sorbitan esters, 68% C12 sorbitol esters and 25% polyol is obtained.
- a disadvantage of the process for preparation described in the prior art is the fact that sorbitan esters are formed here too, as a result of which the hydrophilic portion of the surfactant is reduced, and a poor colour is also obtained.
- the problem addressed by the present invention was that of providing a process for preparing sorbitan esters that is capable of overcoming at least one disadvantage of the prior art processes.
- the sorbitol carboxylates of the invention are excellent thickeners for aqueous surfactant systems compared to the prior art.
- the sorbitol carboxylates of the invention also have excellent colour and very good odour compared to the prior art.
- the sorbitol carboxylates are obtained in a homogeneous reaction mixture, which means that no additional process steps such as extraction, crystallization, filtration or distillation are required.
- An advantage of the present invention is that the process can be carried out at elevated temperatures. This leads to better miscibility of the co-reactants, while the recyclability of the enzyme used is surprisingly high.
- the present invention therefore provides a process for enzymatic preparation of a sorbitol carboxylate, comprising the process steps of
- process step A) comprises blending the sorbitol and the at least one acyl group donor within a temperature range of 80° C. to 120° C., preferably of 90° C. to 120° C., even more preferably of 95° C. to 120° C., even more preferably of 100° C. to 120° C., for at least 10 minutes, preferably at least 30 minutes, even more preferably at least 60 minutes.
- sorbitol carboxylates in the context of the present invention includes a composition that contains a majority of, especially at least 40% by weight, preferably at least 50% by weight, even more preferably at least 60% by weight, of carboxylic esters of sorbitol, based on the overall composition.
- by-products from the respective preparation processes may also be present, for example carboxylic esters of 1,4-anhydrosorbitol, carboxylic esters of 2,5-anhydrosorbitol, carboxylic esters of 1,5-anhydrosorbitol and carboxylic esters of isosorbide, and also unreacted reactants.
- sorbitol carboxylates and “sorbitan carboxylates” are used synonymously in the context of the present invention.
- sorbitan esters to mean a mixture comprising not only esters of 1,4-anhydrosorbitol and esters of 1,5-anhydrosorbitol, but also esters of isosorbide and esters of sorbitol, and also free sorbitol; in this regard see also Food emulsifiers and their applications, 1997, page 26.
- carboxylic esters of sorbitol in the context of the present invention refers to pure sorbitol compounds.
- carboxylic esters of 1,4-anhydrosorbitol in the context of the present invention refers to pure 1,4-anhydrosorbitol compounds.
- carboxylic esters of 2,5-anhydrosorbitol in the context of the present invention refers to pure 2,5-anhydrosorbitol compounds.
- carboxylic esters of 1,5-anhydrosorbitol in the context of the present invention refers to pure 1,5-anhydrosorbitol compounds.
- carboxylic esters of isosorbide in the context of the present invention refers to pure isosorbide compounds.
- acyl group donors include for example carboxylic esters or carboxylic acids themselves, and mixtures thereof.
- the acyl group donor provided in process step A) provides acyl groups that derive from a carboxylic acid containing 2 to 34, preferably 4 to 24, more preferably 6 to 22, carbon atoms, especially a natural fatty acid or mixtures thereof.
- Carboxylic esters used with preference in accordance with the invention as acyl group donor are selected from esters based on alkanols and polyols having up to 6 carbon atoms, particularly preferably having up to 3 carbon atoms, very particularly preferably glycerol esters.
- Carboxylic esters used with particular preference in accordance with the invention as acyl group donor are selected from triglycerides, especially natural fats and oils, particularly preferably selected from the group comprising, preferably consisting of, coconut fat, palm kernel oil, olive oil, palm oil, argan oil, castor oil, linseed oil, babassu oil, rapeseed oil, algal oils, sesame oil, soya oil, avocado oil, jojoba oil, safflower oil, almond oil, cottonseed oil, shea butter, sunflower oil, cupuaçu butter and oils having a high proportion of polyunsaturated fatty acids (PUFAs).
- Sorbitan esters, monoglycerides and diglycerides, in particular containing the acyl groups described hereinbelow, may likewise preferably be used.
- the acyl group donor is selected from fatty acid acyl group donors that in particular provide an acyl group selected from the group of acyl groups of natural fatty acids, or mixtures thereof.
- Preferred fatty acids in this connection are mixtures of natural fatty acids, especially mixtures in which no carboxylic acid chain length has a proportion in the overall chain length distribution of more than 95% by weight, especially more than 99% by weight.
- Natural fatty acids can be produced on the basis of naturally occurring vegetable or animal oils and have preferably 6 to 30 carbon atoms, especially 8 to 22 carbon atoms. Natural fatty acids are generally unbranched and usually consist of an even number of carbon atoms. Any double bonds have cis configuration.
- caproic acid caproic acid, caprylic acid, capric acid, lauric acid, myristic acid, palmitic acid, palmifoleic acid, pelargonic acid (obtainable for example from the ozonolysis or oxidative cleavage of oleic acid), isostearic acid, stearic acid, 12-hydroxystearic acid, dihydroxystearic acid, undecylenic acid (obtainable for example from the pyrolysis of ricinoleic acid), oleic acid, linoleic acid, linolenic acid, petroselinic acid, elaidic acid, arachic acid, behenic acid, erucic acid, gadoleic acid, eicosapentaenoic acid, docosahexaenoic acid and arachidonic acid.
- the acyl group donor is selected from fatty acid acyl group donors that are characterized in that they provide an acyl group mixture containing at least two acyl groups of the carboxylic acids selected from the group of caproic acid, caprylic acid, capric acid, lauric acid, myristic acid, palmitic acid, palmitoleic acid, pelargonic acid (obtainable for example from the ozonolysis or oxidative cleavage of oleic acid), isostearic acid, stearic acid, 12-hydroxystearic acid, dihydroxystearic acid, undecylenic acid (obtainable for example from the pyrolysis of ricinoleic acid), oleic acid, linoleic acid, linolenic acid, petroselinic acid, elaidic acid, arachic acid, behenic acid, erucic acid, gadoleic acid, eicosapentaenoic acid, docos
- Acyl group donors used with preference in accordance with the invention are carboxylic acids, especially fatty acids.
- Preferred fatty acids in this connection are those mentioned above in connection with the fatty acids provided with preference.
- Acyl group donors used alternatively with particular preference are mixtures of fatty acids with glycerol fatty acid esters, preference being given to using those mentioned above in connection with fatty acids provided with preference, both in the case of the fatty acids and in the case of the glycerol fatty acid components, with an identical degree of preference.
- the mixture of fatty acid with glycerol fatty acid ester used preferably has a weight ratio of fatty acid to glycerol fatty acid ester of 80:20 to 99:1, preferably of 90:10 to 99:1, more preferably of 95:5 to 99:1.
- a process preferred in accordance with the invention is characterized in that the sorbitol and the at least one acyl group donor make up at least 80% by weight, preferably at least 90% by weight, more preferably at least 95% by weight, based on the overall reaction mixture at the start of process step B).
- Possible solvents would be for example ketones, for example methyl isohutyl ketone or cyclohexanone, sterically hindered secondary alcohols such as 2-butyl-1-octanol, methylcyclohexanols, 1-methoxy-2-propanol, butane-2,3-diol, 2-octanol, diacetone alcohol, 2-methyl-2-butanol, and ethers such as 1,4-dioxane, tetrahydrofuran and Varonic APM.
- ketones for example methyl isohutyl ketone or cyclohexanone
- sterically hindered secondary alcohols such as 2-butyl-1-octanol, methylcyclohexanols, 1-methoxy-2-propanol, butane-2,3-diol, 2-octanol, diacetone alcohol, 2-methyl-2-butanol
- ethers such as 1,
- solvents are present in a maximum total amount of less than 20% by weight, preferably less than 10% by weight, especially less than 5% by weight.
- the expression “is present in a maximum amount of less than X % by weight” can be equated with “has a content of less than X % by weight”.
- a process preferred in accordance with the invention is thus especially characterized in that, in process step B), the water content based on the overall reaction mixture is less than 15% by weight, preferably less than 5.0% by weight, more preferably less than 1.0% by weight.
- Lipases used with preference in accordance with the invention in process step B) are present immobilized on a solid support.
- Lipases used with preference in accordance with the invention in process step B) are lipases selected from the group comprising the lipase from Thermomyces lanuginosus (accession number O59952), lipases A and B (accession number P41365) from Candida antarctica and the lipase from Mucor miehei (accession number P19515), the lipase from Humicola sp.
- accession numbers listed in the context of the present invention correspond to the ProteinBank database entries of the NCBI with a date of Jan. 1, 2017; generally, in the present context, the version number of the entry is identified by “.digit”, for example “.1”.
- Enzymes that are homologous at the amino acid level preferably have, by comparison with the reference sequence, at least 50%, especially at least 90%, of the enzyme activity in propyl laurate units (PLU) as defined in the context of the present invention.
- PLU propyl laurate units
- PLU propyl laurate units
- 1-propanol and lauric acid are mixed homogeneously in an equimolar ratio at 60° C.
- the reaction is started with addition of enzyme and the reaction time is measured.
- Samples are taken from the reaction mixture at intervals and the content of converted lauric acid is determined by titration with potassium hydroxide solution.
- the enzyme activity in PLU results from the rate at which 1 g of the enzyme in question synthesizes 1 ⁇ mol of propyl laurate per minute at 60° C.; cf. in this respect also US20070087418, in particular [0185].
- lipases that are likewise used with preference in processes according to the invention, are the commercial products Lipozyme TL IM, Novozym 435, Lipozyme IM 20, Lipase SP382, Lipase SP525, Lipase SP523, (all commercial products from Novozymes A/S, Bagsvaerd, Denmark), Chirazyme L2, Chirazyme L5, Chirazyme L8, Chirazyme L9 (all commercial products from Roche Molecular Biochemicals, Mannheim, Germany), CALB IMMO Plus TM from Purolite, and Lipase M “Amano”, Lipase F-AP 15 “Arnano”, Lipase AY “Amano”, Lipase N “Amano”, Lipase R “Amano”, Lipase A “Amano”, Lipase D “Amano”, Lipase G “Amano” (all commercial products from Amano, Japan).
- “Homology at the amino acid level” is for the purposes of the present invention understood as meaning “amino acid identity”, which can be determined with the aid of known methods. In general, use is made of special computer programs with algorithms taking into account specific requirements. Preferred methods for determining the identity first generate the closest match between the sequences to be compared. Computer programs for determining the identity include, but are not limited to, the GCG program package including
- the percentage identity between two amino acid sequences can be determined for example by the algorithm developed by Needleman and Wunsch (J. Mol. Biol. (48): 444-453 (1970)), which has been integrated into the GAP program in the GCG software package (available at http://www.gcg.com), using either a Blossom 62 matrix or a PAM250 matrix, a gap weight of 16, 14, 12, 10, 8, 6 or 4 and a length weight of 1, 2, 3, 4, 5 or 6.
- Blossom 62 matrix is typically employed, using the default settings (gap weight: 12, length weight: 1).
- an identity of 60% means 60% homology. The same applies to higher identities.
- process step B preference is given in accordance with the invention to using 500 PLU to 2000 PLU, preferably from 200 PLU to 1500 PLU, more preferably from 25 PLU to 1250 PLU, of lipase per gram of sorbitol to be converted.
- Process step B) is in accordance with the invention preferably carried out at a pressure of less than 1 bar, preferably less than 0.5 bar and particularly preferably less than 0.1 bar.
- Process step B) is in accordance with the invention alternatively preferably carried out in a bubble column reactor, with at least one inert gas being passed through the reaction mixture; this gas is preferably selected from the group comprising, preferably consisting of, nitrogen and argon.
- the gas stream it is preferable in accordance with the invention for the gas stream to be 1 to 60 kg/h, preferably 5 to 25 kg/h, yet more preferably 10 to 14 kg/h.
- Process step B) is in accordance with the invention preferably characterized in that process step B) is ended no later than 180 hours, preferably 120 hours, particularly preferably 100 hours, after the lipase has been added.
- a process that is preferred in accordance with the invention is characterized in that the molar ratio of sorbitol provided to acyl groups present in all acyl group donors provided is within a range from 1.00:0.50 to 1.00:5.00, preferably from 1.00:0.70 to 1.00:3.00, particularly preferably from 1.00:1.00 to 1.00:2.25, alternatively particularly preferably from 1.00:2.3 to 1.00:4.50.
- a process that is preferred in accordance with the invention is characterized in that by-products formed in process step B), for example water when the acyl group donor used is an acid and the corresponding alcohol when the acyl group donor used is an ester, are removed.
- Process step C) of the process of the invention comprises the purification of the sorbitol carboxylate.
- the process according to the invention includes the removal, in process step C), of the lipase used in the process according to the invention.
- the lipase is removed by filtration through a filter, especially a bag filter, having a fineness of 0.1 ⁇ to 1250 ⁇ , preferably of 0.5 ⁇ to 100 ⁇ .
- the process of the present invention is preferably in accordance with the invention characterized in that it does not involve any use of a molecular sieve.
- the process of the present invention is preferably in accordance with the invention characterized in that the substrates are not immobilized on solid supports such as silica.
- the present invention further provides the sorbitol carboxylate obtainable by the process of the invention.
- sorbitol carboxylates comprising carboxylic esters of sorbitol, carboxylic esters of 1,4-anhydrosorbitol, carboxylic esters of 2,5-anhydrosorbitol, carboxylic esters of 1,5-anhydrosorbitol, and carboxylic esters of isosorbide, where the ratio by weight of the sorbitol residues present in the sorbitol carboxylate to the sum total of all the 1,4-anhydrosorbitol residues, 2,5-anhydrosorbitol residues and 1,5-anhydrosorbitol residues and isosorbide residues present in the sorbitol carboxylate is greater than 90:10, preferably greater than 93:7, more preferably greater than 95:5, most preferably greater than 96:4, characterized in that the molar ratio of esterified primary hydroxyl groups to esterified secondary hydroxyl groups in the carboxylic esters of sorbito
- the weight ratio of the sorbitol residues present in the sorbitol carboxylates according to the invention to the sum total of all 1,4-anhydrosorbitol residues, 2,5-anhydrosorbitol residues, 1,5-anhydrosorbitol residues and isosorbide residues present in the sorbitol carboxylate according to the invention is determined by means of high-performance liquid chromatography (HPLC).
- HPLC high-performance liquid chromatography
- an initial charge of 150 mg of the sorbitol carboxylate to be analysed in 2.00 ml of 1 M aqueous KOH solution is hydrolysed at 95° C. with stirring for 30 min.
- the reaction solution is then cooled to room temperature and adjusted to pH 2-3 with 2 M aqueous HCl solution.
- the carboxylic acids that precipitate out as a result are then extracted with diethyl ether (3 ⁇ 3.00 ml), with removal of the organic supernatant by pipette after each extraction.
- the aqueous solution is heated to 50° C. with stirring for 20 min, which removes the rest of the ether (boiling point of diethyl ether: 34.6° C.).
- the solution obtained above is made up to 10.0 ml with bidistilled H 2 O and then diluted 1:10, and an aliquot of the solution is analysed by HPLC.
- the analysis is carried out under the following conditions:
- Sorbitol and its degradation products are separated by an ion-exchange process.
- the peak area of sorbitol is expressed relative to the sum total of the peak areas of 1,4-anhydrosorbitol, 2,5-anhydrosorbitol, 1,5-anhydrosorbitol and isosorbide.
- Reference substances for the sorbitol degradation products are commercially available or can alternatively be obtained by heating sorbitol in neat form in the presence of acidic (>140° C.) or basic (>180° C.) catalysts.
- the molar ratio of esterified primary hydroxyl groups to esterified secondary hydroxyl groups in the carboxylic esters of sorbitol is determined by 13 C NMR spectroscopy.
- a deuterated solvent to which has been added a relaxation agent (chromium(III) acetylacetonate, 1%).
- DMSO-d6, CDCl 3 and methanol-d4 have been found to be suitable solvents, according to product properties. If the sample does not dissolve completely in one of the solvents, a solvent mixture must be found.
- the prepared sample solution is transferred to a 5 mm NMR tube and introduced into the NMR spectrometer.
- the NMR spectroscopy investigations can in principle be carried out with any commercial NMR instrument.
- a Bruker Avance 400 instrument was used for the present NMR spectroscopy investigations.
- the spectra were recorded with the following parameters:
- Other commercial NMR instruments give comparable results with the same operating parameters.
- the signals are quantified by determining the area under the respective resonance signals, i.e. the area enclosed by the signal from the baseline.
- the spectra were integrated using the “TOPSPIN” software, version 3.0.
- esterified primary and esterified secondary hydroxyl groups For more accurate identification of the esterified primary and esterified secondary hydroxyl groups, a DEPT spectrum is first recorded. The molar ratio of esterified primary to esterified secondary hydroxyl groups is determined by subtracting the integral value P (group of signals for the esterified primary hydroxyl groups) from integral value C (group of signals for the ester carbonyl groups).
- the ratio of P to S ascertained corresponds to the molar ratio of esterified primary hydroxyl groups to esterified secondary hydroxyl groups in the carboxylic esters of sorbitol.
- the average degree of esterification of the carboxylic esters of sorbitol present in the sorbitol carboxylate according to the invention is determined, for example, by first determining the content of free sorbitol and of its 1,4-anhydrosorbitol, 2,5-anhydrosorbitol, 1,5-anhydrosorbitol and isosorbide degradation products in a sample of the sorbitol carboxylate in question. It is additionally necessary to determine the saponification value, acid value and content of free and neutralized fatty acids (for example via GC as described hereinbelow under “Determination of the content of free carboxylic acid”). The determination of the carboxylic acid composition after alkaline saponification gives an average molar mass of the carboxylic acid mixture that has been esterified.
- This value can then be used to calculate the average degree of esterification.
- a sorbitol carboxylate that is characterized in that the carboxylic esters of sorbitoi present comprise monoesters of sorbitol, diesters of sorbitol and triesters of sorbitol, where the triesters of sorbitol are present preferably in an amount, based on all carboxylic esters of sorbitol present, of 10% to 50% by weight, preferably of 15% by weight to 45% by weight, more preferably of 20% by weight to 40% by weight.
- carboxylic esters of sorbitol present comprise monoesters of sorbitol, diesters of sorbitol, triesters of sorbitol and tetraesters of sorbitol.
- a sorbitol carboxylate that is characterized in that it contains 0.05% to 40% by weight, preferably 0.2% to 25% by weight, more preferably 0.5% to 10% by weight, of free sorbitol,
- sorbitol present in the sorbitol carboxylate of the invention For determination of the sorbitol present in the sorbitol carboxylate of the invention by GC, a portion of the sample is dissolved in pyridine:chloroform (4:1). 0.25 ml of this solution is mixed with 0.5 ml of MSTFA [N-methyl-N-(trimethylsilyl)trifluoroacetamide] and 0.5 ml of a mixture of N-trimethylsilylimidazole and pyridine (11:39).
- the alcohols are quantitatively converted into their trimethylsilyl ethers by reaction at 80° C. (30 minutes) and then analysed by GC/FID.
- Carrier gas Hydrogen, constant flow, 2 ml/min
- Temperature program 100° C. to 140° C. at 10° C./min, then 140° C. to 300° C. at 5° C./min, then conditioning at 300° C. for 5 minutes.
- the sorbitol is separated off and its proportion by mass determined by an internal standard method.
- the GC system is calibrated by analysing mixtures of sorbitol and of the internal standard of known composition.
- a sorbitol carboxylate that is characterized in that it contains less than 25% by weight, preferably from 0.01% by weight to 20% by weight, more preferably from 0.05% by weight to 10% by weight, of at least one free carboxylic acid, the percentages by weight being based on the overall sorbitol carboxylate.
- the at least one free carboxylic acid may be in protonated or neutralized form.
- the acid value is first determined. Through the acid value and molecular weight of the fatty acid concerned, it is possible to determine the proportion by weight.
- Suitable methods for determining the acid number are particularly those according to DGF C-V 2, DIN EN ISO 2114, Ph. Eur. 2.5.1, ISO 3682 and ASTM D 974.
- a GC analysis can also additionally be carried out after saponification of the sorbitol carboxylate, in order to determine an average molecular weight of the carboxylic acid mixture present.
- 0.6 g of the sorbitol carboxylate of the invention is boiled under reflux in 25 ml of 0.5 M ethanolic KOH solution for 4 hours.
- the pH is then adjusted to 2-3 with sulfuric acid and the liberated carboxylic acids are separated by extracting three times with a volume of petroleum ether.
- the combined extracts are concentrated to about 10 ml by evaporation.
- Suitable methods for determining the fatty acid distribution are in particular those according to DGF C VI 11a, DGF C-VI 10 a and GAT ring test 7/99.
- a 0.5 ml aliquot of the petroleum ether extract obtained as described above is mixed in an autosampler vial with 0.5 ml of MTBE and 1 ml of trimethylanilinium hydroxide (0.2 M in methanol) and analysed by GC. This is performed in a gas chromatograph equipped with a split/splitless injector, a capillary column and a flame ionization detector, under the following conditions:
- Carrier gas Helium, head pressure 70 kPa
- the carboxylic acids are separated according to length of their carbon chain in the form of their methyl esters. By evaluating the peak areas it is possible to determine the mass ratio of these carboxylic acid methyl esters to one another and from this—via their respective molecular weights—their molar ratio, which corresponds to the molar ratio of the associated carboxylic acids. it is in addition possible to determine an average molecular weight of this fatty acid mixture:
- n i a i ( M i + 14 )
- n i Molar amount [mol] of carboxylic acid methyl ester i in 100 g of carboxylic acid methyl ester mixture; from this, the ratios of the individual n i values to one another are obtained, which correspond to the ratios of the molar amounts of the associated carboxylic acids in the sorbitol carboxylate; thus it is possible for the total molar amount n s [mol] of carboxylic acids in 1 g of sorbitol carboxylate, as obtained from the saponification value (see below), to be split into its components according to said ratios.
- M i Molecular weight of the carboxylic acid corresponding to methyl ester i [g/mol].
- M s _ ⁇ i ( n i ⁇ i n i ⁇ M i )
- M s _ Average ⁇ molecular ⁇ weight ⁇ of ⁇ the ⁇ mixture ⁇ of ⁇ carboxylic ⁇ acids .
- n i Molar ⁇ amount [ mol ] ⁇ of ⁇ carboxylic ⁇ ⁇ acid ⁇ methyl ⁇ ester ⁇ i ⁇ in ⁇ 100 ⁇ g ⁇ of ⁇ carboxylic ⁇ acid ⁇ methyl ⁇ ester ⁇ mixture .
- M i Molecular ⁇ weight ⁇ of ⁇ the ⁇ carboxylic ⁇ acid ⁇ i [ g / mol ] .
- a sorbitol carboxylate that is characterized in that the total monoester component of the carboxylic ester of sorbitol contains from 5% by weight to 25% by weight, preferably from 7% by weight to 15% by weight, more preferably from 9% by weight to 13% by weight, of secondary ester regiolsomers.
- a sorbitol carboxylate that is characterized in that the total monoester component of the carboxylic ester of sorbitol and the total diester component of the carboxylic ester of sorbitol each comprise at least two regioisomers.
- a sorbitol carboxylate that is characterized in that the total diester component of the carboxylic ester of sorbitol contains from 25% by weight to 45% by weight, preferably from 28% by weight to 39% by weight, more preferably from 30% by weight to 37% by weight, of regioisomers in which at least one secondary hydroxyl group has been esterified.
- the determination of the content of secondary ester regiolsomer in the total monoester component of the carboxylic ester of sorbitol of the invention, the determination of the content of triester species based on the sum total of all carboxylic esters of sorbitol that are present, and the determination of the content of regioisorners in the total diester component in which at least one secondary hydroxyl group has been esterified can be performed by gas chromatography, optionally coupled with mass spectrometry (GC-FID and GC-MS):
- the esters present in the sample are separated according to their total chain length.
- the ratios of the individual ester species to one another are determined via the respective area percentage of the GC-FID peak.
- the peaks are identified/assigned to the individual ester species via GC-MS, if appropriate also via a comparison of retention time of separately prepared and isolated standards, for example for the mono- and diesters esterified exclusively at primary hydroxyl groups.
- This method can likewise be used to detect the content of free protonated and also free neutralized carboxylic acids, since these are likewise derivatized.
- the present invention further provides for the use of the sorbitol carboxylates according to the invention as viscosity regulator, care active ingredient, foam booster or solubilizer, antimicrobial, antistat, binder, corrosion inhibitor, dispersant, emulsifier, film former, humectant, opacifier, oral care agent, preservative, skincare agent, hydrophilic emollient, foam stabilizer and nonionic surfactant, preferably as viscosity regulator, emulsifier, antimicrobial and hydrophilic emollient, particularly preferably as viscosity regulator, especially as thickener, especially in cleansing or care formulations.
- viscosity regulator preferably as viscosity regulator, care active ingredient, foam booster or solubilizer, antimicrobial, antistat, binder, corrosion inhibitor, dispersant, emulsifier, film former, humectant, opacifier, oral care agent, preservative, skincare agent, hydrophilic emollient, foam stabilizer and nonionic
- a 25% solution of the sample to be analysed was prepared in a mixture of concentrated acetic acid and toluene (3:1), and filtered if necessary to give a clear solution.
- An aliquot (approx. 10 g; so that the cuvette is sufficiently filled) was measured in a Lica 690 spectral colorimeter at room temperature in an 11 mm round cuvette, and the colour numbers reported in each case were recorded.
- Example 1B Sorbitan Ester According to “Example 0” in DE102009001748A (Not According to the Invention)
- Example 1C Enzymatic Esterification of Sorbitol with 1.55 eq. of Caprylic Acid According to Biotechnol Bioeng 1995 48 214-221 (Not According to the Invention)
- Example 2B Enzymatic Esterification of Sorbitol with 1.00 eq. of Oleic Acid According to Biotechnol Bioeng 1995 48 214-221 (Not According to the Invention)
- a mixture of sorbitol (100.1 g, 0.549 mol, 1.00 eq.), oleic acid (>99%, 155.1 g, 0.549 mol, 1.00 eq.) and Novozym 435 (38.7 g, 271126 PLU) was stirred at 90° C. and ⁇ 7 mbar for 24 h, and the water formed was distilled off continuously. The mixture was then filtered at 85° C. through a Büchner funnel with black band filter to remove the enzyme. The product obtained had an acid number of 12.8 mg KOH/g.
- the mixture was cooled down to 90° C., immobilized Candida antarctica lipase B enzyme (6.28 g; Purolite D5619, corresponding to 54350 PLU) was added, and stirring of the mixture was continued at 90° C. and ⁇ 7 mbar for 24 h, during which time the water formed was distilled off continuously.
- the mixture was then filtered at 85° C. through a Büchner funnel with black band filter to remove the enzyme.
- the product obtained had an acid number of 6.5 mg KOH/g.
- Example 3B Enzymatic Esterification of Sorbitol with 1.50 eq. of Stearic Acid According to Biotechnol Bioeng 1995 48 214-221 (Not According to the Invention)
- Example 4D Enzymatic Esterification of Sorbitol with 1.80 eq. of Lauric Acid According to Biotechnol Bioeng 1995 48 214-221 (Not According to the Invention)
- Table 1 compares the parameters determined for the examples according to the invention and the noninventive examples.
- Formulation 1 consisted of 9% SLES, 3% Cocamidopropyl Betaine and 0.7% NaCl in water.
- the pH of formulation 1 was adjusted to 5.2 with citric acid.
- Subsequently incorporated into this formulation in each case was 1.1% of the example substances mentioned above by stirring at 60° C. for 30 min, and the viscosities were measured using a Brookfield viscometer (spindle 62, 30 rpm, in Examples 1, 1B, 1C, 2, 2B; spindle 2, 60 rpm, in Examples 3, 3B, 4, 4B, 4C, 4D) at 22° C.
- Brookfield viscometer spindle 62, 30 rpm, in Examples 1, 1B, 1C, 2, 2B; spindle 2, 60 rpm, in Examples 3, 3B, 4, 4B, 4C, 4D
- Formulation 2 consisted of 5.6% AM C, 4.4% Lauryl Glucoside, 1.2% Coco-Glucoside and 3.6% Glutamate in water.
- the pH of formulation 2 was adjusted to 5.2 with citric acid.
- Subsequently incorporated into this formulation in each case was 1.0% of the example substances mentioned above by stirring at 60° C. for 30 min, and the viscosities were measured using a Brookfield viscometer (spindle 62, 30 rpm, in Examples 1, 1B, 1C, 2, 2B; spindle 2, 60 rpm, in Examples 3, 3B, 4, 4B, 4C, 4D) at 22° C.
- Viscosity of the example formulation containing 1.1% thickener Viscosity of Viscosity of formulation formulation
- Example 3B was not fully soluble in formulation 2, which is a further disadvantage of this noninventive example.
- Recipe 3a 3b 3c Composition from example 3 4.8% 4.8% 4.8% C18-C22 Hydroxyalkyl Hydroxypropyl 0.25% Guar (ESAFLOR HM 22, Lamberts S.p.A.) Hydroxypropyl Guar (ESAFLOR HDR, 0.25% 0.25% Lamberts S.p.A.) Isopropyl Palmitate (TEGOSOFT ® P, 5.0% 5.0% 5.0% Evonik Operations GmbH) Water ad 100% ad 100% ad 100% Glycerin 3.0% 3.0% 3.0% Potassium alum 5.0% 5.0% 5.0% 5.0% Methylisothiazolinone, Methylparaben, 0.8% 0.8% Ethylparaben; Dipropylene Glycol (Microcare MEM, Thor) Pentylene Glycol (dermosoft ® Pentiol 3.5% eco, Evonik Dr. Straetmans GmbH
- Recipe 4a 4b Composition from example 3 3.0% 3.0% Diethylhexyl Carbonate (TEGOSOFT ® DEC, Evonik Operations 3.0% 3.0% GmbH) PPG-14 Butyl Ether (TEGOSOFT ® PBE, Evonik Operations 3.0% 3.0% GmbH) Polyglycery-3 Caprylate (TEGO ® Cosmo P813, Evonik 0.5% 0.5% Operations GmbH) Demineralized water ad 100% ad 100% Hydroxyethylcellulose (Natrosol 250 HHR, Ashland Specialty 1.0% 1.0% Chemicals) Aluminium Chlorohydrate (50%) (Reach 501L, Reheis) 15.0% 15.0% Methylisothiazolinone, Methylparaben, Ethylparaben; Dipropylene 0.8% 3.0% Glycol (Microcare MEM, Thor) 1,2-Hexanediol (dermosoft ® Hexiol, Evonik Dr. Straetmans 2.8% GmbH)
- Recipe 6a 6b Composition from example 3 4.0% 4.0% Phenoxyethyl Caprylate (TEGOSOFT ® XC, Evonik Operations 3.2% 3.2% GmbH) Isopropyl Palmitate (TEGOSOFT ® P, Evonik Operations GmbH) 2.0% 2.0% Bis-Ethylhexyloxyphenol Methoxyphenyl Triazine (Tinosorb S, 3.0% 3.0% BASF SE) Butyl Methoxydibenzoylmethane 2.0% 2.0% EHC 2.0% 2.0% Ethylhexyl Salicylate 4.0% 4.0% Octocrylene 4.0% 4.0% Glycerin 3.0% 3.0% Water ad 100% ad 100% Carbomer suspension 1 (Acrylates/C10-30 Alkyl Acrylate 1.0% 1.0% Crosspolymer, TEGO ® Carbomer 341ER, Evonik Operations GmbH, 20% in Phenoxyethyl Caprylate) Tris(hydroxymethyl)aminomethane (30% aq.
- Recipe 7a 7b 7c Composition from example 3 3.0% 2.5% 2.5% Glyceryl Stearate Citrate (AXOL ® C 62, Evonik Operations GmbH) 0.5% 0.5% Glyceryl Stearate 0.5% 0.5% 0.5% 0.5% Stearyl Alcohol 0.5% 0.5% 0.5% 0.5% Bis-Ethythexyloxyphenol Methoxyphenyl Triazine (Tinosorb S, BASF 3.0% 3.0% 3.0% SE) Butyl Methoxydibenzoylmethane 2.0% 2.0% 2.0% Ethylhexyl Methoxycinnamate 2.0% 2.0% 2.0% Ethylhexyl Salicylate 4.0% 4.0% 4.0% Octocrylene 4.0% 4.0% 4.0% Isopropyl Palmitate 2.0% 2.0% 2.0% Phenoxyethyl Caprylate (TEGOSOFT ® XC, Evonik Operations GmbH) 3.2% 3.2% 3.2% Glycerin 3.0% 3.0% 3.0% Demineralized water ad 100% ad 100% a
- Recipe 8a 8b 8c Composition from exampie 3 3.00% 2.00% 2.00% Cetearyl Glucoside (TEGO ® Care CG 90, Evonik 0.50% 0.50% Operations GmbH) Phenoxyethyl Caprylate (TEGOSOFT ® XC, Evonik 8.00% 8.00% Operations GmbH) Diethylamino Hydroxybenzoyl Hexyl Benzoate (Uvinul A 6.00% 6.00% 6.00% Pius, BASF SE) Ethylhexyl Methoxycinnamate 8.00% 8.00% 8.00% Stearyl Alcohol 1.00% 1.00% 1.00% Glyceryl Stearate 1.00% 1.00% 1.00% Tocopheryl Acetate 0.50% 0.50% 0.50% Glycerin 2.00% 2.00% 2.00% Demineralized water ad 100% ad 100% ad 100% Tromethamine 0.90% 0.90% 0.90% Phenylbenzimidazole Sulfonic Acid 2.00% 2.00% 2.00% 2.00%
- Recipe 9a 9b 9c Composition from exampie 3 3.00% 2.50% 2.50% Sodium Cetearyl Sulfate (Lanette E, BASF SE) 0.50% 0.50% Phenoxyethyl Caprylate (TEGOSOFT ® XC, Evonik 7.30% 7.30% 7.30% Operations GmbH) Butyl Methoxydibenzoylmethane 5.00% 5.00% Diethylhexyl Butamido Triazone (UVAsorb HEB, 3V 1.00% 1.00% 1.00% Sigma) Ethylhexyl Salicylate 1.50% 1.50% 1.50% 1.50% Octocrylene 3.50% 3.50% 3.50% 3.50% Titanium Dioxide; Diethylhexyl Carbonate; Polyglyceryl-6 2.20% 2.20% 2.20% Polyhydroxystearate (TEGO ® Sun TDEC 45, Evonik Operations GmbH) Stearyl Alcohol 1.00% 1.00% 1.00% Nylon-10/10 (TEGOLON ® ECO
- Recipe 11a 11b 11c Composition from example 3 3.00% 2.50% 2.50% Polyglycery-3 Methylglucose Distearate (TEGO ® Care 450, 0.50% 0.50% Evonik Operations GmbH) Phenoxyethyl Caprylate (TEGOSOFT ® XC, Evonik 2.00% 2.00% 2.00% Operations GmbH) Nylon-10/10 (TEGOLON ® ECO 10-10, Evonik 0.50% 0.50% 0.50% Operations GmbH) Butyl Methoxydibenzoylmethane 5.00% 5.00% 5.00% Diethylhexyl Butamido Triazone (UVAsorb HEB, 3V Sigma) 1.00% 1.00% 1.00% 1.00% Bis-Ethylhexyloxyphenol Methoxyphenyl Triazine 3.00% 3.00% 3.00% (Tinosorb S, BASF SE) Ethylhexyl Salicylate 1.00% 1.00% 1.00% 1.00% Octocrylene
- Recipe 12a 12b 12c Composition from example 3 3.50% 3.00% 3.00% Glyceryl Stearate Citrate (AXOL ® C 62, 1.00% 1.00% Evonik Operations GmbH) Phenoxyethyl Caprylate (TEGOSOFT ® 2.50% 2.50% 2.50% XC, Evonik Operations GmbH) Diethylamino Hydroxybenzoyl, 10.00% 10.00% 10.00% Hexyl Benzoate Ethylhexyl Methoxycinnamate 10.00% 10.00% 10.00% 10.00% Stearyl Alcohol 1.00% 1.00% 1.00% Glyceryl Stearate 1.00% 1.00% 1.00% 1.00% Xanthan Gum (Keltrol CG-SFT, CP Kelco) 0.50% 0.50% 0.50% 0.50% Tocopheryl Acetate 0.50% 0.50% 0.50% Glycerin 2.00% 2.00% 2.00% Demineralized water ad ad ad 100% 100% 100% 100% Phen
- Recipe 13a 13b 13c Composition from example 3 3.00% 2.5% 2.5% Potassium Cetyl Phosphate 1.0% 1.0% Phenoxyethyl Caprylate (TEGOSOFT ® 3.00% 3.00% 3.00% XC, Evonik Operations GmbH) Butyl Methoxydibenzoylmethane 5.00% 5.00% Octocrylene 4.90% 4.90% 4.90% Ethylhexyl Methoxycinnamate 0.10% 0.10% 0.10% 0.10% Bis-Ethylhexyloxyphenol Methoxyphenyl 4.70% 4.70% 4.70% Triazine (Tinosorb S, BASF SE) Diethylhexyl Butamido Triazone (UVAsorb 3.70% 3.70% 3.70% HEB, 3 V Sigma) Titanium Dioxide; Diethylhexyl Carbonate; 11.00% 11.00% 11.00% Polyglyceryl-6 Polyhydroxystearate (TEGO ® Sun TD
- Recipe 14a 14b Composition from example 3 4.0% 4.0% Isoamyl Cocoate (TEGOSOFT ® AC, 2.5% 2.5% Evonik Operations GmbH) Caprylic/Capric Triglyceride (TEGOSOFT ® 3.5% 3.5% CT, Evonik Operations GmbH) Water ad ad 100% 100% Creatine (TEGO ® Cosmo C 100, 0.5% 0.5% Evonik Operations GmbH) Carbomer suspension 2 (Carbomer, TEGO ® 1.0% 1.0% Carbomer 141, Evonik Operations GmbH, 20% in Ethylhexyl Stearate) Sodium Hydroxide (10% aq.) 0.6% 0.6% Phenoxyethanol, Ethylhexylglycerin (Euxyl 0.7% PE 9010, Schülke & Mayr GmbH) Aqua; Sodium Levulinate; Sodium Benzoate 1.5% (Verstatil ® BL; Evonik Dr. Straetmans GmbH) Glyceryl Caprylate (dermosoft ®
- Recipe 17a 17b Composition from example 3 6.0% 6.0% Myristyl Myristate (TEGOSOFT ® MM, 2.0% 2.0% Evonik Operations GmbH) Isopropyl Myristate (TEGOSOFT ® M, 6.0% 6.0% Evonik Operations GmbH) Decyl Cocoale (TEGOSOFT ® DC, 6.0% 6.0% Evonik Operations GmbH) Cetyl Ricinoleate (TEGOSOFT ® CR, 1.0% 1.0% Evonik Operations GmbH) Water ad ad 100% 100% Glycerin 1.0% 1.0% Titanium Dioxide (Hombitan AC 360, 8.0% 8.0% Sachtleben) Iron Oxides (Sicovit Yellow 10 E 172, 0.9% 0.9% Rockwood Pigments) Iron Oxides (Sicovit Red 30 E 172, 0.2% 0.2% Rockwood Pigments) Iron Oxides (Sicovit Brown 70 E 172, 0.4% 0.4% Rockwood Pigments) Iron Oxides (Sicovit Black 80 E 172, 0.1% 0.1% Rockwood Pigments) Cellulose (
- Recipe 19a 19b 19c Composition from example 3 3.0% 2.0% 2.0% Polyglyceryl-3 Dicitrate/Stearate (TEGO ® Care PSC 3 1.0% 1.0% (Evonik Operations GmbH) Cetearyl Alcohol 0.5% 0.5% 0.5% Caprylic/Capric Triglyceride 6.5% 6.5% 6.5% Demineralized water ad ad ad 100% 100% 100% Xanthan Gum (Keltrol CG-SFT, CP Kelco) 0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5% Methylisothiazolinone, Methylparaben, Ethylparaben; 0.8% 0.8% Dipropylene Glycol (Microcare MEM, Thor) Glycerin; Aqua; Sodium Levulinate; Sodium Anisate 3.0% (dermosoft ® 1388; Evonik Dr. Straetmans GmbH)
- Recipe 21a 21b 21c Composition from example 3 4.00% 3.00% 3.00% Polyglycery-3 Methylglucose Distearate (TEGO ® Care 450, 1.00% 1.00% Evonik Operations GmbH) Glyceryl Stearate 0.75% 0.75% 0.75% Stearyl Alcohol 0.75% 0.75% 0.75% 0.75% Diethylhexyl Carbonate (TEGOSOFT ® DEC, Evonik 7.40% 7.40% 7.40% Operations GmbH) Aqua; Ethylhexyl Stearate; Sodium Hyaluronate Crosspolymer; 2.00% 2.00% 2.00% Polyglyceryl-4 Diisostearate/Polyhydroxystearate/Sebacate; Sodium isostearate (HyaCare ® Filler CL, Evonik Operations GmbH) Ethylhexyl Methoxycinnamate 5.00% 5.00% Diethylamino Hydroxybenzoyl Hexyl Benzoate (Uvinul A Plus
- Recipe 24a 24b 24c Composition from example 3 3.0% 2.0% 3.0% (AXOL ® C 62, Evonik Operations GmbH) 1.0% Glyceryl Stearate 0.2% 0.2% 0.5% Stearyl Alcohol 0.2% 0.2% 0.5% Primus Amygdalus Dulcis (sweet almond) Oil 10.0% 10.0% 10.0% Isoamyl Cocoate (TEGOSOFT ® AC, Evonik Operations GmbH) 6.6% 6.6% 6.0% Glycerin 4.0% 4.0% 4.0% Demineralized water ad ad ad 100.0% 100.0% 100.0% 100.0% Caprylyl Glycol, Glycerin, Glyceryl Caprylate, Phenylpropanol 1.0% 1.0% (Dermosoft ® LP, Evonik Dr, Straetmans GmbH) Methylpropanediol, Caprylyl Glycol, Phenylpropanol 4.0% (Dermosoft ® OMP, Evonik Dr. Straetmans GmbH
- Recipe 24d 24e 241 Composition from example 3 3.0% 3.0% 1.5% Glyceryl Stearate SE 0.5% Polyglycery-3 Dicitrate/Stearate (TEGO ® Care PSC 3, Evonik 1.5% Operations GmbH) Glyceryl Stearate 0.5% 0.5% 0.5% Stearyl Alcohol 0.5% 0.5% 0.5% Prunus Amygdalus Dulcis (sweet almond) Oil 10.0% 10.0% 10.0% 10.0% Isoamyl Cocoate (TEGOSOFT ® AC, Evonik Operations GmbH) 6.0% 6.0% 6.0% 6.0% Glycerin 4.0% 4.0% 4.0% Demineralized water ad ad ad 100.0% 100.0% 100.0% Methylpropanediol, Caprylyl Glycol, Phenylpropanol (Dermosoft ® 4.0% OMP, Evonik Dr.
- Recipe 26a 26b Composition from example 2 2.0% 2.0% Mineral oil 17.0% 17.0% Castor wax 0.4% 0.4% Microcrystalline Wax 0.6% 0.6% Water ad ad 100% 100% Sodium Chloride 0.5% 0.5% Urea 10.0% 10.0% Phenoxyethanol; Ethylhexylglycerin 0.7% (Euxyl PE 9010, Schülke & Mayr GmbH) Glyceryl Caprylate (dermosoft ® GMC; 0.35% Evonik Dr. Straetmans GmbH) Pentylene Glycol (dermosoft ® Pentiol 2.0% eco; Evonik Dr. Straetmans GmbH)
- Recipe 28a 28b 28c Composition from example 2 2.0% 1.5% 1.5% Polyglyceryl-4 — 0.5% 0.5% Diisostearate/Polyhydroxystearate/ Sebacate (ISOLAN ® GPS, Evonik Operations GmbH) Castor wax 0.5% 0.5% 0.5% Beeswax 0.5% 0.5% 0.5% Ethylhexyl Stearate (Tegosoft ® OS, 10.0% 10.0% 10.0% Evonik Operations GmbH) Diethylhexyl Carbonate (TEGOSOFT ® 8.5% 8.5% 8.5% DEC, Evonik Operations GmbH) Dimethicone (Belsil DM 5, 6.0% 6.0% 6.0% Wacker Chemical Corp.) Tocopheryl Acetate 0.5% 0.5% 0.5% Glycerin 3.0% 3.0% 3.0% Water ad ad ad 100% 100% 100% Sodium Chloride 1.0% 1.0% 1.0% Ethanol 20.0% 20.0% 20.0% Ethylhexylglycerin (dermosoft ® 0.5% EHG; Evonik Dr
- Recipe 29a 29b 23c Composition from example 2 3.0% 2.5% 2.5% Diisostearoyl Polyglyceryl-3 Dimer Dilinoleate — 0.5% 0.5% (ISOLAN ® PDI, Evonik Operations GmbH) Diethylhexyl Carbonate (TEGOSOFT ® DEC, 7.0% 7.0% 7.0% Evonik Operations GmbH) Oleyl Erucate (TEGOSOFT ® OER, Evonik 3.0% 3.0% 3.0% Operations GmbH) Almond oil 7.0% 7.0% 7.0% Shea butter 2.0% 2.0% 2.0% Cetyl Ricinoleate (TEGOSOFT ® CR, Evonik 1.0% 1.0% 1.0% Operations GmbH) Beeswax 0.6% 0.6% 0.6% Castor wax 0.4% 0.4% 0.4% Glycerin 5.0% 5.0% 5.0% 5.0% Water ad ad ad 100% 100% 100% 100% 100% Magnesium sulfate heptahydrate 1.5% 1.5% 1.5% Sodium Benzoate, Potassium Sorbate (Euxyl
- Recipe 30a 30b 30c Composition from example 2 3.0% 2.5% 2.5% Polyglyceryl-3 Oleate (ISOLAN ® — 0.5% 0.5% GO 33, Evonik Operations GmbH) Isoamyl Coooate (TEGOSOFT ® AC, 5.0% 5.0% 5.0% Evonik Operations GmbH) Diethylhexyl Carbonate 12.0% 12.0% 12.0% (TEGOSOFT ® DEC, Evonik Operations GmbH) Phenoxyethyl Caprylate 4.0% 4.0% 4.0% (TEGOSOFT ® XC, Evonik Operations GmbH) Zinc Stearate 0.5% 0.5% 0.5% Water ad ad ad 100% 100% 100% 100% Glycerin 3.0% 3.0% 3.0% Sodium Chloride 1.5% 1.5% 1.5% Phenoxyethanol; Ethylhexylglycerin 0.7% 0.7% (Euxyl PE 9010, Schülke & Mayr GmbH) Benzyl Alcohol; Caprylyl Glycol; 1.5% Benzoic Acid (Verstat
- Recipe 33a 33b 33c Composition from example 2 3.0% 2.0% 2.0% Paraffinum Liquidum; Petrolatum; — 1.0% 1.0% Ozokerite; Glyceryl Oleate; Lanolin Alcohol (PROTEGIN ® XN, Evonik Operations GmbH) Castor wax 0.1% 0.1% 0.1% Microcrystalline Wax 0.1% 0.1% 0.1% Oleyl Erucate (TEGOSOFT ® OER, 1.0% 1.0% 1.0% Evonik Operations GmbH) Isoamyl Cocoate (TEGOSOFT ® AC, 3.8% 3.8% 3.8% Evonik Operations GmbH) Ethylhexyl Palmitate (TEGOSOFT ® 1.0% 1.0% 1.0% OP, Evonik Operations GmbH) Almond oil 1.0% 1.0% 1.0% Zinc Oxide 20.0% 20.0% 20.0% Glycerin 3.0% 3.0% 3.0% Magnesium sulfate heptahydrate 1.0% 1.0% 1.0% Sodium Lactate; Sodium PCA; Glycine; 5.0% 5.0% Fructose;
- Recipe 34a 34b 34c Composition from example 2 3.0% 2.5% 2.5% Petrolatum; Ozokerite; Hydrogenated — 0.5% 0.5% Castor Oil; Glyceryl Isostearate; Polyglycery-3 Oleate (PROTEGIN ® W, Evonik Operations GmbH) Castor wax 0.1% 0.1% 0.1% Microcrystalline Wax 0.1% 0.1% 0.1% Diethylhexyl Carbonate (TEGOSOFT ® 9.0% 9.0% 9.0% DEC, Evonik Operations GmbH) Ethylhexyl Palmitate (TEGOSOFT ® OP, 9.0% 9.0% 9.0% Evonik Operations GmbH) Stearyl Heptanoate (Tegosoft ® SH, 8.8% 8.8% 8.8% Evonik Operations GmbH) Glycerin 3.0% 3.0% 3.0% Magnesium sulfate heptahydrate 1.0% 1.0% 1.0% Ceramide NP; Ceramide AP; 5.0% 5.0% Ceramide EOP; Phytosphingosine; Cholesterol; Sodium Lauroyl
- Recipe 36a 36b Composition from example 2 3.0% 2.0% Polyglycery/-3 Polyricinoleate (Cithrol PG3PR, — 1.0% (Croda Int. Plc) Isoamyl Cocoate (TEGOSOFT ® AC, Evonik 2.0% 2.0% Operations GmbH) Decyl Cocoate (TEGOSOFT ® DC, Evonik 10.0% 10.0% Operations GmbH) Isopropyl Palmitate (TEGOSOFT ® P, Evonik 10.0% 10.0% Operations GmbH) Zinc Oxide (Zinc Oxide PI, Symrise) 16.0% 16.0% Titanium Dioxide (nano); Alumina; Stearic Acid 9.0% 9.0% (Eusolex T-S, Merck KGaA) Water ad ad 100% 100% Glycerin 3.0% 3.0% Magnesium sulfate heptahydrate 1.0% 1.0% Sodium Benzoate, Potassium Sorbate (Euxyl K 0.5% 0.5% 712, Schülke &
- Recipe 38a 38b 38c 38d Composition from example 2 3.0% 2.5% 3.0% 2.5% Cetyl PEG/PPG-10/1 Dimethicone (ABIL ® — 1.0% — 1.0% EM 90, Evonik Operations GmbH) Microcrystalline Wax 0.3% 0.3% 0.3% 0.3% Castor wax 0.3% 0.3% 0.3% 0.3% 0.3% Diethylhexyl Carbonate (TEGOSOFT ® DEC, 2.4% 2.4% — — Evonik Operations GmbH) Phenoxyethyl Caprylate (TEGOSOFT ® XC, — — 3.9% 3.9% Evonik Operations GmbH) Bis-Ethythexyloxyphenol Methoxyphenyl Triazine 6.0% 6.0% — — (Tinosorb S, BASF SE) Diethylarino Hydroxybenzoyl Hexyl Benzoate 7.0% 7.0% 5.0% 5.0% (Uvinul A Plus, BASF SE) Butyl Methoxydibenzoylmethane — — 4.
- Recipe 40a 40b 40c 40d 40e 40f Composition from example 2 4.5% 2.5% 3.0% 2.5% 2.0% 2.0% Bis-(Glyceryl/Lauryl) — 2.0% — — — — Glyceryl Lauryl Dimethicone; Caprylic/Capric Triglyceride (ABIL ® EM 120, Evonik Operations GmbH) Polyglyceryl-4 Isostearate — — 1.0% — — — (ISOLAN ® GI 34, Evonik Operations GmbH) Cetyl Diglyceryl — — 1.0% — — Tris(Trimethyisiloxy) Silylethyl Dimethicone (DC-5600, Dow Corning Corp.) Lauryl Polyglycery-3 — — — — 1.0% — Polydimethylsiloxyethyl Dimethicone (KF-6105, Shin-Etsu Chemical Co.) Polyglyceryl-4 Isostearate; — — — —
- Formulations 41a, 41b, 41c, 41d, 41e, 41f and 41g CC (Colour Control) Fluid
- Recipe 42a 42b 42c 42d 42e Composition from 3.0% 2.0% 3.0% 2.0% 2.0% example 2
- Polyglyceryl-4 1.0% — 1.0% 1.0% Diisostearate/ Polyhydroxy- stearate/Sebacate (ISOLAN ® GPS, Evonik Operations GmbH) Isopropyl Palmitate 20.0% 20.0% 20.0% 20.0% 20.0% (TEGOSOFT ® P, Evonik Operations GmbH) Diethylhexyl Carbonate 7.0% 7.0% 7.0% 7.0% 7.0% 7.0% 7.0% 7.0% (TEGOSOFT ® DEC, Evonik Operations GmbH) Triethyl Citrate 5.0% (dermofeel ® TEC eco; Evonik Dr.
- Phase A Composition from example 1 5.0% Lavandula Angustifolia (lavender) Oil 0.2% (AEC Lavender Oil, A & E Connock Ltd.) Perfume 0.1%
- Phase B Sodium Cocoamphoacetate 10.0% (REWOTERIC ® AM C, Evonik, 32%) Phase C Water ad 100.0% Xanthan Gum (Keitrol CG-SFT, CP Kelco) 1.2% Phase D Sodium Lauroyl Methyl Isethionate (Iselux, 4.5% innospec Active Chemicals) Capryl/Capramidopropyl Betaine 4.5% (TEGO ® Betaine 810, Evonik, 38%) Citric Acid 1.2% Phase E Water 10.0% Polyquaternium-7 (Merquat 550, Nalco) 0.4% Preservative q.s
- Recipes 47a 47b Water ad ad 100.0% 100.0% Composition from example 1 2.5% 2.5% Composition from example 3 1.5% 1.5% Cocamidopropyl Betaine (TEGO ® Betain F 50, Evonik, 38%) 22.0% 22.0% Lauryl Glucoside (Plantacare 1200 UP, BASF, 50%) 6.0% 6.0% Sodium Cocoyl Glutamate (Plantapon ACG HC, BASF) 1.5% 1.5% Sodium Cocoyl Glycinate (Hostapon SG, Clariant) 0.8% 0.8% Zinc Pyrithione (Microcare ZP, Thor) 0.1% 0.1% PEG-120 Methyl Glucose Dioleate (ANTIL ® 120 Plus, Evonik) 0.4% 0.4% Sodium Chloride 0.5% 0.5% Isostearamide MIPA; Glyceryl Laurate (ANTIL ® SPA 80, Evonik) 0.5% 0.5% Xanthan Gum (Keltrol CG-SFT, CP
- Formulation 49 Cream Soap
- Glycine Soja Oil Croda Europe, Ltd.
- Composition from example 1 12.0% Polyglyceryl-3 Palmitate (Dermofeel ® PP, Evonik Dr. 4.5% Straetmans) Glyceryl Caprylate (Dermosoft ® GMCY, Evonik Dr.
- Formulation 51 Micellar Water for Makeup Removal
- Recipe 52a 52b Composition from example 1 3.5% 3.5% Aloe Barbadensis Leaf Extract (Aloe-Con UP 40, Florida Food 0.2% 0.2% Products Inc.) Isopropyl Myristate (TEGOSOFT ® M, Evonik) 0.2% 0.2% Disodium Cocoamphodiacetate (REWOTERIC ® AM 2 C NM, 1.5% 1.5% Evonik, 39%) Perfume 0.2% 0.2% Propylene Glycol (Euxyl K 320, Schülke & Mayr GmbH) 2.5% 2.5% Hydrolyzed Silk (Crosilk 10000, Croda Inc.) 0.2% 0.2% Caprylyl/Capryl Glucoside (Plantacare 810 UP, BASF) 1.0% 1.0% Water ad ad 100.0% 100.0% Citric Acid ad pH 5.0 ad pH 5.0 Phenoxyethanol (S&M Phenoxyethanol, Schülke & Mayr GmbH) 0.5% 0.5% Dehydroacetic Acid (Unisept D
- Phase A Composition from example 1 4.0% Dicaprylyl Ether (Cetiol OE, BASF) 0.3% Geraniol (Nerol 800, International Flavors & 0.1% Fragrances Inc.) Linalool (Lipofresh, Lipo Chemicals, Inc.) 0.1% Perfume 0.1% Phase B Propylene Glycol (Euxyl K 320, Schellerke & Mayr 1.0% GmbH) Butylene Glycol (Oxea Corparation) 0.2% Water 5.0% Palmitamidopropyltrimonium Chloride 1.0% (VARISOFT ® PATC, Evonik) Phase C Water 50.0% Hydroxethyl ethylcellulose (Structure Cel 4400 E, 0.8% AkzoNobel) Sodium Hydroxide (10% in water) 0.3% Phase D Aluminium Chiorohydrate (Locron L, Cladant) 15.0% Phase E Preservative q.s. Water ad 100.0%
- composition from example 1 0.4% Glycolipids (Rheance One, Evonik) 0.2% Flavour 0.2% Water ad 100.0% Sorbitol (Karion FP Liquid, Merck) 3.0% Preservative q.s. Dyes q.s.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Cosmetics (AREA)
- Detergent Compositions (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
A process can be used for enzymatic preparation of sorbitan carboxylates. Sorbitan carboxylates are obtainable by this process.
Description
- The invention provides a process for enzymatic preparation of sorbitan carboxylates, and the sorbitan carboxylates obtainable by this process.
- Sorbitol carboxylates are products of interest to the food and cosmetics industries not only on account of their surfactant properties, but also because of the possibility of obtaining them from natural and renewable raw materials.
- DE102009001748A describes sorbitan esters obtained from the solvent-free reaction of 1 mol of sorbitol (also called glucitol) with 1.55 mol of caprylic acid, and the use of the sorbitan esters thus obtained as thickener for aqueous surfactant systems. It is a disadvantage of the process that, under the reaction conditions described, the sorbitol is dehydrated virtually completely, but at least partially, and forms what is called sorbitan (a product mixture).
- Four degradation products of sorbitol that frequently occur under such conditions are the anhydrohexitols 1,4-anhydrosorbitol, 2,5-anhydrosorbitol, 1,5-anhydrosorbitol (Advances in Carbohydrate Chemistry and Biochemistry, 1983, 41, 27-66) and isosorbide (1,4:3,6-dianhydrosorbitol; ChemSusChem. 5 (1): 167-176).
- A further disadvantage of these sorbitol esters is their dark colour, which requires aftertreatment, for example with activated carbon, in order to achieve product qualities usable in the cosmetics sector.
- JP63133991 describes the reaction of 1.0 equivalent of oleic acid with 1.0 equivalent of sorbitol in the presence of >9% lipase (Candida Sp) at 40-50° C. and 100 mmHg (133 mbar). A disadvantage of this process described in the prior art is that only about 70% esterification is attained. A further disadvantage is that only pure oleic acid is used, which is too costly for industrial applications in the food and cosmetics sector and hence uneconomic.
- DE3430944 describes the reaction of ≥4.0 equivalents of oleic acid or stearic acid with 1.0 equivalent of sorbitol in the presence of about 7% lipase at 40° C. for 72 h, wherein the reactants and the enzyme are reacted with one another in a concentration by mass of about 28 g per 1000 ml in an aqueous buffer system. A disadvantage of this process described in the prior art is the use of aqueous phosphate buffer, the salt burden of which in the product is undesirable for use in cosmetics. A further disadvantage is that the concentration by mass of the reactants and of the lipase in the buffer system is only about 3%, which means much too low a space-time yield for industrial conversions. A further disadvantage is that only pure oleic acid and pure stearic acid are used.
- Lorie et al. describe, in Biotechnol. Bioeng. 1995, 48, 214-221, the reaction of sorbitol with 1.0 equivalent of oleic acid in the presence of 15% Novozym 435 (lipase from Candida antarctica; about 494 000 PLU per mole of fatty acid) at 90° C. and a pressure of <0.7 kPa (<7 mbar). One disadvantage of the process described in the prior art is that the sorbitol used remains as a highly viscous semisolid at the base of the reaction vessel, while oleic acid is the layer above it. This behaviour additionally complicates the mixing of the reactants, which is difficult in any case.
- EP1755545B1 describes a mixture of sorbitan esters and sorbitol esters, wherein the chain length of the fatty acid of the sorbitan ester is greater than the chain length of the fatty acid of the sorbitol ester, and more than 80% saturated fatty acids is always used. The sorbitan esters are at least 50% of the mixture. The sorbitol esters consist solely of mono- and diesters, with at least 40% monoesters and less than 60% diesters, and are used to influence emulsion stability and viscosity. Proceeding from lauric acid, a mixture consisting of 7% sorbitan esters, 68% C12 sorbitol esters and 25% polyol is obtained. A disadvantage of the process for preparation described in the prior art is the fact that sorbitan esters are formed here too, as a result of which the hydrophilic portion of the surfactant is reduced, and a poor colour is also obtained.
- The problem addressed by the present invention was that of providing a process for preparing sorbitan esters that is capable of overcoming at least one disadvantage of the prior art processes.
- It has been found that, surprisingly, the object of the invention is achieved by the sorbitol carboxylates described hereinafter and the process described hereinafter.
- It is an advantage of the present invention that the sorbitol carboxylates of the invention are excellent thickeners for aqueous surfactant systems compared to the prior art.
- It is a further advantage that the sorbitol carboxylates of the invention also have excellent colour and very good odour compared to the prior art.
- It is an advantage of the present invention that only very small amounts of sorbitol degradation products or esters of the degradation products are obtained as reaction products.
- It is an advantage of the present invention that the process according to the invention can be performed in the absence of a solvent.
- It is a further advantage of the present invention that the sorbitol carboxylates are obtained in a homogeneous reaction mixture, which means that no additional process steps such as extraction, crystallization, filtration or distillation are required.
- An advantage of the present invention is that the process can be carried out at elevated temperatures. This leads to better miscibility of the co-reactants, while the recyclability of the enzyme used is surprisingly high.
- It is a further advantage of the present invention that the sorbitol carboxylates obtained can be incorporated very readily into formulations, particularly into cosmetic formulations.
- The present invention therefore provides a process for enzymatic preparation of a sorbitol carboxylate, comprising the process steps of
- A) providing sorbitol and at least one acyl group donor, preferably fatty acid acyl group donor, selected in particular from fatty acid esters and fatty acids, more preferably fatty acids,
- B) reacting sorbitol with the at least one acyl group donor in the presence of a lipase at a temperature of 75° C. to 110° C., preferably of 77° C. to 100° C., even more preferably 80° C. to 95° C., to give a sorbitol carboxylate, and optionally
- C) purifying the sorbitol carboxylate,
- characterized in that process step A) comprises blending the sorbitol and the at least one acyl group donor within a temperature range of 80° C. to 120° C., preferably of 90° C. to 120° C., even more preferably of 95° C. to 120° C., even more preferably of 100° C. to 120° C., for at least 10 minutes, preferably at least 30 minutes, even more preferably at least 60 minutes.
- The term “sorbitol carboxylates” in the context of the present invention includes a composition that contains a majority of, especially at least 40% by weight, preferably at least 50% by weight, even more preferably at least 60% by weight, of carboxylic esters of sorbitol, based on the overall composition. However, as the case may be, by-products from the respective preparation processes may also be present, for example carboxylic esters of 1,4-anhydrosorbitol, carboxylic esters of 2,5-anhydrosorbitol, carboxylic esters of 1,5-anhydrosorbitol and carboxylic esters of isosorbide, and also unreacted reactants.
- The terms “sorbitol carboxylates” and “sorbitan carboxylates” are used synonymously in the context of the present invention.
- This use of the term is based on the common nomenclature for polyol esters, which are known to be prone to dehydration during their synthesis, and so the products are mixed compositions. Those skilled in the art will thus understand the term “sorbitan esters” to mean a mixture comprising not only esters of 1,4-anhydrosorbitol and esters of 1,5-anhydrosorbitol, but also esters of isosorbide and esters of sorbitol, and also free sorbitol; in this regard see also Food emulsifiers and their applications, 1997, page 26.
- The term “carboxylic esters of sorbitol” in the context of the present invention refers to pure sorbitol compounds.
- The term “carboxylic esters of 1,4-anhydrosorbitol” in the context of the present invention refers to pure 1,4-anhydrosorbitol compounds.
- The term “carboxylic esters of 2,5-anhydrosorbitol” in the context of the present invention refers to pure 2,5-anhydrosorbitol compounds.
- The term “carboxylic esters of 1,5-anhydrosorbitol” in the context of the present invention refers to pure 1,5-anhydrosorbitol compounds.
- The term “carboxylic esters of isosorbide” in the context of the present invention refers to pure isosorbide compounds.
- Unless stated otherwise, all stated percentages (%) are percentages by weight.
- According to the invention, it is possible in accordance with the invention to use any acyl group donors. These include for example carboxylic esters or carboxylic acids themselves, and mixtures thereof.
- It is preferable in accordance with the invention that the acyl group donor provided in process step A) provides acyl groups that derive from a carboxylic acid containing 2 to 34, preferably 4 to 24, more preferably 6 to 22, carbon atoms, especially a natural fatty acid or mixtures thereof.
- Carboxylic esters used with preference in accordance with the invention as acyl group donor are selected from esters based on alkanols and polyols having up to 6 carbon atoms, particularly preferably having up to 3 carbon atoms, very particularly preferably glycerol esters.
- Carboxylic esters used with particular preference in accordance with the invention as acyl group donor are selected from triglycerides, especially natural fats and oils, particularly preferably selected from the group comprising, preferably consisting of, coconut fat, palm kernel oil, olive oil, palm oil, argan oil, castor oil, linseed oil, babassu oil, rapeseed oil, algal oils, sesame oil, soya oil, avocado oil, jojoba oil, safflower oil, almond oil, cottonseed oil, shea butter, sunflower oil, cupuaçu butter and oils having a high proportion of polyunsaturated fatty acids (PUFAs). Sorbitan esters, monoglycerides and diglycerides, in particular containing the acyl groups described hereinbelow, may likewise preferably be used.
- More preferably in accordance with the invention, the acyl group donor is selected from fatty acid acyl group donors that in particular provide an acyl group selected from the group of acyl groups of natural fatty acids, or mixtures thereof.
- Preferred fatty acids in this connection are mixtures of natural fatty acids, especially mixtures in which no carboxylic acid chain length has a proportion in the overall chain length distribution of more than 95% by weight, especially more than 99% by weight.
- Natural fatty acids can be produced on the basis of naturally occurring vegetable or animal oils and have preferably 6 to 30 carbon atoms, especially 8 to 22 carbon atoms. Natural fatty acids are generally unbranched and usually consist of an even number of carbon atoms. Any double bonds have cis configuration. Examples are: caproic acid, caprylic acid, capric acid, lauric acid, myristic acid, palmitic acid, palmifoleic acid, pelargonic acid (obtainable for example from the ozonolysis or oxidative cleavage of oleic acid), isostearic acid, stearic acid, 12-hydroxystearic acid, dihydroxystearic acid, undecylenic acid (obtainable for example from the pyrolysis of ricinoleic acid), oleic acid, linoleic acid, linolenic acid, petroselinic acid, elaidic acid, arachic acid, behenic acid, erucic acid, gadoleic acid, eicosapentaenoic acid, docosahexaenoic acid and arachidonic acid.
- More preferably in accordance with the invention, the acyl group donor is selected from fatty acid acyl group donors that are characterized in that they provide an acyl group mixture containing at least two acyl groups of the carboxylic acids selected from the group of caproic acid, caprylic acid, capric acid, lauric acid, myristic acid, palmitic acid, palmitoleic acid, pelargonic acid (obtainable for example from the ozonolysis or oxidative cleavage of oleic acid), isostearic acid, stearic acid, 12-hydroxystearic acid, dihydroxystearic acid, undecylenic acid (obtainable for example from the pyrolysis of ricinoleic acid), oleic acid, linoleic acid, linolenic acid, petroselinic acid, elaidic acid, arachic acid, behenic acid, erucic acid, gadoleic acid, eicosapentaenoic acid, docosahexaenoic acid and arachidonic acid.
- Acyl group donors used with preference in accordance with the invention are carboxylic acids, especially fatty acids. Preferred fatty acids in this connection are those mentioned above in connection with the fatty acids provided with preference.
- Acyl group donors used alternatively with particular preference are mixtures of fatty acids with glycerol fatty acid esters, preference being given to using those mentioned above in connection with fatty acids provided with preference, both in the case of the fatty acids and in the case of the glycerol fatty acid components, with an identical degree of preference.
- The mixture of fatty acid with glycerol fatty acid ester used preferably has a weight ratio of fatty acid to glycerol fatty acid ester of 80:20 to 99:1, preferably of 90:10 to 99:1, more preferably of 95:5 to 99:1.
- A process preferred in accordance with the invention is characterized in that the sorbitol and the at least one acyl group donor make up at least 80% by weight, preferably at least 90% by weight, more preferably at least 95% by weight, based on the overall reaction mixture at the start of process step B).
- Since the overall reaction mixture in this context consists largely of the reactants, i.e. sorbitol and acyl group donor, only very little solvent—if any—can he present in the overall reaction mixture. It is clear on the basis of the above that the acyl group donor is not covered by the term “solvent” in the process according to the invention.
- Possible solvents would be for example ketones, for example methyl isohutyl ketone or cyclohexanone, sterically hindered secondary alcohols such as 2-butyl-1-octanol, methylcyclohexanols, 1-methoxy-2-propanol, butane-2,3-diol, 2-octanol, diacetone alcohol, 2-methyl-2-butanol, and ethers such as 1,4-dioxane, tetrahydrofuran and Varonic APM.
- Based on the overall reaction mixture, solvents are present in a maximum total amount of less than 20% by weight, preferably less than 10% by weight, especially less than 5% by weight. The expression “is present in a maximum amount of less than X % by weight” can be equated with “has a content of less than X % by weight”.
- Particular preference is given to carrying out the process according to the invention in the absence of solvent.
- A process preferred in accordance with the invention is thus especially characterized in that, in process step B), the water content based on the overall reaction mixture is less than 15% by weight, preferably less than 5.0% by weight, more preferably less than 1.0% by weight.
- Lipases used with preference in accordance with the invention in process step B) are present immobilized on a solid support.
- Lipases used with preference in accordance with the invention in process step B) are lipases selected from the group comprising the lipase from Thermomyces lanuginosus (accession number O59952), lipases A and B (accession number P41365) from Candida antarctica and the lipase from Mucor miehei (accession number P19515), the lipase from Humicola sp. (accession number O59952), the lipase from Rhizomucor javanicus (accession number S32492), the lipase from Rhizopus oryzae (accession number P61872), the lipases from Candida rugosa (accession number P20261, P32946, P32947, P3294 and P32949), the lipase from Rhizopus niveus (accession number P61871), the lipase from Penicillium camemberti (accession number P25234), the lipases from Aspergillus niger (ABG73613, ABG73614 and ABG37906) and the lipase from Penicillium cyclopium (accession number P61869), particular preference being given to lipases A and B (accession number P41365) from Candida antarctica, and their respective at least 60%, with preference at least 80%, preferably at least 90% and especially preferably at least 95%, 98% or 99%, homologues at the amino acid level.
- The accession numbers listed in the context of the present invention correspond to the ProteinBank database entries of the NCBI with a date of Jan. 1, 2017; generally, in the present context, the version number of the entry is identified by “.digit”, for example “.1”.
- Enzymes that are homologous at the amino acid level preferably have, by comparison with the reference sequence, at least 50%, especially at least 90%, of the enzyme activity in propyl laurate units (PLU) as defined in the context of the present invention.
- To determine the enzyme activity in PLU (propyl laurate units), 1-propanol and lauric acid are mixed homogeneously in an equimolar ratio at 60° C. The reaction is started with addition of enzyme and the reaction time is measured. Samples are taken from the reaction mixture at intervals and the content of converted lauric acid is determined by titration with potassium hydroxide solution. The enzyme activity in PLU results from the rate at which 1 g of the enzyme in question synthesizes 1 μmol of propyl laurate per minute at 60° C.; cf. in this respect also US20070087418, in particular [0185].
- Commercial examples, and lipases that are likewise used with preference in processes according to the invention, are the commercial products Lipozyme TL IM, Novozym 435, Lipozyme IM 20, Lipase SP382, Lipase SP525, Lipase SP523, (all commercial products from Novozymes A/S, Bagsvaerd, Denmark), Chirazyme L2, Chirazyme L5, Chirazyme L8, Chirazyme L9 (all commercial products from Roche Molecular Biochemicals, Mannheim, Germany), CALB IMMO Plus TM from Purolite, and Lipase M “Amano”, Lipase F-AP 15 “Arnano”, Lipase AY “Amano”, Lipase N “Amano”, Lipase R “Amano”, Lipase A “Amano”, Lipase D “Amano”, Lipase G “Amano” (all commercial products from Amano, Japan).
- “Homology at the amino acid level” is for the purposes of the present invention understood as meaning “amino acid identity”, which can be determined with the aid of known methods. In general, use is made of special computer programs with algorithms taking into account specific requirements. Preferred methods for determining the identity first generate the closest match between the sequences to be compared. Computer programs for determining the identity include, but are not limited to, the GCG program package including
-
- GAP (Deveroy, J. et al., Nucleic Acid Research 12 (1984), page 387, Genetics Computer Group University of Wisconsin, Medicine (WI), and
- BLASTP, BLASTN and FASTA (Altschul, S. et al., Journal of Molecular Biology 215 (1990), pages 403-410. The BLAST program can be obtained from the National Center For Biotechnology Information (NCBI) and from other sources (BLAST Handbook, Altschul S. et al., NCBI NLM NIH Bethesda ND 22894; Altschul S. et al., above).
- Those skilled in the art are aware that various computer programs are available for the calculation of similarity or identity between two nucleotide or amino acid sequences. For instance, the percentage identity between two amino acid sequences can be determined for example by the algorithm developed by Needleman and Wunsch (J. Mol. Biol. (48): 444-453 (1970)), which has been integrated into the GAP program in the GCG software package (available at http://www.gcg.com), using either a Blossom 62 matrix or a PAM250 matrix, a gap weight of 16, 14, 12, 10, 8, 6 or 4 and a length weight of 1, 2, 3, 4, 5 or 6. Those skilled in the art will recognize that the use of different parameters will lead to slightly different results, but that the percentage identity between two amino acid sequences overall will not be significantly different. The Blossom 62 matrix is typically employed, using the default settings (gap weight: 12, length weight: 1).
- In the context of the present invention, an identity of 60% according to the above algorithm means 60% homology. The same applies to higher identities.
- In process step B), preference is given in accordance with the invention to using 500 PLU to 2000 PLU, preferably from 200 PLU to 1500 PLU, more preferably from 25 PLU to 1250 PLU, of lipase per gram of sorbitol to be converted.
- Process step B) is in accordance with the invention preferably carried out at a pressure of less than 1 bar, preferably less than 0.5 bar and particularly preferably less than 0.1 bar.
- Process step B) is in accordance with the invention alternatively preferably carried out in a bubble column reactor, with at least one inert gas being passed through the reaction mixture; this gas is preferably selected from the group comprising, preferably consisting of, nitrogen and argon. In this connection, it is preferable in accordance with the invention for the gas stream to be 1 to 60 kg/h, preferably 5 to 25 kg/h, yet more preferably 10 to 14 kg/h.
- Process step B) is in accordance with the invention preferably characterized in that process step B) is ended no later than 180 hours, preferably 120 hours, particularly preferably 100 hours, after the lipase has been added.
- A process that is preferred in accordance with the invention is characterized in that the molar ratio of sorbitol provided to acyl groups present in all acyl group donors provided is within a range from 1.00:0.50 to 1.00:5.00, preferably from 1.00:0.70 to 1.00:3.00, particularly preferably from 1.00:1.00 to 1.00:2.25, alternatively particularly preferably from 1.00:2.3 to 1.00:4.50.
- A process that is preferred in accordance with the invention is characterized in that by-products formed in process step B), for example water when the acyl group donor used is an acid and the corresponding alcohol when the acyl group donor used is an ester, are removed.
- This is possible by distillation for example.
- Process step C) of the process of the invention comprises the purification of the sorbitol carboxylate.
- All methodologies that allow the sorbitol carboxylate to be obtained in higher concentration can be employed for this purpose.
- It is in accordance with the invention preferable that the process according to the invention includes the removal, in process step C), of the lipase used in the process according to the invention.
- When the lipase is mmobilized on a support, it is preferable in accordance with the invention that the lipase is removed by filtration through a filter, especially a bag filter, having a fineness of 0.1 μ to 1250 μ, preferably of 0.5 μ to 100 μ.
- The process of the present invention is preferably in accordance with the invention characterized in that it does not involve any use of a molecular sieve.
- The process of the present invention is preferably in accordance with the invention characterized in that the substrates are not immobilized on solid supports such as silica.
- The present invention further provides the sorbitol carboxylate obtainable by the process of the invention.
- Preference is given in accordance with the invention to sorbitol carboxylates comprising carboxylic esters of sorbitol, carboxylic esters of 1,4-anhydrosorbitol, carboxylic esters of 2,5-anhydrosorbitol, carboxylic esters of 1,5-anhydrosorbitol, and carboxylic esters of isosorbide, where the ratio by weight of the sorbitol residues present in the sorbitol carboxylate to the sum total of all the 1,4-anhydrosorbitol residues, 2,5-anhydrosorbitol residues and 1,5-anhydrosorbitol residues and isosorbide residues present in the sorbitol carboxylate is greater than 90:10, preferably greater than 93:7, more preferably greater than 95:5, most preferably greater than 96:4, characterized in that the molar ratio of esterified primary hydroxyl groups to esterified secondary hydroxyl groups in the carboxylic esters of sorbitol is 80:20 to 20:80, preferably 70:30 to 30:70, even more preferably 60:40 to 40:60, even more preferably from 55:45 to 45:55.
- It is clearly apparent from the expression “sorbitol carboxylates containing carboxylic esters of sorbitol, carboxylic esters of 1,4-anhydrosorbitol, carboxylic esters of 2,5-anhydrosorbitol, carboxylic esters of 1,5-anhydrosorbitol and carboxylic esters of isosorbide, where the weight ratio of the sorbitol residues present in the carboxylic esters to the sum total of all 1,4-anhydrosorbitol residues, 2,5-anhydrosorbitol residues, 1,5-anhydrosorbitol residues and isosorbide residues present in the carboxylic esters is greater than 90:10” that the content of at least one selected from carboxylic esters of 1,4-anhydrosorbitol, carboxylic esters of 2,5-anhydrosorbitol, carboxylic esters of 1,5-anhydrosorbitol and carboxylic esters of isosorbide must be non-0 (zero), since divisions by 0 are undefined.
- The weight ratio of the sorbitol residues present in the sorbitol carboxylates according to the invention to the sum total of all 1,4-anhydrosorbitol residues, 2,5-anhydrosorbitol residues, 1,5-anhydrosorbitol residues and isosorbide residues present in the sorbitol carboxylate according to the invention is determined by means of high-performance liquid chromatography (HPLC). This method includes the alkaline hydrolysis of the sorbitol carboxylate to be analysed, removal of the carboxylic acids and analysis of the sorbitol and the 1,4-anhydrosorbitol, 2,5-anhydrosorbitol, 1,5-anhydrosorbitol and isosorbide degradation products thereof.
- For this purpose, an initial charge of 150 mg of the sorbitol carboxylate to be analysed in 2.00 ml of 1 M aqueous KOH solution is hydrolysed at 95° C. with stirring for 30 min. The reaction solution is then cooled to room temperature and adjusted to pH 2-3 with 2 M aqueous HCl solution. The carboxylic acids that precipitate out as a result are then extracted with diethyl ether (3×3.00 ml), with removal of the organic supernatant by pipette after each extraction. After the extraction, the aqueous solution is heated to 50° C. with stirring for 20 min, which removes the rest of the ether (boiling point of diethyl ether: 34.6° C.).
- The solution obtained above is made up to 10.0 ml with bidistilled H2O and then diluted 1:10, and an aliquot of the solution is analysed by HPLC. The analysis is carried out under the following conditions:
- Column: Aminex HPX-87C column 300×7.8 mm
- Eluent: H2O
- Injected volume: 10.0 μl
- Flow rate: 0.60 ml/min
- Column temperature: 50° C.
- Detector: G1362A/1260 RID (from Agilent), 35° C.
- Run time: 30.0 min
- Sorbitol and its degradation products are separated by an ion-exchange process.
- For the evaluation, the peak area of sorbitol is expressed relative to the sum total of the peak areas of 1,4-anhydrosorbitol, 2,5-anhydrosorbitol, 1,5-anhydrosorbitol and isosorbide.
- Reference substances for the sorbitol degradation products are commercially available or can alternatively be obtained by heating sorbitol in neat form in the presence of acidic (>140° C.) or basic (>180° C.) catalysts.
- The molar ratio of esterified primary hydroxyl groups to esterified secondary hydroxyl groups in the carboxylic esters of sorbitol is determined by 13C NMR spectroscopy. For sample preparation, 50-70 mg of substance is dissolved in 1 ml of a deuterated solvent to which has been added a relaxation agent (chromium(III) acetylacetonate, 1%). DMSO-d6, CDCl3 and methanol-d4 have been found to be suitable solvents, according to product properties. If the sample does not dissolve completely in one of the solvents, a solvent mixture must be found. The prepared sample solution is transferred to a 5 mm NMR tube and introduced into the NMR spectrometer.
- The NMR spectroscopy investigations can in principle be carried out with any commercial NMR instrument. For the present NMR spectroscopy investigations, a Bruker Avance 400 instrument was used. The spectra were recorded with the following parameters:
- Temperature: T=295 K, Time delay: D1=2 s. Number of scans: NS=2048, Transmitter frequency offset: O1P=110 ppm, Sweep width: SW=300 ppm, Probe: PA BBI 400 S1 H-BB-D-05-Z.
- The resonance signals were recorded against the chemical shift of tetramethylsilane (TMS=0 ppm) as internal standard. Other commercial NMR instruments give comparable results with the same operating parameters. The signals are quantified by determining the area under the respective resonance signals, i.e. the area enclosed by the signal from the baseline. In the present NMR spectroscopy investigations, the spectra were integrated using the “TOPSPIN” software, version 3.0.
- For more accurate identification of the esterified primary and esterified secondary hydroxyl groups, a DEPT spectrum is first recorded. The molar ratio of esterified primary to esterified secondary hydroxyl groups is determined by subtracting the integral value P (group of signals for the esterified primary hydroxyl groups) from integral value C (group of signals for the ester carbonyl groups).
- This gives an internal value S for the group of signals for the esterified secondary hydroxyl groups, which cannot be determined directly because of superimposition with other signals.
- P=Integral value of the esterified primary hydroxyl groups [R—CH2—OC(O)R groups]
- C=Integral value of the ester carbonyl groups
- S=C−P=Integral value of the esterified secondary hydroxyl groups [R2—CH—OC(O)R groups]
- The ratio of P to S ascertained corresponds to the molar ratio of esterified primary hydroxyl groups to esterified secondary hydroxyl groups in the carboxylic esters of sorbitol.
- Preference is given in accordance with the invention to sorbitol carboxylates that are characterized in that the average degree of esterification of the carboxylic esters of sorbitol present is from 0.3 to 4.0, preferably from 1.0 to 3.0, more preferably from 1.1 to 2.7, especially preferably from 1.3 to 2.6. Preference is alternatively given in accordance with the invention to sorbitol carboxylates that are characterized in that the average degree of esterification of the carboxylic esters of sorbitol present is from 2.7 to 4.0.
- The average degree of esterification of the carboxylic esters of sorbitol present in the sorbitol carboxylate according to the invention is determined, for example, by first determining the content of free sorbitol and of its 1,4-anhydrosorbitol, 2,5-anhydrosorbitol, 1,5-anhydrosorbitol and isosorbide degradation products in a sample of the sorbitol carboxylate in question. It is additionally necessary to determine the saponification value, acid value and content of free and neutralized fatty acids (for example via GC as described hereinbelow under “Determination of the content of free carboxylic acid”). The determination of the carboxylic acid composition after alkaline saponification gives an average molar mass of the carboxylic acid mixture that has been esterified.
- This value can then be used to calculate the average degree of esterification.
- Preference is given in accordance with the invention to a sorbitol carboxylate that is characterized in that the carboxylic esters of sorbitoi present comprise monoesters of sorbitol, diesters of sorbitol and triesters of sorbitol, where the triesters of sorbitol are present preferably in an amount, based on all carboxylic esters of sorbitol present, of 10% to 50% by weight, preferably of 15% by weight to 45% by weight, more preferably of 20% by weight to 40% by weight. In this connection, it is further preferable in accordance with the invention that the carboxylic esters of sorbitol present comprise monoesters of sorbitol, diesters of sorbitol, triesters of sorbitol and tetraesters of sorbitol.
- Preference is given in accordance with the invention to a sorbitol carboxylate that is characterized in that it contains 0.05% to 40% by weight, preferably 0.2% to 25% by weight, more preferably 0.5% to 10% by weight, of free sorbitol,
- where the percentages by weight are based on the overall sorbitol carboxylate.
- For determination of the sorbitol present in the sorbitol carboxylate of the invention by GC, a portion of the sample is dissolved in pyridine:chloroform (4:1). 0.25 ml of this solution is mixed with 0.5 ml of MSTFA [N-methyl-N-(trimethylsilyl)trifluoroacetamide] and 0.5 ml of a mixture of N-trimethylsilylimidazole and pyridine (11:39).
- The alcohols are quantitatively converted into their trimethylsilyl ethers by reaction at 80° C. (30 minutes) and then analysed by GC/FID.
- This is performed in a gas chromatograph equipped with a split/splitless injector, a capillary column and a flame ionization detector, under the following conditions:
- Injector: 290° C., split 30 ml
- Injected volume: 1 μl
- Column: 50 m*0.32 mm HP5 1.05 μm
- Carrier gas: Hydrogen, constant flow, 2 ml/min
- Temperature program: 100° C. to 140° C. at 10° C./min, then 140° C. to 300° C. at 5° C./min, then conditioning at 300° C. for 5 minutes.
- Detector: FID at 310° C. Hydrogen 30 min Air 400 ml/min Make-up gas 12 ml/min
- The sorbitol is separated off and its proportion by mass determined by an internal standard method. For this purpose, the GC system is calibrated by analysing mixtures of sorbitol and of the internal standard of known composition.
- Preference is given in accordance with the invention to a sorbitol carboxylate that is characterized in that it contains less than 25% by weight, preferably from 0.01% by weight to 20% by weight, more preferably from 0.05% by weight to 10% by weight, of at least one free carboxylic acid, the percentages by weight being based on the overall sorbitol carboxylate.
- The at least one free carboxylic acid may be in protonated or neutralized form.
- To determine the content of free carboxylic acid in the sorbitol carboxylate of the invention, the acid value is first determined. Through the acid value and molecular weight of the fatty acid concerned, it is possible to determine the proportion by weight.
- Suitable methods for determining the acid number are particularly those according to DGF C-V 2, DIN EN ISO 2114, Ph. Eur. 2.5.1, ISO 3682 and ASTM D 974.
- It is known to those skilled in the art that, where there is a mixture of carboxylic acids, a GC analysis can also additionally be carried out after saponification of the sorbitol carboxylate, in order to determine an average molecular weight of the carboxylic acid mixture present.
- For this purpose, 0.6 g of the sorbitol carboxylate of the invention is boiled under reflux in 25 ml of 0.5 M ethanolic KOH solution for 4 hours. The pH is then adjusted to 2-3 with sulfuric acid and the liberated carboxylic acids are separated by extracting three times with a volume of petroleum ether.
- The combined extracts are concentrated to about 10 ml by evaporation.
- Suitable methods for determining the fatty acid distribution are in particular those according to DGF C VI 11a, DGF C-VI 10 a and GAT ring test 7/99.
- A 0.5 ml aliquot of the petroleum ether extract obtained as described above is mixed in an autosampler vial with 0.5 ml of MTBE and 1 ml of trimethylanilinium hydroxide (0.2 M in methanol) and analysed by GC. This is performed in a gas chromatograph equipped with a split/splitless injector, a capillary column and a flame ionization detector, under the following conditions:
- Injector: 290° C., split 30 ml
- Injected volume: 1 μl
- Column: 30 m*0.32 mm HP1 0.25 μm
- Carrier gas: Helium, head pressure 70 kPa
- Temperature program: 80° C.-300° C. at 8° C./min, then conditioning for 20 minutes at 300° C.
- Detector: FID at 320° C. Hydrogen 35 ml/min Air 240 ml/min Make-up gas 12 ml/min
- The carboxylic acids are separated according to length of their carbon chain in the form of their methyl esters. By evaluating the peak areas it is possible to determine the mass ratio of these carboxylic acid methyl esters to one another and from this—via their respective molecular weights—their molar ratio, which corresponds to the molar ratio of the associated carboxylic acids. it is in addition possible to determine an average molecular weight of this fatty acid mixture:
-
- where ai=Normalized proportion by mass of carboxylic acid methyl ester i in the mixture of all carboxylic acid methyl esters [%]. Ai=Peak area of carboxylic acid methyl ester i in the GC chromatogram [%].
-
- where ni=Molar amount [mol] of carboxylic acid methyl ester i in 100 g of carboxylic acid methyl ester mixture; from this, the ratios of the individual ni values to one another are obtained, which correspond to the ratios of the molar amounts of the associated carboxylic acids in the sorbitol carboxylate; thus it is possible for the total molar amount ns [mol] of carboxylic acids in 1 g of sorbitol carboxylate, as obtained from the saponification value (see below), to be split into its components according to said ratios. Mi=Molecular weight of the carboxylic acid corresponding to methyl ester i [g/mol].
-
- Preference is given in accordance with the invention to a sorbitol carboxylate that is characterized in that the total monoester component of the carboxylic ester of sorbitol contains from 5% by weight to 25% by weight, preferably from 7% by weight to 15% by weight, more preferably from 9% by weight to 13% by weight, of secondary ester regiolsomers.
- Preference is given in accordance with the invention to a sorbitol carboxylate that is characterized in that the total monoester component of the carboxylic ester of sorbitol and the total diester component of the carboxylic ester of sorbitol each comprise at least two regioisomers.
- Preference is given in accordance with the invention to a sorbitol carboxylate that is characterized in that the total diester component of the carboxylic ester of sorbitol contains from 25% by weight to 45% by weight, preferably from 28% by weight to 39% by weight, more preferably from 30% by weight to 37% by weight, of regioisomers in which at least one secondary hydroxyl group has been esterified.
- The determination of the content of secondary ester regiolsomer in the total monoester component of the carboxylic ester of sorbitol of the invention, the determination of the content of triester species based on the sum total of all carboxylic esters of sorbitol that are present, and the determination of the content of regioisorners in the total diester component in which at least one secondary hydroxyl group has been esterified can be performed by gas chromatography, optionally coupled with mass spectrometry (GC-FID and GC-MS):
- 10 mg of a sample of the corresponding sorbitol carboxylates is first dissolved in 1.5 ml of trichloromethane, and then 0.15 ml of N-methyl-N-(trimethylsilyl)trifluoroacetamide (MSTFA) is added. The derivatization is carried out at 80° C. for 30 minutes. A sample of the clear solution thus obtained is analysed by GC-FID and GC-MS. The parameters of the analysis method are:
- Gas chromatograph: Agilent MSD 7890
- Column: Agilent HP-5 (50 m, 0.32 mm, 0.5 μm),
- Flow rate: constant 2 ml/min with hydrogen (GC-MS: helium)
- Thermal equilibration at 80° C., 8° C./min; 300° C., 30 min, injector 1 μl, split 1:20, detector at 310° C.
- Detector: FID, 310° C./GC-MS scan 35-650 d
- In the GC-FID analysis, the esters present in the sample are separated according to their total chain length. The ratios of the individual ester species to one another are determined via the respective area percentage of the GC-FID peak. The peaks are identified/assigned to the individual ester species via GC-MS, if appropriate also via a comparison of retention time of separately prepared and isolated standards, for example for the mono- and diesters esterified exclusively at primary hydroxyl groups.
- This method can likewise be used to detect the content of free protonated and also free neutralized carboxylic acids, since these are likewise derivatized.
- The present invention further provides for the use of the sorbitol carboxylates according to the invention as viscosity regulator, care active ingredient, foam booster or solubilizer, antimicrobial, antistat, binder, corrosion inhibitor, dispersant, emulsifier, film former, humectant, opacifier, oral care agent, preservative, skincare agent, hydrophilic emollient, foam stabilizer and nonionic surfactant, preferably as viscosity regulator, emulsifier, antimicrobial and hydrophilic emollient, particularly preferably as viscosity regulator, especially as thickener, especially in cleansing or care formulations.
- The examples that follow describe the present invention by way of example, without any intention to limit the invention, the scope of application of which is apparent from the entirety of the description and the claims, to the embodiments specified in the examples.
- Various sorbitol carboxylates were synthesized as described hereinafter.
- A 25% solution of the sample to be analysed was prepared in a mixture of concentrated acetic acid and toluene (3:1), and filtered if necessary to give a clear solution. An aliquot (approx. 10 g; so that the cuvette is sufficiently filled) was measured in a Lica 690 spectral colorimeter at room temperature in an 11 mm round cuvette, and the colour numbers reported in each case were recorded.
- A mixture of sorbitol (96.5 g, 0.529 mol, 1.00 eq.) and caprylic acid (acid number=389 mg KOH/g, >98%, 118.34 g, 0.821 mol, 1.55 eq.) was heated to 100° C. while stirring and passing N2 through. After 1 h, the mixture was cooled down to 85° C., immobilized Candida antarctica lipase B enzyme (6.44 g; Purolite D5619, corresponding to 55747 PLU) was added, and stirring of the mixture was continued at 85° C. and 15 mbar for 24 h, during which time the water formed was distilled off continuously. The mixture was then filtered at 80° C. through a Büchner funnel with black band filter to remove the enzyme. The product obtained had an acid number of 3.0 mg KOH/g.
- A mixture of sorbitol (70% aqueous solution, 390.45 g, 1.50 mol, 1.00 eq.), phosphoric acid (2.9 g) and sodium hydroxide (5.0 g) was dehydrated at 140° C. for 30 min. Subsequently, caprylic acid (acid number=389 mg KOH/g, >93%, 334.8 g, 2.32 mol, 1.55 eq.) was added, and the mixture was stirred at 200° C. until an acid number of 8.1 mg KOH/g had been attained.
- A mixture of sorbitol (96.5 g, 0.529 mol, 1.00 eq.), caprylic acid (acid number=389 mg KOH/g, >98%, 118.34 g, 0.821 mol, 1.55 eq.) and Novozym 435 (57.9 g, 405475 PLU) was stirred at 90° C. and <7 mbar for 24 h, and the water formed was distilled off continuously. The mixture was then filtered at 85° C. through a Büchner funnel with black band filter to remove the enzyme. The product obtained had an acid number of 2.0 mg KOH/g.
- A mixture of sorbitol (51.3 g, 0.282 mol, 1.00 eq.) and oleic acid (acid number=200 mg KOH/g, iodine number=92.3 g I2/100 g, 157.9 g, 0.563 mol, 2.00 eq.) was heated to 100° C. while stirring and passing N2 through. After 1 h, the mixture was cooled down to 85° C., immobilized Candida antarctica lipase B enzyme (6.28 g; Purolite D5619, corresponding to 54361 PLU) was added, and stirring of the mixture was continued at 85° C. and 20 mbar for 24 h, during which time the water formed was distilled off continuously. The mixture was then filtered at 80° C. through a Büchner funnel with black band filter to remove the enzyme. The product obtained had an acid number of 4.2 mg KOH/g.
- A mixture of sorbitol (100.1 g, 0.549 mol, 1.00 eq.), oleic acid (>99%, 155.1 g, 0.549 mol, 1.00 eq.) and Novozym 435 (38.7 g, 271126 PLU) was stirred at 90° C. and <7 mbar for 24 h, and the water formed was distilled off continuously. The mixture was then filtered at 85° C. through a Büchner funnel with black band filter to remove the enzyme. The product obtained had an acid number of 12.8 mg KOH/g.
- A mixture of sorbitol (62.6 g, 0.344 mol, 1.00 eq.) and stearic acid (acid number=198 mg KOH/g, ≥92%, 146.7 g, 0.516 mol, 1.50 eq.) was heated to 115° C. while stirring and passing N2 through.
- After 1 h, the mixture was cooled down to 90° C., immobilized Candida antarctica lipase B enzyme (6.28 g; Purolite D5619, corresponding to 54350 PLU) was added, and stirring of the mixture was continued at 90° C. and <7 mbar for 24 h, during which time the water formed was distilled off continuously. The mixture was then filtered at 85° C. through a Büchner funnel with black band filter to remove the enzyme. The product obtained had an acid number of 6.5 mg KOH/g.
- A mixture of sorbitol (62.6 g, 0.344 mol, 1.00 eq.), stearic acid (acid number=198 mg KOH/g, ≥92%, 146.7 g, 0.516 mol, 1.50 eq.) and Novozym 435 (7.77 g, 54393 PLU) was stirred at 90° C. and <7 mbar for 24 h, and the water formed was distilled off continuously. The mixture was then filtered at 85° C. through a Büchner funnel with black band filter to remove the enzyme. The product obtained had an acid number of 10.4 mg KOH/g.
- A mixture of sorbitol (71.4 g, 0.392 mol, 1.00 eq.) and lauric acid (acid number=280 mg KOH/g, ≥99%, 141.3 g, 0.705 mol, 1.80 eq.) was heated to 100° C. while stirring and passing N2 through. After 1 h, the mixture was cooled down to 95° C., immobilized Candida antarctica lipase B enzyme (6.38 g; Purolite D5619, corresponding to 55227 PLU) was added, and stirring of the mixture was continued at 95° C. and 20 mbar for 24 h, during which time the water formed was distilled off continuously. The mixture was then filtered at 80° C. through a Büchner funnel with black band filter to remove the enzyme. The product obtained had an acid number of 3.5 mg KOH/g.
- A mixture of sorbitol (70% aqueous solution, 390.0 g, 1.50 mol, 1.00 eq.), lauric acid (acid number=280 mg KOH/g, ≥99%, 330.0 g, 1.65 mol, 1.10 eq.) and K2CO3 (16 g) were heated to 180° C. while stirring and passing N2 through, and the water formed was distilled off continuously until an acid number of 3.5 mg KOH/g had been attained.
- A mixture of sorbitol (99.0 g, 0.54 mol, 1.00 eq.), methyl laurate (140.0 g, 0.65 mol, 1.20 eq.) and K2CO3 (6 g) was heated to 160° C. at 50 mbar while stirring for 5 h, during which time the methanol formed was distilled off continuously.
- A mixture of sorbitol (71.4 g, 0.392 mol, 1.00 eq.), lauric acid (acid number=280 mg KOH/g, ≥99%, 141.3 g, 0.705 mol, 1.80 eq.) and Novozym 435 (49.8 g, 348253 PLU) was stirred at 90° C. and <7 mbar for 24 h, and the water formed was distilled off continuously. The mixture was then filtered at 85° C. through a Büchner funnel with black band filter to remove the enzyme. The product obtained had an acid number of 2.8 mg KOH/g.
- Table 1 compares the parameters determined for the examples according to the invention and the noninventive examples.
- More particularly, it is apparent from Examples 4, 4B and 4C that the sorbitol carboxylates prepared by the process according to the invention have a better colour than those from the conventional chemical synthesis.
-
TABLE 1 Inventive examples are marked by * NMR Sorbitol: Iodine colour prim. vs. degradation number in sec. ester products solution Example 1 * 49:51 98:2 0.1 Example 1B n.a. 14:86 2.1 Example 1C 43:57 98:2 0.1 Example 2* 48:52 98:2 0.1 Example 2B 48:52 97:3 0.8 Example 3* 46:54 99:1 0.1 Example 3B 45:55 98:2 0.1 Example 4* 47:53 98:2 0.1 Example 4B 47:53 89:11 2.2 Example 4C 34:66 78:22 1.0 Example 4D 47:53 98:2 0.1 - The thickening action of the inventive examples was evaluated by comparison with the corresponding noninventive examples in two different formulations:
- Formulation 1 consisted of 9% SLES, 3% Cocamidopropyl Betaine and 0.7% NaCl in water. The pH of formulation 1 was adjusted to 5.2 with citric acid. Subsequently incorporated into this formulation in each case was 1.1% of the example substances mentioned above by stirring at 60° C. for 30 min, and the viscosities were measured using a Brookfield viscometer (spindle 62, 30 rpm, in Examples 1, 1B, 1C, 2, 2B; spindle 2, 60 rpm, in Examples 3, 3B, 4, 4B, 4C, 4D) at 22° C.
- Formulation 2 consisted of 5.6% AM C, 4.4% Lauryl Glucoside, 1.2% Coco-Glucoside and 3.6% Glutamate in water. The pH of formulation 2 was adjusted to 5.2 with citric acid. Subsequently incorporated into this formulation in each case was 1.0% of the example substances mentioned above by stirring at 60° C. for 30 min, and the viscosities were measured using a Brookfield viscometer (spindle 62, 30 rpm, in Examples 1, 1B, 1C, 2, 2B; spindle 2, 60 rpm, in Examples 3, 3B, 4, 4B, 4C, 4D) at 22° C.
- The results of the viscosity measurements are shown in Table 2.
-
TABLE 2 Viscosity of the example formulation containing 1.1% thickener Viscosity of Viscosity of formulation formulation Example 1 [mPa*s] 2 [mPa*s] 1 inventive 6517 4341 1B noninventive 6221 3723 1C noninventive 4627 1877 2 inventive 93 350 2B noninventive 42 170 3 inventive 50 144 3B noninventive 26 98§ 4 inventive 74 2027 4B noninventive 50 1000 4C noninventive 21 981 4D noninventive 35 200 §Example 3B was not fully soluble in formulation 2, which is a further disadvantage of this noninventive example. - The results from Table 2 show that higher viscosities are achieved with the inventive Example 1 in both formulations than with the noninventive Examples 1B and 1C, The same is found for the inventive Example 2 compared to the noninventive Example 2B, and for 3 versus 3B and 4 versus 4B, 4C and 4D.
- The literature Biotechnol Bioeng 1995 48 214-221 describes the use of extremely high amounts of enzyme, namely about 494 000 PLU per mole of fatty acid used. Such a high enzyme load is uneconomic. Loads of interest are around 100 000 PLU per mole of fatty acid used or lower. In the case of Examples 3 (inventive) and 3B (noninventive), after the reaction had ended and after the enzyme had been removed, the acid number was determined and an aliquot (about 30 g) in a 100 ml glass measuring cylinder was left in a heated cabinet at 90° C. for 24 h and then, after the phases had separated, the ratio (v/v) of the upper ester phase to the lower sorbitol phase was determined.
- Table 2 presents the results.
-
TABLE 2 Acid number and ratio (v/v) of ester to sorbitol phase Acid number Ratio (v/v) [mg KOH/g] of ester to Enzyme load per after reaction sorbitol mole of fatty acid time 24 h phase Example inventive about 105 000 6.5 89:11 3 Example Non- about 105 000 10.4 83:17 3B inventive - It becomes clear from the data shown in Table 2 that the process according to the invention has the advantage compared to the process described in the prior art that, after a reaction time of 24 h, a low acid number has already been attained, which is desirable, and the sorbitol phase that separates in the melt likewise represents a smaller proportion.
- A further advantage of the process according to the invention is found in a comparison of Example 1 with 1C. In spite of seven times the amount of lipase, after a reaction time of 24 h, in the prior art process, the conversion rate measured by the acid number is within the same range as in the process according to the invention.
-
TABLE 3 Acid value Enzyme load Acid number [mg per mole of KOH/g] after reaction fatty acid time 24 h Example 1 inventive about 68 000 3.0 Example 1C Non-inventive about 500 000 2.0 - A similar picture is found in a comparison of Example 2 with 2B. With the same amount of lipase, after a reaction time of 24 h, in the prior art process, the conversion rate measured by the acid number is actually clearly lower than in the process according to the invention.
-
TABLE 4 Acid value Enzyme load Acid number [mg per mole of KOH/g] after reaction fatty acid time 24 h Example 2 inventive about 97 000 4.2 Example 2B noninventive about 500 000 12.8 - A similar picture is found in a comparison of Example 4 with 4D. With the same amount of lipase, after a reaction time of 24 h, in the prior art process, the conversion rate is within the same range as in the process according to the invention.
-
TABLE 5 Acid value Enzyme load Acid number [mg per mole of KOH/g] after reaction fatty acid time 24 h Example 4 inventive about 78,000 3.5 Example 4D noninventive about 500 000 2.8 -
-
Recipe 1a 1b 1c Composition from example 3 3.2% 3.2% 3.2% C18-C22 Hydroxyalkyl Hydroxypropyl Guar 0.2% (ESAFLOR HM 22, Lamberti S.p.A.) Hydroxypropyl Guar (ESAFLOR HDR, Lamberti 0.2% 0.2% S.p.A.) Isoamyl Cocoate (TEGOSOFT ® AC, Evonik 5.4% 5.4% 5.4% Operations GmbH) Water ad 100% ad 100% ad 100% Aluminium Chlorohydrate (50% aq.; Locron LIC, 20.0% 20.0% 20.0% Clariant AG) Methylisothiazolinone, Methylparaben, Ethylparaben; 0.8% 0.8% Dipropylene Glycol (Microcare MEM, Thor) Undecylenamidopropyitrimonium Methosulfate; Aqua; 1.0% Propylene Glycol (dermosoft ® UTM, Evonik Dr. Straetmans GmbH) -
-
Recipe 2a 2b 2c Composition from example 3 3.2% 3.2% 3.2% C18-C22 Hydroxyalkyl Hydroxypropyl Guar (ESAFLOR 0.15% HM 22, Lamberti S.p.A.) Hydroxypropyl Guar (ESAFLOR HDR, Lamberti S.p.A.) 0.15% 0.15% Polyglyceryl-3 Caprylate (TEGO ® Cosmo P 813, Evonik 0.5% 0.5% 0.5% Operations GmbH) Zinc Ricinoleate (TEGODEO ® PY 88 G, Evonik 1.0% 1.0% 1.0% Operations GmbH) Caprylic/Capric Triglyceride (TEGOSOFT ® CT, Evonik 5.65% 5.65% 5.65% Operations GmbH) Water ad 100% ad 100% ad 100% Glycerin 3.0% 3.0% 3.0% Benzyl Alcohol, Benzoic Acid, Sorbic Acid (Rokonsal 1.0% 1.0% 1.0% BSB-N, Ashland Specialty Ingredients) Citric Acid (50% aq.) q.s. q.s. q.s. Pentylene Giycoi (dermosoft ® Pentiol eco, Evonik Dr. 4.0 Straetmans GmbH) -
-
Recipe 3a 3b 3c Composition from example 3 4.8% 4.8% 4.8% C18-C22 Hydroxyalkyl Hydroxypropyl 0.25% Guar (ESAFLOR HM 22, Lamberts S.p.A.) Hydroxypropyl Guar (ESAFLOR HDR, 0.25% 0.25% Lamberts S.p.A.) Isopropyl Palmitate (TEGOSOFT ® P, 5.0% 5.0% 5.0% Evonik Operations GmbH) Water ad 100% ad 100% ad 100% Glycerin 3.0% 3.0% 3.0% Potassium alum 5.0% 5.0% 5.0% Methylisothiazolinone, Methylparaben, 0.8% 0.8% Ethylparaben; Dipropylene Glycol (Microcare MEM, Thor) Pentylene Glycol (dermosoft ® Pentiol 3.5% eco, Evonik Dr. Straetmans GmbH -
-
Recipe 4a 4b Composition from example 3 3.0% 3.0% Diethylhexyl Carbonate (TEGOSOFT ® DEC, Evonik Operations 3.0% 3.0% GmbH) PPG-14 Butyl Ether (TEGOSOFT ® PBE, Evonik Operations 3.0% 3.0% GmbH) Polyglycery-3 Caprylate (TEGO ® Cosmo P813, Evonik 0.5% 0.5% Operations GmbH) Demineralized water ad 100% ad 100% Hydroxyethylcellulose (Natrosol 250 HHR, Ashland Specialty 1.0% 1.0% Chemicals) Aluminium Chlorohydrate (50%) (Reach 501L, Reheis) 15.0% 15.0% Methylisothiazolinone, Methylparaben, Ethylparaben; Dipropylene 0.8% 3.0% Glycol (Microcare MEM, Thor) 1,2-Hexanediol (dermosoft ® Hexiol, Evonik Dr. Straetmans 2.8% GmbH) -
-
Recipe 5a 5b 5c Composition from example 3 3.0% 2.5% 2.5% Sodium Cetearyl Sulfate (Lanette E, BASF SE) 0.5% 0.5% Glyceryl Stearate 1.0% 1.0% 1.0% Stearyl Alcohol 1.0% 1.0% 1.0% PPG-15 Stearyl Ether 5.0% 5.0% 5.0% Isoamyl Cocoate (TEGOSOFT ® AC, Evonik Operations 5.0% 5.0% 5.0% GmbH) Diethylhexyl Carbonate (TEGOSOFT ® DEC, Evonik 5.0% 5.0% 5.0% Operations GmbH) Persea Gratissima (avocado) Oil 2.0% 2.0% 2.0% Polyglycery-3 Caprylate (TEGO ® Cosmo P813, Evonik 0.5% 0.5% 0.5% Operations GmbH) Zinc Ricinoleate (TEGODEO ® PY88 G, Evonik 1.0% 1.0% 1.0% Operations GmbH) Demineralized water ad 100% ad 100% ad 100% Hydroxyethylcellulose (Natrosol 250 HHR (Ashland 1.0% 1.0% 1.0% Specialty Chemicals) Aluminium Chlorohydrate (50% aq.; Locron LIC, Clariant 15.0% 15.0% 15.0% AG) Methylisothiazolinone, Methylparaben, Ethylparaben: 0.8% 0.8% Dipropylene Glycol (Microcare MEM, Thor) Methylpropanediol; Caprylyl Glycol; Phenylpropanol 3.5% (dermosoft ® OMP; Evonik Dr. Straetmans GmbH) -
-
Recipe 6a 6b Composition from example 3 4.0% 4.0% Phenoxyethyl Caprylate (TEGOSOFT ® XC, Evonik Operations 3.2% 3.2% GmbH) Isopropyl Palmitate (TEGOSOFT ® P, Evonik Operations GmbH) 2.0% 2.0% Bis-Ethylhexyloxyphenol Methoxyphenyl Triazine (Tinosorb S, 3.0% 3.0% BASF SE) Butyl Methoxydibenzoylmethane 2.0% 2.0% EHC 2.0% 2.0% Ethylhexyl Salicylate 4.0% 4.0% Octocrylene 4.0% 4.0% Glycerin 3.0% 3.0% Water ad 100% ad 100% Carbomer suspension 1 (Acrylates/C10-30 Alkyl Acrylate 1.0% 1.0% Crosspolymer, TEGO ® Carbomer 341ER, Evonik Operations GmbH, 20% in Phenoxyethyl Caprylate) Tris(hydroxymethyl)aminomethane (30% aq.) 0.6% 0.6% UV filter solution (20% Phenylbenzimidazole Sulfonic Acid, 8.8% 10.0% 10.0% tris(hydroxymethyf)aminomethane, demineralized water to 100%) Methylisothiazolinone, Methylparaben, Ethylparaben; Dipropylene 0.8% Glycol (Microcare MEM, Thor) Methylpropanediol; Caprylyl Glycol (dermosoft ® OM, Evonik Dr. 4.0 Straetmans GmbH) -
-
Recipe 7a 7b 7c Composition from example 3 3.0% 2.5% 2.5% Glyceryl Stearate Citrate (AXOL ® C 62, Evonik Operations GmbH) 0.5% 0.5% Glyceryl Stearate 0.5% 0.5% 0.5% Stearyl Alcohol 0.5% 0.5% 0.5% Bis-Ethythexyloxyphenol Methoxyphenyl Triazine (Tinosorb S, BASF 3.0% 3.0% 3.0% SE) Butyl Methoxydibenzoylmethane 2.0% 2.0% 2.0% Ethylhexyl Methoxycinnamate 2.0% 2.0% 2.0% Ethylhexyl Salicylate 4.0% 4.0% 4.0% Octocrylene 4.0% 4.0% 4.0% Isopropyl Palmitate 2.0% 2.0% 2.0% Phenoxyethyl Caprylate (TEGOSOFT ® XC, Evonik Operations GmbH) 3.2% 3.2% 3.2% Glycerin 3.0% 3.0% 3.0% Demineralized water ad 100% ad 100% ad 100% Carbomer suspension (Acrylates/C10-30 Alkyl Acrylate Crosspolymer, 1.0% 1.0% 1.0% TEGO ® Carbomer 341ER, 20% in Phenoxyethyl Caprylate) Tromethamine (30%) 0.9% 0.9% 0.9% UV filter solution (20% Phenylbenzimidazole Sulfonic Acid, 8.8% 10.0% 10.0% 10.0% tris(hydroxymethyl)aminomethane, demineralized water to 100%) Methylisothiazolinone, Methylparaben, Ethylparaben; Dipropylene Glycol 0.8% 0.8% (Microcare MEM, Thor) Methylpropanediol; Caprylyl Glycol; Phenylpropanol (dermosoft ® OMP; 3.0% Evonik Dr. Straetmans GmbH) -
-
Recipe 8a 8b 8c Composition from exampie 3 3.00% 2.00% 2.00% Cetearyl Glucoside (TEGO ® Care CG 90, Evonik 0.50% 0.50% Operations GmbH) Phenoxyethyl Caprylate (TEGOSOFT ® XC, Evonik 8.00% 8.00% 8.00% Operations GmbH) Diethylamino Hydroxybenzoyl Hexyl Benzoate (Uvinul A 6.00% 6.00% 6.00% Pius, BASF SE) Ethylhexyl Methoxycinnamate 8.00% 8.00% 8.00% Stearyl Alcohol 1.00% 1.00% 1.00% Glyceryl Stearate 1.00% 1.00% 1.00% Tocopheryl Acetate 0.50% 0.50% 0.50% Glycerin 2.00% 2.00% 2.00% Demineralized water ad 100% ad 100% ad 100% Tromethamine 0.90% 0.90% 0.90% Phenylbenzimidazole Sulfonic Acid 2.00% 2.00% 2.00% Acrylates/C10-30 Alkyl Acrylate Crosspolymer (TEGO ® 0.30% 0.30% 0.30% Carbomer 341 ER, Evonik Operations GmbH) Sodium hydroxide (10% aq.) q.s. q.s. q.s. Methylisothiazolinone, Methylparaben, Ethylparaben; 0.80% 0.80% Dipropylene Glycol (Microcare MEM, Thor) Caprylyl Glycol; Glycerin; Glyceryl Caprylate: 1.0 Phenylpropanol; Aqua (dermosoft ® LP MB; Evonik Dr. Straetmans GmbH) -
-
Recipe 9a 9b 9c Composition from exampie 3 3.00% 2.50% 2.50% Sodium Cetearyl Sulfate (Lanette E, BASF SE) 0.50% 0.50% Phenoxyethyl Caprylate (TEGOSOFT ® XC, Evonik 7.30% 7.30% 7.30% Operations GmbH) Butyl Methoxydibenzoylmethane 5.00% 5.00% 5.00% Diethylhexyl Butamido Triazone (UVAsorb HEB, 3V 1.00% 1.00% 1.00% Sigma) Ethylhexyl Salicylate 1.50% 1.50% 1.50% Octocrylene 3.50% 3.50% 3.50% Titanium Dioxide; Diethylhexyl Carbonate; Polyglyceryl-6 2.20% 2.20% 2.20% Polyhydroxystearate (TEGO ® Sun TDEC 45, Evonik Operations GmbH) Stearyl Alcohol 1.00% 1.00% 1.00% Nylon-10/10 (TEGOLON ® ECO 10-10, Evonik Operations 0.50% 0.50% 0.50% GmbH) Glyceryl Stearate 1.00% 1.00% 1.00% Tocopheryl Acetate 0.50% 0.50% 0.50% Glycerin 2.00% 2.00% 2.00% Demineralized water ad 100% ad 100% ad 100% Citric Acid (50% aq.) 0.10% 0.10% 0.10% Bis-Ethylhexyloxyphenol Methoxyphenyl Triazine 20.00% 20.00% 20.00% (Tinosorb S, BASF SE) Acrylates/C10-30 Alkyl Acrylate Crosspolymer (TEGO ® 0.30% 0.30% 0.30% Carbomer 341 ER, Evonik Operations GmbH) Sodium Hydroxide (10% aq.) 0.90% 0.90% 0.90% Methylisothiazolinone, Methylparaben, Ethylparaben; 0.80% 0.80% Dipropylene Glycol (Microcare MEM. Thor) Triethyl Citrate; Caprylyl Glycol; Benzoic Acid (Verstatil ® 1.0% TBO; Evonik Dr. Straetmans GmbH) -
-
Recipe 10a 10b 10c Composition from exampie 3 3.00% 2.00% 2.00% Methyl Glucose Sesquistearate (TEGO ® Care PS, 1.00% 1.00% Evonik Operations GmbH) Phenoxyethyl Caprylate (TEGOSOFT ® XC, Evonik 1.50% 1.50% 1.50% Operations GmbH) Octocrylene 10.00% 10.00% 10.00% Butyl Methoxydibenzoylmethane 3.50% 3.50% 3.50% Titanium Dioxide; Diethylhexyl Carbonate; 14.50% 14.50% 14.50% Polyglycery-6 Polyhydroxystearate (TEGO ® Sun TDEC 45, Evonik Operations GmbH) Stearyl Alcohol 0.20% 0.20% 0.20% Glyceryl Stearate 0.20% 0.20% 0.20% Tocopheryl Acetate 0.50% 0.50% 0.50% Glycerin 2.00% 2.00% 2.00% Demineralized water ad 100% ad 100% ad 100% Acry lates/C10-30 Alkyl Acrylate Crosspolymer 0.20% 0.20% 0.20% (TEGO ® Carbomer 341 ER, Evonik Operations GmbH) Sodium Hydroxide (10% aq.) 0.60% 0.60% 0.60% Methylisothiazolinone, Methylparaben, Ethylparaben; 0.80% 0.80% Dipropylene Glycol (Microcare MEM, Thor) Methylpropanediol; Caprylyl Glycol; Phenylpropanol 3.0% (dermosoft ® OMP; Evonik Dr. Straetmans GmbH) -
-
Recipe 11a 11b 11c Composition from example 3 3.00% 2.50% 2.50% Polyglycery-3 Methylglucose Distearate (TEGO ® Care 450, 0.50% 0.50% Evonik Operations GmbH) Phenoxyethyl Caprylate (TEGOSOFT ® XC, Evonik 2.00% 2.00% 2.00% Operations GmbH) Nylon-10/10 (TEGOLON ® ECO 10-10, Evonik 0.50% 0.50% 0.50% Operations GmbH) Butyl Methoxydibenzoylmethane 5.00% 5.00% 5.00% Diethylhexyl Butamido Triazone (UVAsorb HEB, 3V Sigma) 1.00% 1.00% 1.00% Bis-Ethylhexyloxyphenol Methoxyphenyl Triazine 3.00% 3.00% 3.00% (Tinosorb S, BASF SE) Ethylhexyl Salicylate 1.00% 1.00% 1.00% Octocrylene 8.00% 8.00% 8.00% Stearyi Alcohol 0.45% 0.45% 0.45% Glyceryl Stearate 0.45% 0.45% 0.45% Xanthan Gum (Keltrol CG-SFT, CP Kelco) 0.30% 0.30% 0.30% Tocopheryl Acetate 0.50% 0.50% 0.50% Hydroxyethylcellulose (Natrosol 250 HHR (Ashland 0.50% 0.50% 0.50% Specialty Chemicals) Demineralized water ad 100% ad 100% ad 100% Sodium Hydroxide (10% aq., pH adjustment to 7.5) q.s. q.s. q.s. Disodium Phenyl Dibenzimidazole Tetrasulfonate 5.00% 5.00% 5.00% (Neoheliopan AP, Symrise) Methylene Bis-Benzotriazolyl Tetramethylbutyiphenol 8.00% 8.00% 8.00% (Tinosorb M, BASF SE) Methylisothiazolinone, Methylparaben, Ethylparaben; 0.80% 0.80% Dipropylene Glycol (Microcare MEM, Thor) Methylpropanediol; Caprylyl Glycol (dermosoft ® OM, 3.8% Evonik Dr. Straetmans GmbH) -
-
Recipe 12a 12b 12c Composition from example 3 3.50% 3.00% 3.00% Glyceryl Stearate Citrate (AXOL ® C 62, 1.00% 1.00% Evonik Operations GmbH) Phenoxyethyl Caprylate (TEGOSOFT ® 2.50% 2.50% 2.50% XC, Evonik Operations GmbH) Diethylamino Hydroxybenzoyl, 10.00% 10.00% 10.00% Hexyl Benzoate Ethylhexyl Methoxycinnamate 10.00% 10.00% 10.00% Stearyl Alcohol 1.00% 1.00% 1.00% Glyceryl Stearate 1.00% 1.00% 1.00% Xanthan Gum (Keltrol CG-SFT, CP Kelco) 0.50% 0.50% 0.50% Tocopheryl Acetate 0.50% 0.50% 0.50% Glycerin 2.00% 2.00% 2.00% Demineralized water ad ad ad 100% 100% 100% Phenylbenzimidazole Sulfonic Acid 4.00% 4.00% 4.00% Tromethamine 1.80% 1.80% 1.80% Methylisothiazolinone, Methylparaben, 0.80% 0.80% Ethylparaben; Dipropylene Glycol (Microcare MEM, Thor) Triethyl Citrate; Glyceryl Caprylate; 1.2% Benzoic Acid (Verstatil ® TBG MB, Evonik Dr. Straetmans GmbH) -
-
Recipe 13a 13b 13c Composition from example 3 3.00% 2.5% 2.5% Potassium Cetyl Phosphate 1.0% 1.0% Phenoxyethyl Caprylate (TEGOSOFT ® 3.00% 3.00% 3.00% XC, Evonik Operations GmbH) Butyl Methoxydibenzoylmethane 5.00% 5.00% 5.00% Octocrylene 4.90% 4.90% 4.90% Ethylhexyl Methoxycinnamate 0.10% 0.10% 0.10% Bis-Ethylhexyloxyphenol Methoxyphenyl 4.70% 4.70% 4.70% Triazine (Tinosorb S, BASF SE) Diethylhexyl Butamido Triazone (UVAsorb 3.70% 3.70% 3.70% HEB, 3 V Sigma) Titanium Dioxide; Diethylhexyl Carbonate; 11.00% 11.00% 11.00% Polyglyceryl-6 Polyhydroxystearate (TEGO ® Sun TDEC 45, Evonik Operations GmbH) Stearyl Alcohol 0.50% 0.50% 0.50% Glyceryl Stearate 0.50% 0.50% 0.50% Xanthan Gum (Keltrol CG-SFT, 0.20% 0.20% 0.20% CP Kelco) Glycerin 2.00% 2.00% 2.00% Demineralized water ad ad ad 100% 100% 100% Methylisothiazolinone, Methylparaben, 0.80% 0.80% Ethylparaben; Dipropylene Glycol (Microcare MEM, Thor) Triethyl Citrate; Caprylyl Glycol; 0.9% Benzoic Acid (Verstatil ® TBO; Evonik Dr. Straetmans GmbH) -
-
Recipe 14a 14b Composition from example 3 4.0% 4.0% Isoamyl Cocoate (TEGOSOFT ® AC, 2.5% 2.5% Evonik Operations GmbH) Caprylic/Capric Triglyceride (TEGOSOFT ® 3.5% 3.5% CT, Evonik Operations GmbH) Water ad ad 100% 100% Creatine (TEGO ® Cosmo C 100, 0.5% 0.5% Evonik Operations GmbH) Carbomer suspension 2 (Carbomer, TEGO ® 1.0% 1.0% Carbomer 141, Evonik Operations GmbH, 20% in Ethylhexyl Stearate) Sodium Hydroxide (10% aq.) 0.6% 0.6% Phenoxyethanol, Ethylhexylglycerin (Euxyl 0.7% PE 9010, Schülke & Mayr GmbH) Aqua; Sodium Levulinate; Sodium Benzoate 1.5% (Verstatil ® BL; Evonik Dr. Straetmans GmbH) Glyceryl Caprylate (dermosoft ® GMCY MB; 0.3% Evonik Dr. Straetmans GmbH) -
-
Recipe 15a 15b Composition from example 3 6.0% 6.0% Caprylic/Capric Triglyceride (TEGOSOFT ® 8.0% 8.0% CT, Evonik Operations GmbH) Isopropyl Palmitate (TEGOSOFT ® P, 11.0% 11.0% Evonik Operations GmbH) Prunus Amygdalus Dulcis (sweet almond) Oil 10.0% 10.0% Water ad ad 100% 100% Glycerin 3.0% 3.0% Sodium Hydroxide (10% aq.) 0.2% 0.2% Benzyl Alcohol, Benzoic Acid, Sorbic 0.8% Acid (Rokonsal BSB-N, Ashland Specialty Ingredients) Glycerin; Aqua; Sodium Levulinate; 3% Sodium Anisate (dermosoft ® 1388 eco; Evonik Dr. Straetmans GmbH) Glyceryl Caprylate (dermosoft ® GMCY 0.2% MB; Evonik Dr. Straetmans GmbH) -
-
Recipe 16a 16b Composition from example 3 6.0% 6.0% Caprylic/Capric Triglyceride (TEGOSOFT ® CT, Evonik Operations 9.5% 9.5% GmbH) C12-15 Alkyl Benzoate (TEGOSOFT ® TN, Evonik Operations 9.5% 9.5% GmbH) Water ad ad 100% 100% Glycerin 3.0% 3.0% Tetrapeptide-21; Glycerin; Butylene Glycol; Aqua (TEGO ® 4.0% 4.0% Pep 4-17, Evonik Operations GmbH) Sodium Hyaluronate (HyaCare ®, Evonik Operations GmbH) 0.1% 0.1% Hydrolyzed Hyaluronic Acid (HyaCare ® 50, Evonik Operations 0.1% 0.1% GmbH) Aqua: Ethylhexyl Stearate; Sodium Hyaluronate Crosspolymer; 5.0% 5.0% Polyglyceryl-4 Diisostearate/Polyhydroxystearate/Sebacate; Sodium Isostearate (HyaCare ® Filler CL, Evonik Operations GmbH) Methylisothiazolinone, Methylparaben, Ethylparaben; Dipropylene 0.8% Glycol (Microcare MEM, Thor) Aqua; Sodium Levulinate; Potassium Sorbate (Verstatil SL non 1.2% GMO; Evonik Dr. Straetmans GmbH) Caprylyl Glycol (dermosoft ® Octiol; Evonik Dr. Straetmans GmbH) 0.2% -
-
Recipe 17a 17b Composition from example 3 6.0% 6.0% Myristyl Myristate (TEGOSOFT ® MM, 2.0% 2.0% Evonik Operations GmbH) Isopropyl Myristate (TEGOSOFT ® M, 6.0% 6.0% Evonik Operations GmbH) Decyl Cocoale (TEGOSOFT ® DC, 6.0% 6.0% Evonik Operations GmbH) Cetyl Ricinoleate (TEGOSOFT ® CR, 1.0% 1.0% Evonik Operations GmbH) Water ad ad 100% 100% Glycerin 1.0% 1.0% Titanium Dioxide (Hombitan AC 360, 8.0% 8.0% Sachtleben) Iron Oxides (Sicovit Yellow 10 E 172, 0.9% 0.9% Rockwood Pigments) Iron Oxides (Sicovit Red 30 E 172, 0.2% 0.2% Rockwood Pigments) Iron Oxides (Sicovit Brown 70 E 172, 0.4% 0.4% Rockwood Pigments) Iron Oxides (Sicovit Black 80 E 172, 0.1% 0.1% Rockwood Pigments) Cellulose (TEGO ® Feel Green, 2.0% 2.0% Evonik Operations GmbH) Sodium Hydroxide (10% aq.) 0.2% 0.2% Benzyl Alcohol, Benzoic Acid, 1.0% Sorbic Acid (Rokonsal BSB-N, Ashland Specialty Ingredients) Methylpropanediol; Caprylyl Glycol: 3.2% Phenylpropanol (dermosoft ® OMP; Evonik Dr. Straetmans GmbH) -
-
Recipe 18a 18b 18c 18d Composition from example 3 3.5% 3.5% 3.0% 3.0% Stearic Acid 0.5% 0.5% Glyceryl Stearate 0.5% 0.6% 0.6% 0.6% Cetearyl Alcohol 0.5% 0.6% 0.6% 0.6% Caprylic/Capric Triglyceride 8.5% 8.5% 8.5% 8.5% Ethylhexyl Palmitate 8.5% 8.5% 8.5% 8.5% (TEGOSOFT ® OP, Evonik Operations GmbH) Demineralized water ad ad ad ad 100% 100% 100% 100% Xanthan Gum (Keltrol CG-SFT, 0.8% 0.8% 0.8% 0.8% CP Kelco) Terminalia Arjuna Bark Extract; 2.0% 2.0% 2.0% Pentylene Glycol (proposed; TEGO ® Arjuna S, Evonik Operations GmbH) Betaine; Urea; Potassium 5.0% Lactate; Sodium Polyglutamate (proposed); Hydrolyzed Sclerotium Gum (TEGO ® Smooth; Evonik Operations GmbH) Phenoxyethanol, 1.0% Methylparaben, Ethylparaben, Propylparaben (Phenonip XB (Clariant International Ltd.) Methylisothiazolinone, 0.8% 0.8% Methylparaben, Ethylparaben; Dipropylene Glycol (Microcare MEM, Thor) Caprylyl Glycol; Glyceryl 1.0% Caprylate; Dipropylene Glycol (dermosoft ® MCAV MB; Evonik Dr. Straetmans GmbH) -
-
Recipe 19a 19b 19c Composition from example 3 3.0% 2.0% 2.0% Polyglyceryl-3 Dicitrate/Stearate (TEGO ® Care PSC 3 1.0% 1.0% (Evonik Operations GmbH) Cetearyl Alcohol 0.5% 0.5% 0.5% Caprylic/Capric Triglyceride 6.5% 6.5% 6.5% Demineralized water ad ad ad 100% 100% 100% Xanthan Gum (Keltrol CG-SFT, CP Kelco) 0.5% 0.5% 0.5% Methylisothiazolinone, Methylparaben, Ethylparaben; 0.8% 0.8% Dipropylene Glycol (Microcare MEM, Thor) Glycerin; Aqua; Sodium Levulinate; Sodium Anisate 3.0% (dermosoft ® 1388; Evonik Dr. Straetmans GmbH) -
-
Recipe 20a 20b 20c 20d Composition from example 3 2.5% 2.5% 4.0% 4.0% Sodium Stearoyl Glutamate (Eumulgin SG, 1.0% BASF SE) Glyceryl Stearate 0.75% 0.75% Stearyl Alcohol 0.75% 0.75% Caprylic/Capric Triglyceride 2.0% 2.0% 2.0% 2.0% Oleyl Erucate (TEGOSOFT ® OER, Evonik 2.0% 2.0% 2.0% 2.0% Operations GmbH) Isoamyl Cocoate (TEGOSOFT ® AC, Evonik 3.0% 3.0% Operations GmbH) Persea Gratissima (avocado) Oil 1.0% 1.0% 1.0% 1.0% Aqua; Ethylhexyl Stearate; Sodium Hyaluronate 3.0% 3.0% Crosspolymer; Polyglycery/-4 Diisostearate/Polyhydroxystearate/Sebacate; Sodium Isostearate (HyaCare ® Filler CL, Evonik Operations GmbH) Demineralized water ad ad ad ad 100% 100% 100% 100% Butylene Glycol 5.0% 5.0% 5.0% 5.0% Tetrapeptide-21; Glycerin; Butylene Glycol; Aqua 2.0% 2.0% 2.0% 2.0% (TEGO ® Pep 4-17, Evonik Operations GmbH) Hydrolyzed Hyaluronic Acid (HyaCare ® 50, 0.1% 0.1% 0.1% 0.1% Evonik Operations GmbH) Xanthan Gum (Keltrol CG-SFT, CP Kelco) 0.5% 0.5% 0.5% 0.5% Sodium Hydroxide (10% aq.) 0.2% 0.2% 0.2% 0.2% Benzyl Alcohol, Benzoic Acid, Sorbic Acid 0.8% 0.8% 0.8% (Rokonsal BSB-N, Ashland Specialty Ingredients) Polyglutamic Acid; Sclerotium glucan; Betaine; 3.0% 3.0% 3.0% 3.0% Urea; Potassium Lactate (TEGO ® Smooth Complex, Evonik Operations GmbH) Triethyl Citrate; Glyceryl Caprylate; Benzoic Acid 1.2% (Verstatil ® TBG; Evonik Dr. Straetmans GmbH) -
-
Recipe 20e 20f 20g 20h Composition from example 3 3.0% 3.0% 2.0% 2.0% Cetearyl Glucoside (TEGO ® Care CG 90, Evonik 0.5% Operations GmbH) Polyglycery-3 Dicitrate/Stearate (TEGO ® Care PSC 3, 1.5% 1.5% Evonik Operations GmbH) Glyceryl Stearate 0.75% 0.5% 0.5% 0.5% Stearyl Alcohol 0.75% 0.5% 0.5% 0.5% Caprylic/Capric Triglyceride 2.0% 2.0% 2.0% 2.0% Oleyl Erucate (TEGOSOFT ® OER, Evonik Operations 2.0% 2.0% 2.0% 2.0% GmbH) Isoamyl Cocoate (TEGOSOFT ® AC, Evonik Operations 3.0% GmbH) Persea Gratissima (avocado) Oil 1.0% 1.0% 1.0% 1.0% Aqua; Ethylhexyl Stearate; Sodium Hyaluronate 3.0% 3.0% 3.0% Crosspolymer; Polyglycery/-4 Diisostearate/Polyhydroxystearate/Sebacate; Sodium Isostearate (HyaCare ® Filler CL, Evonik Operations GmbH) Demineralized water ad ad ad ad 100% 100% 100% 100% Butylene Glycol 5.0% 5.0% 5.0% 5.0% Tetrapeptide-21; Glycerin; Butylene Glycol; Aqua 2.0% 2.0% 2.0% 2.0% (TEGO ® Pep 4-17, Evonik Operations GmbH) Hydrolyzed Hyaluronic Acid (HyaCare ® 50, Evonik 0.1% 0.1% 0.1% 0.1% Operations GmbH) Xanthan Gum (Keltrol CG-SFT, CP Kelco) 0.5% 0.5% 0.5% 0.5% Sodium Hydroxide (10% aq.) 0.2% 0.2% 0.2% 0.2% Benzyl Alcohol, Benzoic Acid, Sorbic Acid (Rokonsal 0.8% 0.8% 0.8% BSB-N, Ashland Specialty Ingredients) Polyglutamic Acid; Sclerotium glucan; Betaine; 3.0% 3.0% Urea; Potassium Lactate (TEGO ® Smooth Complex, Evonik Operations GmbH) Triethyl Citrate; Caprylyl Glycol; Benzoic Acid (Verstatil ® 1.0% TBO; Evonik Dr. Straetmans GmbH) -
-
Recipe 21a 21b 21c Composition from example 3 4.00% 3.00% 3.00% Polyglycery-3 Methylglucose Distearate (TEGO ® Care 450, 1.00% 1.00% Evonik Operations GmbH) Glyceryl Stearate 0.75% 0.75% 0.75% Stearyl Alcohol 0.75% 0.75% 0.75% Diethylhexyl Carbonate (TEGOSOFT ® DEC, Evonik 7.40% 7.40% 7.40% Operations GmbH) Aqua; Ethylhexyl Stearate; Sodium Hyaluronate Crosspolymer; 2.00% 2.00% 2.00% Polyglyceryl-4 Diisostearate/Polyhydroxystearate/Sebacate; Sodium isostearate (HyaCare ® Filler CL, Evonik Operations GmbH) Ethylhexyl Methoxycinnamate 5.00% 5.00% 5.00% Diethylamino Hydroxybenzoyl Hexyl Benzoate (Uvinul A Plus, 3.00% 3.00% 3.00% BASF SE) Phytosphingosine 0.10% 0.10% 0.10% Hydrolyzed Hyaluronic Acid (HyaCare ® 50, Evonik Operations 0.10% 0.10% 0.10% GmbH) Tetrapeptide-21; Glycerin; Butylene Glycol; Aqua (TEGO ® 2.00% 2.00% 2.00% Pep 4-17, Evonik Operations GmbH) Demineralized water ad ad ad 100% 100% 100% Titanium Dioxide (Hombitan AC 360, Sachtleben) 3.00% 3.00% 3.00% Talc 2.00% 2.00% 2.00% Iron Oxide (Unipure Yellow LC 182, Sensient Technologies) 0.36% 0.36% 0.36% Iron Oxide (Unipure Red LC 381, Sensient Technologies) 0.12% 0.12% 0.12% Iron Oxide (Unipure Black LC 989, Sensient Technologies) 0.08% 0.08% 0.08% Isoamyl Cocoale (TEGOSOFT ® AC, Evonik Operations GmbH) 4.44% 4.44% 4.44% Phenoxyethyl Caprylate (TEGOSOFT ® XC, Evonik Operations 4.00% 4.00% 4.00% GmbH) Nylon-10/10 (TEGOLON ® ECO 10-10, Evonik Operations 3.00% 3.00% 3.00% GmbH) Glycerin 3.00% 3.00% 3.00% Xanthan Gum (Keltrol CG-SFT, CP Kelco) 0.50% 0.50% 0.50% Ethanol 3.00% 3.00% 3.00% Methylisothiazolinone, Methylparaben, Ethylparaben; 0.80% 0.80% Dipropylene Glycol (Microcare MEM, Thor) Methylpropanediol; Caprylyl Glycol (dermosoft ® OM, Evonik 4.0% Dr. Straetmans GmbH) -
-
Recipe 22a 22b 22c 22d Composition from example 3 3.0% 3.0% 3.0% 3.0% Glyceryl Stearate 0.5% 1.0% 0.5% 0.5% Cetearyl Alcohol 1.0% 1.0% 1.0% 1.0% Butyrospermum Parkii Butter (shea butter) 3.0% 3.0% 3.0% 3.0% Caprylic/Capric Triglyceride 5.0% 5.0% 5.0% 5.0% Isopropyl Palmitate (TEGOSOFT ® P, Evonik Operations GmbH) 5.0% 5.0% 5.0% 5.0% Xanthan Gum (Keltrol CG-SFT, CP Kelco) 0.2% 0.2% 0.2% 0.2% Glycerin 5.0% 5.0% 5.0% 5.0% Urea 10.0% 15.0% 20.0% 20.0% Demineralized water ad ad ad ad 100% 100% 100% 100% Phenoxyethanol, Ethylhexylglycerin (Euxyl PE 9010, Schülke & 0.7% Mayr GmbH) Sodium Hydroxide (10% aq.) (pH adjustment to 5.0) q.s. Sodium Benzoate, Potassium Sorbate (Euxyl K 712, Schülke & 1.2% Mayr GmbH) Methylisothiazolinone, Methylparaben, Ethylparaben; 0.8% Dipropylene Glycol (Microcare MEM, Thor) Sodium Anisate (dermosoft ® anisate; Evonik Dr. Straetmans 0.12% GmbH) Levulinic Acid; Sodium Levulinate; Glycerin: Aqua (dermosoft ® 1.0% 700B; Evonik Dr. Straetmans GmbH) Glyceryl Caprylate (dermosoft ® GMC MB; Evonik Dr. 0.3% Straetmans GmbH) -
-
Recipe 23a 23b 23c 23d Composition from example 3 3.0% 2.5% 3.0% 3.0% Sodium Stearoyl Glutamate (Eumulgin SG, BASF SE) 1.0% Glyceryl Stearate 1.0% 1.0% 1.5% 1.5% Cetearyl Alcohol 1.0% 1.0% 1.5% 1.5% Cetyl Ricinoleate 2.0% 2.0% 2.0% 2.0% Oleyl Erucate (TEGOSOFT ® OER, Evonik Operations GmbH) 5.0% 5.0% 5.0% 5.0% Isoamyl Cocoate (TEGOSOFT ® AC, Evonik Operations GmbH) 8.0% 8.0% 8.0% 8.0% Decyl Cocoate (TEGOSOFT ® DC, Evonik Operations GmbH) 3.0% 3.0% 3.0% 3.0% Xanthan Gum (Keltrol CG-SFT, CP Kelco) 0.2% 0.2% 0.2% 0.2% Glycerin 5.0% 5.0% 5.0% 5.0% Urea 10.0% 10.0% 15.0% 15.0% Demineralized water ad ad ad ad 100% 100% 100% 100% Methylisothiazolinone, Methylparaben, Ethylparaben; 0.8% 0.8% 0.8% Dipropylene Glycol (Microcare MEM, Thor) Phenethyl Alcohol (dermosoft ® PEA; Evonik Dr. Straetmans 1.0% GmbH) -
-
Recipe 23e 23f 23g 23h Composition from example 3 2.5% 3.0% 3.0% 3.0% Polyglyceryl-6 Distearate 0.5% Stearic Acid 0.5% 0.5% Glyceryl Stearate 1.5% 1.5% 1.5% 1.5% Cetearyl Alcohol 1.5% 1.5% 1.5% 1.5% Cetyl Ricinoleate 2.0% 2.0% 2.0% 2.0% Oleyl Erucate (TEGOSOFT ® OER, Evonik Operations GmbH) 5.0% 5.0% 5.0% 5.0% Isoamyl Cocoate (TEGOSOFT ® AC, Evonik Operations GmbH) 8.0% 8.0% 8.0% 8.0% Decyl Cocoate (TEGOSOFT ® DC, Evonik Operations GmbH) 3.0% 3.0% 3.0% 3.0% Xanthan Gum (Keltrol CG-SFT, CP Kelco) 0.2% 0.2% 0.2% 0.2% Glycerin 5.0% 5.0% 5.0% 5.0% Urea 15.0% 20.0% 20.0% 20.0% Demineralized water ad ad ad ad 100% 100% 100% 100% Methylisothiazolinone, Methylparaben, Ethylparaben; 0.8% 0.8% 0.8% Dipropylene Glycol (Microcare MEM, Thor) Phenylpropanol (dermosoft ® 250 eco; Evonik Dr. Straetmans 0.4% GmbH) 1,2-Hexanediol (dermosoft ® Hexiol; Evonik Dr. Straetmans 3.0% GmbH) -
-
Recipe 24a 24b 24c Composition from example 3 3.0% 2.0% 3.0% (AXOL ® C 62, Evonik Operations GmbH) 1.0% Glyceryl Stearate 0.2% 0.2% 0.5% Stearyl Alcohol 0.2% 0.2% 0.5% Primus Amygdalus Dulcis (sweet almond) Oil 10.0% 10.0% 10.0% Isoamyl Cocoate (TEGOSOFT ® AC, Evonik Operations GmbH) 6.6% 6.6% 6.0% Glycerin 4.0% 4.0% 4.0% Demineralized water ad ad ad 100.0% 100.0% 100.0% Caprylyl Glycol, Glycerin, Glyceryl Caprylate, Phenylpropanol 1.0% 1.0% (Dermosoft ® LP, Evonik Dr, Straetmans GmbH) Methylpropanediol, Caprylyl Glycol, Phenylpropanol 4.0% (Dermosoft ® OMP, Evonik Dr. Straetmans GmbH) Xanthan Gum (Keltrol CG-SFT, CP Kelco) 0.5% 0.5% 0.5% -
-
Recipe 24d 24e 241 Composition from example 3 3.0% 3.0% 1.5% Glyceryl Stearate SE 0.5% Polyglycery-3 Dicitrate/Stearate (TEGO ® Care PSC 3, Evonik 1.5% Operations GmbH) Glyceryl Stearate 0.5% 0.5% 0.5% Stearyl Alcohol 0.5% 0.5% 0.5% Prunus Amygdalus Dulcis (sweet almond) Oil 10.0% 10.0% 10.0% Isoamyl Cocoate (TEGOSOFT ® AC, Evonik Operations GmbH) 6.0% 6.0% 6.0% Glycerin 4.0% 4.0% 4.0% Demineralized water ad ad ad 100.0% 100.0% 100.0% Methylpropanediol, Caprylyl Glycol, Phenylpropanol (Dermosoft ® 4.0% OMP, Evonik Dr. Straetmans GmbH) Caprylyl Glycol (Dermosoft ® Octiol, Evonik Dr. Straetmans 0.4% 0.4% GmbH) p-Anisio Acid 10% solution (dissolve 3.0 g of Sodium Hydroxide 2.0% 2.0% in 56.5 g of demineralized water, add 30.0 g of Glycerin and 10.0 g of Dermosoft ® Octiol (Evonik Dr. Straetmans GmbH), and stir until the solution is clear) Citric Acid (10% aq.) (pH adjustment to 6.0) q.s. q.s. Xanthan Gum (Keltrol CG-SFT, CP Kelco) 0.5% 0.5% 0.5% -
-
Recipe 25a 25b Composition from example 2 2.0% 2.0% Beeswax 0.5% 0.5% Castor wax 0.5% 0.5% Paraffinum perliquidum 10.5% 10.5% Decyl Cocoale (TEGOSOFT ® DC, 8.0% 8.0% Evonik Operations GmbH) Tocopheryl Acetate 0.5% 0.5% Cyclopentasiloxane 6.0% 6.0% Sodium Chloride 0.5% 0.5% Water ad ad 100% 100% Glycerin 3.0% 3.0% Phenoxyethanol; Ethylhexylglycerin 0.7% (Euxyl PE 9010, Schülke & Mayr GmbH) Ethanol 5.0% 5.0% Glyceryl Caprylate (dermosoft ® GMC; 0.4% Evonik Dr. Straetmans GmbH) Zinc Sulfate 1.0% -
-
Recipe 26a 26b Composition from example 2 2.0% 2.0% Mineral oil 17.0% 17.0% Castor wax 0.4% 0.4% Microcrystalline Wax 0.6% 0.6% Water ad ad 100% 100% Sodium Chloride 0.5% 0.5% Urea 10.0% 10.0% Phenoxyethanol; Ethylhexylglycerin 0.7% (Euxyl PE 9010, Schülke & Mayr GmbH) Glyceryl Caprylate (dermosoft ® GMC; 0.35% Evonik Dr. Straetmans GmbH) Pentylene Glycol (dermosoft ® Pentiol 2.0% eco; Evonik Dr. Straetmans GmbH) -
-
Recipe 27a 27b Composition from example 2 0.8% 0.8% Cetyl Dimethicone (ABIL ® Wax 9801, 1.6% 1.6% Evonik Operations GmbH) Diethylhexyl Carbonate (TEGOSOFT ® 4.0% 4.0% DEC, Evonik Operations GmbH) Dimethicone (ABIL ® 350, Evonik 1.0% 1.0% Operations GmbH) Cyclopentasiloxane 4.0% 4.0% Magnesium Stearate 0.3% 0.3% Water ad ad 100% 100% Propylene Glycol 5.0% 5.0% Sodium Chloride 1.0% 1.0% Methylisothiazolinone, Methylparaben, 0.8% Ethylparaben; Dipropylene Glycol (Microcare MEM, Thor) Glyceryl Caprylate (dermosoft ® GMC; 0.25% Evonik Dr. Straetmans GmbH) Phenylpropanol (dermosoft ® 250 eco; 0.35% Evonik Dr. Straetmans GmbH) -
-
Recipe 28a 28b 28c Composition from example 2 2.0% 1.5% 1.5% Polyglyceryl-4 — 0.5% 0.5% Diisostearate/Polyhydroxystearate/ Sebacate (ISOLAN ® GPS, Evonik Operations GmbH) Castor wax 0.5% 0.5% 0.5% Beeswax 0.5% 0.5% 0.5% Ethylhexyl Stearate (Tegosoft ® OS, 10.0% 10.0% 10.0% Evonik Operations GmbH) Diethylhexyl Carbonate (TEGOSOFT ® 8.5% 8.5% 8.5% DEC, Evonik Operations GmbH) Dimethicone (Belsil DM 5, 6.0% 6.0% 6.0% Wacker Chemical Corp.) Tocopheryl Acetate 0.5% 0.5% 0.5% Glycerin 3.0% 3.0% 3.0% Water ad ad ad 100% 100% 100% Sodium Chloride 1.0% 1.0% 1.0% Ethanol 20.0% 20.0% 20.0% Ethylhexylglycerin (dermosoft ® 0.5% EHG; Evonik Dr. Straetmans GmbH) -
-
Recipe 29a 29b 23c Composition from example 2 3.0% 2.5% 2.5% Diisostearoyl Polyglyceryl-3 Dimer Dilinoleate — 0.5% 0.5% (ISOLAN ® PDI, Evonik Operations GmbH) Diethylhexyl Carbonate (TEGOSOFT ® DEC, 7.0% 7.0% 7.0% Evonik Operations GmbH) Oleyl Erucate (TEGOSOFT ® OER, Evonik 3.0% 3.0% 3.0% Operations GmbH) Almond oil 7.0% 7.0% 7.0% Shea butter 2.0% 2.0% 2.0% Cetyl Ricinoleate (TEGOSOFT ® CR, Evonik 1.0% 1.0% 1.0% Operations GmbH) Beeswax 0.6% 0.6% 0.6% Castor wax 0.4% 0.4% 0.4% Glycerin 5.0% 5.0% 5.0% Water ad ad ad 100% 100% 100% Magnesium sulfate heptahydrate 1.5% 1.5% 1.5% Sodium Benzoate, Potassium Sorbate (Euxyl K 0.5% 0.5% 712, Schülke & Mayr GmbH) Pentylene Glycol (dermosoft ® Pentiol eco; 3.0% Evonik Dr. Straetmans GmbH) -
-
Recipe 30a 30b 30c Composition from example 2 3.0% 2.5% 2.5% Polyglyceryl-3 Oleate (ISOLAN ® — 0.5% 0.5% GO 33, Evonik Operations GmbH) Isoamyl Coooate (TEGOSOFT ® AC, 5.0% 5.0% 5.0% Evonik Operations GmbH) Diethylhexyl Carbonate 12.0% 12.0% 12.0% (TEGOSOFT ® DEC, Evonik Operations GmbH) Phenoxyethyl Caprylate 4.0% 4.0% 4.0% (TEGOSOFT ® XC, Evonik Operations GmbH) Zinc Stearate 0.5% 0.5% 0.5% Water ad ad ad 100% 100% 100% Glycerin 3.0% 3.0% 3.0% Sodium Chloride 1.5% 1.5% 1.5% Phenoxyethanol; Ethylhexylglycerin 0.7% 0.7% (Euxyl PE 9010, Schülke & Mayr GmbH) Benzyl Alcohol; Caprylyl Glycol; 1.5% Benzoic Acid (Verstatil ® BOB; Evonik Dr. Straetmans GmbH) -
-
Recipe 31a 31b 31c Composition from example 2 2.0% 1.5% 1.5% Cetyl PEG/PPG-10/1 Dimethicone — 0.5% 0.5% (ABIL ® EM 180, Evonik Operations GmbH) Microcrystalline Wax 0.5% 0.5% 0.5% Castor wax 0.5% 0.5% 0.5% C12-15 Alkyl Benzoate 7.5% 7.5% 7.5% Oleyl Erucate (TEGOSOFT ® OER, 5.0% 5.0% 5.0% Evonik Operations GmbH) Ethylhexyl Palmitate (TEGOSOFT ® 5.0% 5.0% 5.0% OP, Evonik Operations GmbH) Caprylic/Capric Triglyceride 5.0% 5.0% 5.0% Glycerin 3.0% 3.0% 3.0% Urea 20.0% 20.0% 20.0% Magnesium sulfate heptahydrate 1.0% 1.0% 1.0% Water ad ad ad 100% 100% 100% Phenoxyethanol; Ethylhexylglycerin 0.70% 0.70% (Euxyl PE 9010, Schülke & Mayr GmbH) Parfum 0.10% 0.10% 0.10% Methylpropanediol; Phenoxyethanol; 1.5% Caprylyl Glycol (Verstatil ® MPC; Evonik Dr. Straetmans GmbH) -
-
Recipe 32a 32b 32c 33d Composition from example 2 2.5% 2.0% 2.0% 2.0% Cetyl PEG/PPG-10/1 Dimethicone (ABIL ® — 0.5% — — EM 90, Evonik Operations GmbH) Bis-PEG/PPG-14/14 Dimethicone; Dimethicone — — 1.0% 1.0% (ABIL ® EM 97 S, Evonik Operations GmbH) Microcrystalline Wax 0.1% 0.1% 0.1% 0.1% Castor wax 0.1% 0.1% 0.1% 0.1% Diethylhexyl Carbonate (TEGOSOFT ® DEC, 11.8% 11.8% 11.8% 11.8% Evonik Operations GmbH) Myristyl Myristate (TEGOSOFT ® MM, Evonik 1.0% 1.0% 1.0% 1.0% Operations GmbH) Dimethicone (Belsil DM 5, Wacker Chemical 8.0% 8.0% 8.0% 8.0% Corp.) Dimethicone (ABIL ® 350, Evonik Operations 0.5% 0.5% 0.5% 0.5% GmbH) Glycerin 3.0% 3.0% 3.0% 3.0% Magnesium sulfate heptahydrate 1.5% 1.5% 1.5% 1.5% Water ad ad ad ad 100% 100% 100 100% Benzyl Alcohol; Ethylhexylglycerin; Tocopherol 0.7% 0.7% 0.7% (Euxyl K 900, Schülke & Mayr GmbH) Phenoxyethanol; Ethylhexylglycerin (Verstatil ® 1.0% PE; Evonik Dr. Straetmans GmbH) -
-
Recipe 33a 33b 33c Composition from example 2 3.0% 2.0% 2.0% Paraffinum Liquidum; Petrolatum; — 1.0% 1.0% Ozokerite; Glyceryl Oleate; Lanolin Alcohol (PROTEGIN ® XN, Evonik Operations GmbH) Castor wax 0.1% 0.1% 0.1% Microcrystalline Wax 0.1% 0.1% 0.1% Oleyl Erucate (TEGOSOFT ® OER, 1.0% 1.0% 1.0% Evonik Operations GmbH) Isoamyl Cocoate (TEGOSOFT ® AC, 3.8% 3.8% 3.8% Evonik Operations GmbH) Ethylhexyl Palmitate (TEGOSOFT ® 1.0% 1.0% 1.0% OP, Evonik Operations GmbH) Almond oil 1.0% 1.0% 1.0% Zinc Oxide 20.0% 20.0% 20.0% Glycerin 3.0% 3.0% 3.0% Magnesium sulfate heptahydrate 1.0% 1.0% 1.0% Sodium Lactate; Sodium PCA; Glycine; 5.0% 5.0% 5.0% Fructose; Urea; Niacinamide; Inositol; Sodium Benzoate; Lactic Acid (LACTIL, Evonik Operations GmbH) Betaine (TEGO ® Natural Betaine, 3.0% 3.0% 3.0% Evonik Operations GmbH) Water ad ad ad 100% 100% 100% Benzyl Alcohol; Ethylhexylglycerin; 0.7% 0.7% Tocopherol (Euxyl K 900, Schülke & Mayr GmbH) p-Anisio Acid (dermosoft ® 688; Evonik 0.12% Dr. Straetmans GmbH) Pentylene Glycol (dermosoft ® Pentiol 2.5% eco; Evonik Dr. Straetmans GmbH) -
-
Recipe 34a 34b 34c Composition from example 2 3.0% 2.5% 2.5% Petrolatum; Ozokerite; Hydrogenated — 0.5% 0.5% Castor Oil; Glyceryl Isostearate; Polyglycery-3 Oleate (PROTEGIN ® W, Evonik Operations GmbH) Castor wax 0.1% 0.1% 0.1% Microcrystalline Wax 0.1% 0.1% 0.1% Diethylhexyl Carbonate (TEGOSOFT ® 9.0% 9.0% 9.0% DEC, Evonik Operations GmbH) Ethylhexyl Palmitate (TEGOSOFT ® OP, 9.0% 9.0% 9.0% Evonik Operations GmbH) Stearyl Heptanoate (Tegosoft ® SH, 8.8% 8.8% 8.8% Evonik Operations GmbH) Glycerin 3.0% 3.0% 3.0% Magnesium sulfate heptahydrate 1.0% 1.0% 1.0% Ceramide NP; Ceramide AP; 5.0% 5.0% 5.0% Ceramide EOP; Phytosphingosine; Cholesterol; Sodium Lauroyl Lactylate; Carbomer; Xanthan Gum (SK-INFLUX V, Evonik Operations GmbH) Betaine (TEGO ® Natural Betaine, 3.0% 3.0% 3.0% Evonik Operations GmbH) Water ad ad ad 100% 100% 100% Benzyl Alcohol; Ethylhexylglycerin; 0.7% 0.7% Tocopherol (Euxyl K 900, Schülke & Mayr GmbH) Phenoxyethanol; Benzoic Acid 1.0% (Verstatil ® BP; Evonik Dr. Straetmans GmbH) -
-
Recipe 35a 35b Composition from example 2 3.0% 2.0% Polyglyceryl-2 — 1.0% Dipolyhydroxystearate (Dehymuls PGPH, BASF SE) Oleyl Erucate (TEGOSOFT ® 1.5% 1.5% OER, Evonik Operations GmbH) Diethylhexyl Carbonate 1.5% 1.5% (TEGOSOFT ® DEC, Evonik Operations GmbH) Diethylamino Hydroxybenzoyl 5.4% 5.4% Hexyl Benzoate (Uvinul A Plus, BASF SE) Ethylhexyl Methoxycinnamate 10.0% 10.0% Octocrylene 2.0% 2.0% Polyacrylamide; C13-14 2.1% 2.1% Isoparaffin; Laureth-7 (Sepigel 305, Seppic) Ethyl 4.0% 4.0% Butylacetylaminopropionate (R3535, Merck KGaA) Tocopheryl Acetate 0.5% 0.5% Glycerin 3.0% 3.0% Ethanol 0.5% 0.5% Magnesium sulfate 1.0% 1.0% heptahydrate Water ad ad 100% 100% Benzyl Alcohol; 0.7% 0.7% Ethylhexylglycerin; Tocopherol (Euxyl K 900, Schülke & Mayr GmbH) Parfum 0.1% 0.1% -
-
Recipe 36a 36b Composition from example 2 3.0% 2.0% Polyglycery/-3 Polyricinoleate (Cithrol PG3PR, — 1.0% (Croda Int. Plc) Isoamyl Cocoate (TEGOSOFT ® AC, Evonik 2.0% 2.0% Operations GmbH) Decyl Cocoate (TEGOSOFT ® DC, Evonik 10.0% 10.0% Operations GmbH) Isopropyl Palmitate (TEGOSOFT ® P, Evonik 10.0% 10.0% Operations GmbH) Zinc Oxide (Zinc Oxide PI, Symrise) 16.0% 16.0% Titanium Dioxide (nano); Alumina; Stearic Acid 9.0% 9.0% (Eusolex T-S, Merck KGaA) Water ad ad 100% 100% Glycerin 3.0% 3.0% Magnesium sulfate heptahydrate 1.0% 1.0% Sodium Benzoate, Potassium Sorbate (Euxyl K 0.5% 0.5% 712, Schülke & Mayr GmbH) -
-
Recipe 37a 37b 37c 37d Composition from example 2 3.0% 2.0% 3.6% 2.0% Cetyl PEG/PPG-10/1 Dimethicone (ABIL ® EM 90, — 1.0% — — Evonik Operations GmbH) Polyglyceryl-4 — — — 1.0% Diisostearate/Polyhydroxystearate/Sebacate (ISOLAN ® GPS, Evonik Operations GmbH) Diethylhexyl Carbonate (TEGOSOFT ® DEC, 13.0% 13.0% 11.3% 11.3% Evonik Operations GmbH) C12-15 Alkyl Benzoate 13.0% 13.0% 11.3% 11.3% Bis-Ethylhexyloxyphenol Methoxyphenyl 1.0% 1.0% 1.5% 1.5% Triazine (Tinosorb S, BASF SE) Butyl Methoxydibenzoylmethane — — 3.0% 3.0% Ethylhexyl Methoxycinnamate 5.0% 5.0% — — Octocrylene — — 6.0% 6.0% Homosalate — — 4.0% 4.0% Diethylamino Hydroxybenzoyl Hexyl Benzoate 5.0% 5.0% — — (Uvinul A Plus, BASF SE) Water ad ad ad ad 100% 100% 100% 100% Glycerin 3.0% 3.0% 3.0% 3.0% Magnesium sulfate heptahydrate 1.0% 1.0% 1.0% 1.0% UV filter solution (20% Phenylbenzimidazole 15.0% 15.0% 15.0% 15.0% Sulfonic Acid (Eusolex 232, Merck KGaA, 8.8% tris(hydroxymethyl)aminomethane, water to 100%) Benzyl Alcohol; Ethylhexylglycerin; Tocopherol 0.7% 0.7% 0.7% 0.7% (Euxyl K 900, Schülke & Mayr GmbH) -
-
Recipe 38a 38b 38c 38d Composition from example 2 3.0% 2.5% 3.0% 2.5% Cetyl PEG/PPG-10/1 Dimethicone (ABIL ® — 1.0% — 1.0% EM 90, Evonik Operations GmbH) Microcrystalline Wax 0.3% 0.3% 0.3% 0.3% Castor wax 0.3% 0.3% 0.3% 0.3% Diethylhexyl Carbonate (TEGOSOFT ® DEC, 2.4% 2.4% — — Evonik Operations GmbH) Phenoxyethyl Caprylate (TEGOSOFT ® XC, — — 3.9% 3.9% Evonik Operations GmbH) Bis-Ethythexyloxyphenol Methoxyphenyl Triazine 6.0% 6.0% — — (Tinosorb S, BASF SE) Diethylarino Hydroxybenzoyl Hexyl Benzoate 7.0% 7.0% 5.0% 5.0% (Uvinul A Plus, BASF SE) Butyl Methoxydibenzoylmethane — — 4.5% 4.5% Ethylhexyl Salicylate 3.0% 3.0% 5.0% 5.0% Ethylhexyl Methoxycinnamate 7.0% 7.0% — — Octocrylene — — 9.0% 9.0% Homosalate 3.0% 3.0% 5.0% 5.0% Ethylhexyl Triazone (Uvinul T 150, BASF SE) 1.0% 1.0% 2.0% 2.0% Titanium Dioxide; silica; Dimethicone (Parsol TX 2.0% 2.0% 2.0% 2.0% (DSM Nutritional Products Llc.) Water ad ad ad ad 100% 100% 100% 100% Glycerin 3.0% 3.0% 3.0% 3.0% Magnesium sulfate heptahydrate 1.5% 1.5% 1.5% 1.5% Benzyl Alcohol; Ethylhexylglycerin; Tocopherol 0.7% 0.7% 0.7% (Euxyl K 900, Schülke & Mayr GmbH) Phenethylalcohol nat. 0.7% -
-
Recipe 39a 39b 39c Composition from example 2 2.0% 1.5% 1.5% Lauryl PEG-10 Tris(Trimethylsiloxy) — 0.5% 0.5% Silylethyl Dimethicone (ES-5300 Formulation Aid, Dow Corning Corp.) Ethylhexyl Methoxycinnamate; 7.5% 7.5% 7.5% Diethylamino Hydroxybenzoyl Hexyl Benzoate (Uvinul A + B, BASF SE) Ethylhexyl Salicylate 5.0% 5.0% 5.0% Homosalate 15.0% 15.0% 15.0% Butyl Methoxydibenzoylmethane 3.0% 3.0% 3.0% Benzophenone-3 6.0% 6.0% 6.0% Octocrylene 10.0% 10.0% 10.0% Triisostearin 2.0% 2.0% 2.0% Microcrystalline Wax 1.2% 1.2% 1.2% Castor wax 0.8% 0.8% 0.8% Cetyl Dimethicone (ABIL ® Wax 2.0% 2.0% 2.0% 9801, Evonik Operations GmbH) Diethylhexyl Carbonate 2.0% 2.0% 2.0% (TEGOSOFT ® DEC, Evonik Operations GmbH) Water ad ad ad 100% 100% 100% Sodium Chloride 1.0% 1.0% 1.0% Ethylenediaminetetraacetic acid 0.1% 0.1% 0.1% Propylene glycol 3.0% 3.0% 3.0% Phenoxyethanol; Ethylhexylglycerin 0.7% 0.7% (Euxyl PE 9010, Schülke & Mayr GmbH) Verstatil PC 1.0% -
-
Recipe 40a 40b 40c 40d 40e 40f Composition from example 2 4.5% 2.5% 3.0% 2.5% 2.0% 2.0% Bis-(Glyceryl/Lauryl) — 2.0% — — — — Glyceryl Lauryl Dimethicone; Caprylic/Capric Triglyceride (ABIL ® EM 120, Evonik Operations GmbH) Polyglyceryl-4 Isostearate — — 1.0% — — — (ISOLAN ® GI 34, Evonik Operations GmbH) Cetyl Diglyceryl — — — 1.0% — — Tris(Trimethyisiloxy) Silylethyl Dimethicone (DC-5600, Dow Corning Corp.) Lauryl Polyglycery-3 — — — — 1.0% — Polydimethylsiloxyethyl Dimethicone (KF-6105, Shin-Etsu Chemical Co.) Polyglyceryl-4 Isostearate; — — — — — 2.0% Cetyl PEG/PPG-10/1 Dimethicone; Hexyl Laurate (ABIL ® WE 09, Evonik Operations GmbH) Isoamyl Cocoate 10.8% 10.8% 10.8% 10.8% 10.8% 10.8% (TEGOSOFT ® AC, Evonik Operations GmbH) Oleyl Erucate (TEGOSOFT ® 8.0% 8.0% 8.0% 8.0% 8.0% 8.0% OER, Evonik Operations GmbH) Titanium Dioxide, Alumina, 4.0% 4.0% 4.0% 4.0% 4.0% 4.0% Triethoxy caprylyisilane (Hombitan AC360, Sachtleben) Iron Oxides (Sicovit Brown 2.1% 2.1% 2.1% 2.1% 2.1% 2.1% 70 E 172, Rockwood) Nylon-12 (TEGOLON ® 12- 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% 20, Evonik Operations GmbH) Cyclopentasiloxane 3.5% 3.5% 3.5% 3.5% 3.5% 3.5% Disteardimonium Hectorite 1.0% 1.0% 1.0% 1.0% 1.0% 1.0% (Bentone 38 V CG, Elementis) Propylene carbonate 0.5% 0.5% 0.5% 0.5% 0.5% 0.5% Water ad ad ad ad ad ad 100% 100% 100% 100% 100% 100% Magnesium sulfate 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% heptahydrate Glycerin 5.0% 5.0% 5.0% 5.0% 5.0% 5.0% Creatine (TEGO ® Cosmo C 0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 100, Evonik Operations GmbH) Ceteareth-25; Glycerin; 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% Cetyl Alcohol; Behenic Acid; Cholesterol; Ceramide EOP; Ceramide EOS; Ceramide NP; Ceramide NS; Ceramide AP; Caprooyl Phytosphingosine; Caprooyl Sphingosine (SKINMIMICS, Evonik Operations GmbH) Benzyl Alcohol; 0.7% 0.7% 0.7% 0.7% 0.7% 0.7% Ethylhexylglycerin; Tocopherol (Euxyl K 900, Schulke & Mayr GmbH) -
-
Recipe 41a 41b 41c 41d 41e 41f 41g Composition from example 2 3.0% 2.0% 2.5% 3.0% 2.5% 2.0% 1.0% Polyglyceryl-4 — 1.0% — — — — — Diisostearate/Polyhydroxyste arate/Sebacate (ISOLAN ® GPS, Evonik Operations GmbH) Sorbitan Oleate (TEGO ® — — 0.5% — — — — SMO V, Evonik Operations GmbH) PEG-30 — — — 1.0% — — — Dipolyhydroxystearate (Arlacel P135, Croda) Polyglycery-3 Diisostearate — — — — 1.5% — — (Lameform TGI, BASF SE) Glyceryl Oleate, Polyglyceryl- — — — — — 1.0% — 3 Polyricinoleate, Olea Europaea (olive) Oil Unsaponifiables (Plantasens Natural Emulsifier CP5, Clariant) Lauryl PEG-9 — — — — — — 1.0% Polydimethylsiloxyethyl Dimethicone (KF-6038, Shin- Etsu Chemical Co.) Ethylhexyl 10.0% 10.0% 10.0% 10.0% 10.0% 10.0% 10.0% Methoxycinnamate; Diethylamino Hydroxybenzoyl Hexyl Benzoate (Uvinul A + B, BASF SE) Cyclopentasiloxane 3.5% 3.5% 3.5% 3.5% 3.5% 3.5% 3.5% Disteardimonium Hectorite 1.0% 1.0% 1.0% 1.0% 1.0% 1.0% 1.0% (Bentone 38 V CG, Elementis) Propylene carbonate 0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5% Titanium Dioxide, Alumina, 4.0% 4.0% 4.0% 4.0% 4.0% 4.0% 4.0% Triethoxycaprylyisilane (Hombitan AC360, Sachtleben) Talc 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% Iron Oxides; 0.4% 0.4% 0.4% 0.4% 0.4% 0.4% 0.4% Triethoxycaprylyisilane (Unipure Yellow LC 182 AS- EM, Sensient) iron Oxides; 0.12% 0.12% 0.12% 0.12% 0.12% 0.12% 0.12% Triethoxycaprylyisilane (Unipure Red LC 381 AS- EM, Sensient) iron Oxides; 0.08% 0.08% 0.08% 0.08% 0.08% 0.08% 0.08% Triethoxycaprylyisilane (Unipure Black LC 989 AS- EM, Sensient) Diethylhexyl Carbonate 4.0% 4.0% 4.0% 4.0% 4.0% 4.0% 4.0% (TEGOSOFT ® DEC, Evonik Operations GmbH) C12-15 Alkyl Benzoate 4.0% 4.0% 4.0% 4.0% 4.0% 4.0% 4.0% isopropyl Palmitate 4.0% 4.0% 4.0% 4.0% 4.0% 4.0% 4.0% (TEGOSOFT ® P, Evonik Operations GmbH) Nylon-12 (TEGOLON ® 12- 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% 20, Evonik Operations GmbH) Water ad ad ad ad ad ad ad 100% 100% 100% 100% 100% 100% 100% Glycerin 5.0% 5.0% 5.0% 5.0% 5.0% 5.0% 5.0% Sodium Chloride 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% Tetrapeptide-30; Glycerin 0.3% 0.3% 0.3% 0.3% 0.3% 0.3% 0.3% (TEGO ® Pep 4-Even, Evonik Operations GmbH) Phenoxyethanol; 0.7% 0.7% 0.7% 0.7% 0.7% 0.7% 0.7% Methylparaben; Ethylparaben; Propylparaben (Phenonip XB, Clariant) -
-
Recipe 42a 42b 42c 42d 42e Composition from 3.0% 2.0% 3.0% 2.0% 2.0% example 2 Polyglyceryl-4 — 1.0% — 1.0% 1.0% Diisostearate/ Polyhydroxy- stearate/Sebacate (ISOLAN ® GPS, Evonik Operations GmbH) Isopropyl Palmitate 20.0% 20.0% 20.0% 20.0% 20.0% (TEGOSOFT ® P, Evonik Operations GmbH) Diethylhexyl Carbonate 7.0% 7.0% 7.0% 7.0% 7.0% (TEGOSOFT ® DEC, Evonik Operations GmbH) Triethyl Citrate 5.0% (dermofeel ® TEC eco; Evonik Dr. Straetmans GmbH) Water ad ad ad ad ad 100% 100% 100% 100% 100% Glycerin 2.0% 2.0% 2.0% 2.0% 2.0% Aluminium Chlorohydrate 30.0% 30.0% 30.0% 30.0% 30.0% (50% aq.; Locron LIC, Clariant AG) Parfum 1.0% 1.0% 1.0% 1.0% 1.0% Propellant — — Mix emulsions 42c and 42d with propellant in mass ratio of 5:2 Phenoxyethanol; Caprylyl 0.8% Glycol (Vestatil ® PC; Evonik Dr. Straetmans GmbH) -
-
Recipe 43a 43b 43c 43d Composition from example 2 4.0% 4.0% 4.0% 4.0% Cetyl PEG/PPG-10/1 Dimethicone — — 1.0% 1.0% (ABIL ® EM 90, Evonik Operations GmbH) C12-15 Alkyl Benzoate 10.0% 8.0% 10.0% 8.0% Diethylhexyl Carbonate 13.0% 10.0% 13.0% 10.0% (TEGOSOFT ® DEC, Evonik Operations GmbH) Bis-Ethylhexyloxyphenol 4.0% 4.0% 4.0% 4.0% Methoxyphenyl Triazine (Tinosorb S, BASF SE) Diethylamino Hydroxybenzoyl Hexyl 5.0% 5.0% 5.0% 5.0% Benzoate (Uvinul A Plus, BASF SE) Ethylhexyl Salicylate 5.0% 5.0% 5.0% 5.0% Ethylhexyl Methoxycinnamate 4.0% 4.0% 4.0% 4.0% Water ad ad ad ad 100% 100% 100% 100% Glycerin 3.0% 3.0% 3.0% 3.0% UV filter solution (20% 20.0% 20.0% 20.0% 20.0% Phenylbenzimidazole Sulfonic Acid (Eusolex 232, Merck KGaA, 8.8% tris(hydroxymethyl)aminomethane, water to 100%) Magnesium sulfate heptahydrate 1.0% 1.0% 1.0% 1.0% Benzyl Alcohol; Ethylhexylglycerin; 0.7% 0.7% 0.7% 0.7% Tocopherol (Euxyl K 900, Schülke & Mayr GmbH) Mix emulsions 43a, 43b, 43c and 43d with propellant in mass ratio of 2:1 -
-
Water ad 100.0% Composition from example 1 1.5% Sodium Laureth Sulfate (Texapon NSO, BASF, 28%) 25.0% Coco-Glucoside (Plantacare 818 UP, BASF, 51%) 8.0% Cocamidopropy Betaine (TEGO ® Betain F 50, Evonik, 38%) 8.0% PEG-18 Glyceryl Oleate/Cocoate (ANTIL ® 171, Evonik) 1.5% Sorbitan Sesquicaprylate (ANTIL ® Soft SC, Evonik) 0.8% Glyceryl Oleate (TEGIN ® O V, Evonik) 0.8% Perfume Spicy Herbs (IFF) 0.2% Polyglyceryl-4 Caprate (TEGOSOFT ® PC 41, Evonik) 0.6% Helianthus Annuus Seed Oil (AEC Sunflower Oil, A & E 0.2% Connock, Perfumery & Cosmetics Ltd.) Linalool (Lipofresh, Lipo Chemicals, Inc.) 0.1% Coumarin (Rhodiascent extra pure, Solvay Rhodia) 0.1% Glycerin (Glycerol EP, vegetable, Spiga Nord) 0.4% Hydroxypropyl Methylcellulose (TEGOCEL ® HPM 50, Evonik) 0.2% Glycol Distearate (TEGIN ® G 1100 Pellets, Evonik) 0.4% Sodium Chloride 0.5% Hydroxypropyl Guar Hydroxypropyltrimonium 0.2% Chloride (Jaguar C-162, Solvay Rhodia) dermofeel TOCO 70 non GMO 0.1% Disodium EDTA (Dissolvine NA-2-P, AkzoNobel) 0.1% Preservative q.s. Citric Acid ad pH 5.2 -
-
Phase A Composition from example 1 5.0% Lavandula Angustifolia (lavender) Oil 0.2% (AEC Lavender Oil, A & E Connock Ltd.) Perfume 0.1% Phase B Sodium Cocoamphoacetate 10.0% (REWOTERIC ® AM C, Evonik, 32%) Phase C Water ad 100.0% Xanthan Gum (Keitrol CG-SFT, CP Kelco) 1.2% Phase D Sodium Lauroyl Methyl Isethionate (Iselux, 4.5% innospec Active Chemicals) Capryl/Capramidopropyl Betaine 4.5% (TEGO ® Betaine 810, Evonik, 38%) Citric Acid 1.2% Phase E Water 10.0% Polyquaternium-7 (Merquat 550, Nalco) 0.4% Preservative q.s -
-
Phase A Composition from example 1 3.5% Isopropyl Myristate (TEGOSOFT ® M, 0.2% Evonik) Perfume 0.1% Phase B Water ad 100.0% Phase C Sodium Lauryl Suifate (Texapon LS 35, 28.0% BASF, 30%) Phase D Cocamidopropyl Betaine (TEGO ® Betain F 9.0% 50, Evonik, 38%) Phase E Cocamide MEA (REWOMID ® C 212, Evonik) 2.0% Xanthan Gum (Keitrol CG-SFT, CP Kelco) 0.3% Water 10.0% Phase F Water 10.0% Polyquaternium-10 (Polymer JR 400, 0.2% Amerchol) Phase G Citric Acid ad pH 5.0 Phase H Preservative q.s. -
-
Recipes 47a 47b Water ad ad 100.0% 100.0% Composition from example 1 2.5% 2.5% Composition from example 3 1.5% 1.5% Cocamidopropyl Betaine (TEGO ® Betain F 50, Evonik, 38%) 22.0% 22.0% Lauryl Glucoside (Plantacare 1200 UP, BASF, 50%) 6.0% 6.0% Sodium Cocoyl Glutamate (Plantapon ACG HC, BASF) 1.5% 1.5% Sodium Cocoyl Glycinate (Hostapon SG, Clariant) 0.8% 0.8% Zinc Pyrithione (Microcare ZP, Thor) 0.1% 0.1% PEG-120 Methyl Glucose Dioleate (ANTIL ® 120 Plus, Evonik) 0.4% 0.4% Sodium Chloride 0.5% 0.5% Isostearamide MIPA; Glyceryl Laurate (ANTIL ® SPA 80, Evonik) 0.5% 0.5% Xanthan Gum (Keltrol CG-SFT, CP Kelco) 0.3% 0.3% Hydroxypropyl Guar Hydroxypropyltrimonium Chloride (Jaguar 0.3% 0.3% C-162, Solvay Rhodia) Quaternium-80 (ABIL ® Quat 3272, Evonik) 0.4% 0.4% Palmitamidopropyltrimonium Chloride (VARISOFT ® PATC, 0.4% 0.4% Evonik) Argania spinosa oil (Argan Oil, DSM Nutritional Products Ltd.) 0.1% 0.1% Glycerin (Glycerol EP, vegetable, Spiga Nord) 0.6% 0.6% Tetrasodium EDTA (Versene 100, The Dow Chemical 0.1% 0.1% Company) Caffeine (Merck KGaA/EMD Chemicals, Inc.) 0.1% 0.1% Hydrolyzed Wheat Protein (Gluadin WLM, BASF) 0.1% 0.1% Limonene (Dipentene No. 122, Hercules Inc.) 0.1% 0.1% Citric Acid ad pH 5.5 ad pH 5.5 Sodium Phytate; Aqua; Alcohol (dermofeel ® PA-3; Evonik Dr. 0.1% Straetmans GmbH (PA-3) Perfume 0.2% Preservative q.s. Aqua; Sodium Levulinate; Sodium Benzoate (Verstatil ® BL non- 1.2% GMO; Evonik Dr. Straetmans GmbH) -
-
Water ad 100% Glycerin (Glycerol EP, vegetable, Spiga Nord) 4.0% Alcohol 4.0% Sodium Coco-Sulfate (Texapon HC G, BASF) 3.0% Lauryl Glucoside (Plantacare 1200 UP, BASF, 50%) 6.0% Composition from example 1 3.0% Xanthan Gum (Keltrol CG-SFT, CP Kelco) 1.5% Mangifera Indica (mango) Fruit Extract (Mango Extract, Draco 0.5% Natural Products) Limonene (Dipentene No. 122, Hercules Inc.) 0.1% Linalool (Lipofresh, Lipo Chemicals, Inc.) 0.1% Citric Acid ad pH 4.9 Preservative q.s. Dyes q.s. -
-
Wafer ad 100% Propylene Glycol (Euxyl K 320, Schülke & Mayr GmbH) 2.0% Coco-Glucoside (Plantacare 818 UP, BASF, 51%) 10.0% Glycerin (Glycerol EP, vegetable, Spiga Nord) 5.0% Composition from example 1 2.5% Disodium Cocoyl Glutamate (Planatpon ACG LC, BASF) 2.5% Xanthan Gum (Keltrol CG-SFT, CP Kelco) 1.2% Stearic Acid (Pristerene 4922, Croda Europe, Ltd.) 1.2% Citric Acid ad pH 5.5 Olea Europaea Fruit Oil (Cropure Olive, Croda Europe, Ltd.) 0.2% Glyceryl Oleate (TEGIN ® O V, Evonik) 1.0% Sodium Cocoyl Glutamate (Plantapon ACG HC, BASF) 0.8% Tetrasodium EDTA (Versene 100, The Dow Chemical 0.2% Company) Perfume 0.1% Preservative q.s. Dyes q.s. -
-
Water to 100.0% Glycine Soja Oil (Cropure Soybean, Croda Europe, Ltd.) 20.0% Composition from example 1 12.0% Polyglyceryl-3 Palmitate (Dermofeel ® PP, Evonik Dr. 4.5% Straetmans) Glyceryl Caprylate (Dermosoft ® GMCY, Evonik Dr. Straetmans) 3.0% Simmondsia Chinensis Seed Oil (AEC Jojoba Oil Refined, A & E 1.2% Connock, Perfumery & Cosmetics Ltd.) Primus Amygdalus Duicis (sweet almond) Oil (Cropure Almond, 1.0% Croda Europe, Ltd.) Triticum Vulgare Germ Oil (Cropure Wheatgerm, Croda Europe, 0.5% Ltd.) Tocopherol (Euxyl K 700, Schülke & Mayr GmbH) 0.2% Limonene (Dipentene No. 122, Hercules Inc.) 0.1% Citral 0.1% Preservative q.s. Dyes q.s. - Formulation 51: Micellar Water for Makeup Removal
-
Water ad 100.0% Perfume 0.1% Composition from example 1 2.0% Capryl/Capramidopropyl Betaine (TEGO ® Betain 810, Evonik, 1.3% 38%) Polyglyceryl-6 Caprylate; Polyglyceryl-3 Cocoate; Polyglyceryl-4 1.0% Caprate; Polyglyceryl-6 Ricinoleate (TEGO ® Solve 61, Evonik) Betaine (TEGO ® Natural Betaine, Evonik) 2.0% Glycerin (Glycerol EP, vegetable, Spiga Nord) 1.0% Preservative q.s -
-
Recipe 52a 52b Composition from example 1 3.5% 3.5% Aloe Barbadensis Leaf Extract (Aloe-Con UP 40, Florida Food 0.2% 0.2% Products Inc.) Isopropyl Myristate (TEGOSOFT ® M, Evonik) 0.2% 0.2% Disodium Cocoamphodiacetate (REWOTERIC ® AM 2 C NM, 1.5% 1.5% Evonik, 39%) Perfume 0.2% 0.2% Propylene Glycol (Euxyl K 320, Schülke & Mayr GmbH) 2.5% 2.5% Hydrolyzed Silk (Crosilk 10000, Croda Inc.) 0.2% 0.2% Caprylyl/Capryl Glucoside (Plantacare 810 UP, BASF) 1.0% 1.0% Water ad ad 100.0% 100.0% Citric Acid ad pH 5.0 ad pH 5.0 Phenoxyethanol (S&M Phenoxyethanol, Schülke & Mayr GmbH) 0.5% 0.5% Dehydroacetic Acid (Unisept DHA (Universal Preserv-A-Chem, 0.1% 0.1% Inc.) Sodium Benzoate (Euxyl K 712, Schülke & Mayr GmbH) 0.4% 0.4% Salicylic Acid (salicylic acid nat.; Evonik Dr. Straetmans GmbH) 0.5% -
-
Phase A Composition from example 1 4.0% Dicaprylyl Ether (Cetiol OE, BASF) 0.3% Geraniol (Nerol 800, International Flavors & 0.1% Fragrances Inc.) Linalool (Lipofresh, Lipo Chemicals, Inc.) 0.1% Perfume 0.1% Phase B Propylene Glycol (Euxyl K 320, Schülke & Mayr 1.0% GmbH) Butylene Glycol (Oxea Corparation) 0.2% Water 5.0% Palmitamidopropyltrimonium Chloride 1.0% (VARISOFT ® PATC, Evonik) Phase C Water 50.0% Hydroxethyl ethylcellulose (Structure Cel 4400 E, 0.8% AkzoNobel) Sodium Hydroxide (10% in water) 0.3% Phase D Aluminium Chiorohydrate (Locron L, Cladant) 15.0% Phase E Preservative q.s. Water ad 100.0% -
-
Composition from example 1 0.4% Glycolipids (Rheance One, Evonik) 0.2% Flavour 0.2% Water ad 100.0% Sorbitol (Karion FP Liquid, Merck) 3.0% Preservative q.s. Dyes q.s. -
-
A Sorbitol (Karion FP Liquid, Merck) 50.0% Water ad 100.0% Sodium carboxymethyl cellulose (Blanose 1.2% 7MXF, Ashland) B Sodium Saccharin (Sigma Aldrich) 0.1% Sodium Fluoride (Sigma Aldrich) 0.1% C Titanium Dioxide (Caesar & Loretz) 0.4% Hydrated Silica (Zeodent ® 113, Evonik) 14.0% Hydrated Silica (Zeodent ® 165, Evonik) 8.0% D Flavour oil 1.0% E Glyceryl Caprylate (dermosoft ® GMCY, Evonik) 0.3% Composition from example 1 3.5%
Claims (20)
1. A process for enzymatic preparation of a sorbitol carboxylate, comprising:
A) blending sorbitol and at least one acyl group donor, within a temperature range of 80° C. to 120° C., for at least 10 minutes.
B) reacting the sorbitol with the at least one acyl group donor in the presence of a lipase at a temperature of 75° C. to 110° C., to give a sorbitol carboxylate, and
C) optionally, purifying the sorbitol carboxylate.
2. The process according to claim 1 , wherein the at least one acyl group donor provided in A) provides acyl groups that derive from a carboxylic acid containing 2 to 34 carbon atoms or a mixture thereof.
3. The process according to claim 1 , wherein the sorbitol and the at least one acyl group donor make up at least 80% by weight, based on an overall reaction mixture at the start of B).
4. The process according to claim 1 , wherein in B), a water content based on an overall reaction mixture is less than 15% by weight.
5. The process according to claim 1 , wherein the lipase is selected from the group consisting of a lipase from Thermomyces lanuginosus, a lipase A or B from Candida antarctica, a lipase from Mucor miehei, a lipase from Humicola sp., a lipase from Rhizomucor javanicus, a lipase from Rhizopus oryzae, a lipase from Candida rugosa, a lipase from Rhizopus niveus, a lipase from Penicillium camemberti, a lipase from Aspergillus niger, a lipase from Penicillium cyclopium, and a respective at least 60% homologue thereof at an amino acid level.
6. The process according to claim 1 , wherein B) is conducted at a pressure of less than 1 bar.
7. The process according to claim 1 , wherein B) is ended no later than 180 hours after the lipase has been added.
8. The process according to claim 1 , wherein a molar ratio of the sorbitol provided to all acyl groups present in the at least one acyl group donor provided is within a range from 1.00:0.50 to 1.00:5.00.
9. A sorbitol carboxylate obtainable by the process according to claim 1 .
10. The sorbitol carboxylate according to claim 9 , containing:
at least one carboxylic ester of sorbitol, and
at least one of a carboxylic ester of 1,4-anhydrosorbitol, a carboxylic ester of 2,5-anhydrosorbitol, a carboxylic ester of 1,5-anhydrosorbitol, and a carboxylic ester of isosorbide,
where a ratio by weight of sorbitol residues present in the sorbitol carboxylate to a sum total of all 1,4-anhydrosorbitol residues, 2,5-anhydrosorbitol residues, 1,5-anhydrosorbitol residues, and isosorbide residues present in the sorbitol carboxylate is greater than 90:10,
wherein a molar ratio of esterified primary hydroxyl groups to esterified secondary hydroxyl groups in the at least one carboxylic ester of sorbitol is 80:20 to 20:80.
11. The sorbitol carboxylate according to claim 9 , wherein an average degree of esterification of the at least one carboxylic ester of sorbitol present is from 0.3 to 4.0.
12. The sorbitol carboxylate according to claim 9 , wherein the sorbitol carboxylate contains 0.05% to 40% by weigh of free sorbitol.
13. The sorbitol carboxylate according to claim 9 , wherein the sorbitol carboxylate contains less than 25% by weight of at least one free carboxylic acid.
14. The sorbitol carboxylate according to claim 9 , wherein a total monoester content of the at least one carboxylic ester of sorbitol contains from 5% by weight to 25% by weight of secondary ester regioisomers.
15. The sorbitol carboxylate according to claim 9 , wherein the sorbitol carboxylate is a viscosity regulator, a care active ingredient, a foam booster or solubilizer, an antimicrobial, an antistat, a binder, a corrosion inhibitor, a dispersant, an emulsifier, a film former, a humectant, an opacifier, an oral care agent, a preservative, a skincare agent, a hydrophilic emollient, a foam stabilizer, or a nonionic surfactant.
16. The process according to claim 1 , wherein the at least one acyl group donor is selected from the group consisting of a fatty acid ester and a fatty acid.
17. The process according to claim 1 , wherein in B), the reacting is at a temperature of 80° C. to 95° C.
18. The process according to claim 1 , wherein in A), the blending is at a temperature range of 100° C. to 120° C., for at least 60 minutes.
19. The process according to claim 2 , wherein the at least one acyl group donor is a natural fatty acid or a mixture thereof.
20. The process according to claim 3 , wherein the sorbitol and the at least one acyl group donor make up at least 95% by weight, based on the overall reaction mixture at the start of B).
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP19218421.6A EP3839052A1 (en) | 2019-12-20 | 2019-12-20 | Method for the enzymatic preparation of sugar esters and / or sugar alcohol esters |
EP19218421.6 | 2019-12-20 | ||
PCT/EP2020/086739 WO2021122973A1 (en) | 2019-12-20 | 2020-12-17 | Sorbitan esters and process for enzymatically preparing same |
Publications (1)
Publication Number | Publication Date |
---|---|
US20230023141A1 true US20230023141A1 (en) | 2023-01-26 |
Family
ID=69411058
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US17/757,711 Pending US20230033620A1 (en) | 2019-12-20 | 2020-12-17 | Carboxylic acid esters of xylitol and process for enzymatically preparing same |
US17/757,528 Pending US20230023141A1 (en) | 2019-12-20 | 2020-12-17 | Sorbitan esters and process for enzymatically preparing same |
US17/757,576 Pending US20230055814A1 (en) | 2019-12-20 | 2020-12-17 | Process for enzymatically preparing sugar esters and/or sugar alcohol esters |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US17/757,711 Pending US20230033620A1 (en) | 2019-12-20 | 2020-12-17 | Carboxylic acid esters of xylitol and process for enzymatically preparing same |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US17/757,576 Pending US20230055814A1 (en) | 2019-12-20 | 2020-12-17 | Process for enzymatically preparing sugar esters and/or sugar alcohol esters |
Country Status (6)
Country | Link |
---|---|
US (3) | US20230033620A1 (en) |
EP (4) | EP3839052A1 (en) |
JP (3) | JP2023507450A (en) |
CN (3) | CN114787118A (en) |
BR (3) | BR112022011988A2 (en) |
WO (3) | WO2021122971A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP4355739A1 (en) | 2021-06-18 | 2024-04-24 | Evonik Operations GmbH | Compositions comprising n-nonanoic acid esters of xylitan and/or sorbitan |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB947830A (en) * | 1961-06-20 | 1964-01-29 | Ledoga Spa | Esters of fatty acids with xylite |
GB1016885A (en) * | 1962-10-16 | 1966-01-12 | Ledoga Spa | Xylitol esters |
BE623684A (en) * | 1962-10-19 | |||
GB1025028A (en) * | 1962-12-28 | 1966-04-06 | Ledoga Spa | Xylitol esters |
JPS58116688A (en) * | 1981-12-28 | 1983-07-11 | Asahi Denka Kogyo Kk | Ester-exchange reaction of oil and fat |
US4614718A (en) | 1983-08-23 | 1986-09-30 | Dai-Ichio Kogyo Seiyaku Co., Ltd. | Synthesis of sugar or sugar-alcohol fatty acid esters |
JPH0665309B2 (en) | 1986-11-26 | 1994-08-24 | 花王株式会社 | Esterification method |
EP0413307A1 (en) * | 1989-08-15 | 1991-02-20 | Lion Corporation | Process for producing saccharide fatty acid monoesters |
DK144292D0 (en) | 1992-12-01 | 1992-12-01 | Novo Nordisk As | IMPROVED PROCEDURE |
US5635614A (en) * | 1995-06-09 | 1997-06-03 | National Research Council Of Canada | Sugar/sugar alcohol esters |
GB0409066D0 (en) | 2004-04-23 | 2004-05-26 | Ici Plc | Surfactant composition |
CN101278047B (en) | 2005-09-30 | 2012-12-12 | 诺维信公司 | Immobilization of enzymes |
DE102009001748A1 (en) | 2009-03-23 | 2010-09-30 | Evonik Goldschmidt Gmbh | Formulations containing sorbitan carboxylic acid ester |
KR101452769B1 (en) * | 2012-09-25 | 2014-10-21 | 지준홍 | Cosmetic compositions comprising xylitol fatty acid ester with continuous cooling effect |
KR101939851B1 (en) | 2013-10-01 | 2019-01-17 | 켐유니온 키미카 엘티디에이 | Compositions containing xylityl esters with antimicrobial, co-emulsifier and thickener properties for cosmetic, pharmaceutical and veterinarian application |
KR20150057589A (en) * | 2013-11-20 | 2015-05-28 | 지준홍 | Antiseptic compositions comprising xylitol fatty acid ester |
CN105754982B (en) * | 2014-12-15 | 2021-12-07 | 丰益(上海)生物技术研发中心有限公司 | Immobilized lipase and method for producing immobilized lipase |
KR101823324B1 (en) * | 2016-07-12 | 2018-03-14 | 주식회사 일신웰스 | Method for sugar fatty acid ester |
-
2019
- 2019-12-20 EP EP19218421.6A patent/EP3839052A1/en not_active Withdrawn
-
2020
- 2020-12-17 JP JP2022537641A patent/JP2023507450A/en active Pending
- 2020-12-17 WO PCT/EP2020/086736 patent/WO2021122971A1/en unknown
- 2020-12-17 JP JP2022537633A patent/JP2023507446A/en active Pending
- 2020-12-17 CN CN202080086956.1A patent/CN114787118A/en active Pending
- 2020-12-17 US US17/757,711 patent/US20230033620A1/en active Pending
- 2020-12-17 JP JP2022537637A patent/JP2023507448A/en active Pending
- 2020-12-17 BR BR112022011988A patent/BR112022011988A2/en unknown
- 2020-12-17 CN CN202080086950.4A patent/CN114787368A/en active Pending
- 2020-12-17 EP EP20833826.9A patent/EP4077698A1/en active Pending
- 2020-12-17 BR BR112022011453A patent/BR112022011453A2/en unknown
- 2020-12-17 WO PCT/EP2020/086739 patent/WO2021122973A1/en unknown
- 2020-12-17 EP EP20833824.4A patent/EP4077696A1/en active Pending
- 2020-12-17 US US17/757,528 patent/US20230023141A1/en active Pending
- 2020-12-17 WO PCT/EP2020/086737 patent/WO2021122972A1/en unknown
- 2020-12-17 CN CN202080086984.3A patent/CN114829617A/en active Pending
- 2020-12-17 BR BR112022011457A patent/BR112022011457A2/en unknown
- 2020-12-17 US US17/757,576 patent/US20230055814A1/en active Pending
- 2020-12-17 EP EP20833825.1A patent/EP4077697A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
CN114787368A (en) | 2022-07-22 |
EP4077698A1 (en) | 2022-10-26 |
JP2023507450A (en) | 2023-02-22 |
BR112022011457A2 (en) | 2022-08-23 |
WO2021122972A1 (en) | 2021-06-24 |
US20230055814A1 (en) | 2023-02-23 |
WO2021122973A1 (en) | 2021-06-24 |
EP4077696A1 (en) | 2022-10-26 |
BR112022011988A2 (en) | 2022-08-30 |
CN114829617A (en) | 2022-07-29 |
WO2021122971A1 (en) | 2021-06-24 |
EP3839052A1 (en) | 2021-06-23 |
EP4077697A1 (en) | 2022-10-26 |
JP2023507446A (en) | 2023-02-22 |
US20230033620A1 (en) | 2023-02-02 |
CN114787118A (en) | 2022-07-22 |
JP2023507448A (en) | 2023-02-22 |
BR112022011453A2 (en) | 2022-08-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2983792B1 (en) | Novel oil-in-water emulsions with a high aqueous phase content, liquid consistencies and storage stability | |
US20150190326A1 (en) | Cosmetic compositions | |
EP3073989A1 (en) | Novel emulsifying composition with cationic nature | |
FR3003862A1 (en) | NOVEL POLYOL-GLYCOSIDE COMPOSITION | |
WO2022122132A1 (en) | Compositions comprising natural polymers and one or more (bio)-alkanediols | |
EP3073988A1 (en) | Composition of alkyl polyglucosides and fatty esters of cationic amino acids | |
KR20230117400A (en) | Compositions containing antimicrobial agents and (bio)-alkanediol for skin protection | |
CN116634990A (en) | Compositions comprising one or more (bio) -alkanediols with active ingredients | |
US20230023141A1 (en) | Sorbitan esters and process for enzymatically preparing same | |
JP2019514954A (en) | Method for improving the moisturizing state of human skin epidermis in a short period of time; Novel moisturizing composition | |
WO2022122133A1 (en) | Compositions comprising uv-filters and one or more (bio)-alkanediols | |
EP3723719B1 (en) | New glyceryl polyrhamnosides, process for the preparation thereof, and cosmetic and/or pharmaceutical composition comprising same | |
EP3723720B1 (en) | New polyol polyrhamnosides, process for the preparation thereof, and cosmetic and/or pharmaceutical composition comprising same | |
WO2019115911A1 (en) | New alkyl polyrhamnosides, process for the preparation thereof, and cosmetic and/or pharmaceutical composition comprising same | |
FR3069774A1 (en) | NOVEL SURFACTANT COMPOSITION, PROCESS FOR PREPARING THE SAME, AND USE AS EMULSIFIER FOR PREPARING TOPICAL OIL-IN-WATER EMULSIONS | |
US20230293403A1 (en) | Compositions Comprising Lipophilic Compounds and One or More (Bio)-Alkanediols | |
EP3773436A1 (en) | Use of sorbityl polyrhamnosides as human skin lightening agents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: EVONIK OPERATIONS GMBH, GERMANY Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:VON HOF, JAN MARIAN;LIEBIG, STEFAN JULIAN;THOMALLA, THOMAS;AND OTHERS;SIGNING DATES FROM 20220223 TO 20220309;REEL/FRAME:060230/0445 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |